# body_systems

code: 1.00
title: Musculoskeletal Disorders
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
intro_text:
  ﻿


      
      
      
      
      

      
      

      
      

      
      

      
      1.00 Musculoskeletal Disorders - Adult

      
      

      
      


      
          table{
          border-collapse:collapse;
          border:1px solid gray;
          }

              table td {
                  border: 1px solid gray;
              }
      


  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(


code: 2.00
title: Special Senses and Speech
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm
intro_text:
  ﻿















   

  2.00-Special Senses and Speech-Adult
   







  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){windo


code: 3.00
title: Respiratory Disorders
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm
intro_text:
  ﻿















   

  3.00-Respiratory-Adult
   







  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onload


code: 4.00
title: Cardiovascular System
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm
intro_text:
  ﻿















   

  4.00-Cardiovascular-Adult
   







  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onl


code: 5.00
title: Digestive System
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/5.00-Digestive-Adult.htm
intro_text:
  ﻿















   

  5.00 - Digestive - Adult | Disability | SSA
   







  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e


code: 6.00
title: Genitourinary Disorders
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/6.00-Genitourinary-Adult.htm
intro_text:
  ﻿















   

  6.00-Genitourinary-Adult
   







  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onlo


code: 8.00
title: Skin Disorders
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/8.00-Skin-Adult.htm
intro_text:
  ﻿















   

  8.00-Skin-Adult
   







  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onload=e&&e.t


code: 9.00
title: Endocrine Disorders
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/9.00-Endocrine-Adult.htm
intro_text:
  ﻿















   

  9.00-Endocrine-Adult
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onlo


code: 10.00
title: Congenital Disorders That Affect Multiple Body Systems
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/10.00-MultipleBody-Adult.htm
intro_text:
  ﻿















   

  10.00 Multiple Body Systems-Adult
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){wind


code: 11.00
title: Neurological Disorders
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
intro_text:
  ﻿















   

  11.00-Neurological-Adult
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_


code: 12.00
title: Mental Disorders
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
intro_text:
  ﻿















   

  12.00-Mental Disorders-Adult
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BO


code: 13.00
title: Cancer (Malignant Neoplastic Diseases)
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
intro_text:
  ﻿















   

  13.00-Malignant Neoplastic Diseases-Adult
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a


code: 14.00
title: Immune System Disorders
population: adult
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
intro_text:
  ﻿















   

  14.00-Immune-Adult
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onload


code: 100.00
title: Low Birth Weight and Failure to Thrive (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm
intro_text:
  ﻿















   

  100.00 Growth Impairment-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){win


code: 101.00
title: Musculoskeletal Disorders (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
intro_text:
  ﻿















   

  101.00-Musculoskeletal-Childhood
   
      






      table {
          border-collapse: collapse;
          border: 1px solid gray;
      }

      table td {
          border: 1px solid gray;
      }



  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.


code: 102.00
title: Special Senses and Speech (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm
intro_text:
  ﻿















   

  102.00-SpecialSensesandSpeech-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e


code: 103.00
title: Respiratory Disorders (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm
intro_text:
  ﻿















   

  103.00-Respiratory-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"SJ-9236081c-a9e7-4aad-92cd-52241826be28","rua.cook":"true","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boo


code: 104.00
title: Cardiovascular System (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm
intro_text:
  ﻿















   

  104.00-Cardiovascular-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"SJ-fb35639b-8c6b-4871-adb0-bd1653e1d5a2","rua.cook":"true","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._


code: 105.00
title: Digestive System (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm
intro_text:
  ﻿















   

  105.00 Digestive Disorders - Childhood | Disability | SSA
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.cl


code: 106.00
title: Genitourinary Disorders (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm
intro_text:
  ﻿















   

  106.00-Genitourinary-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.


code: 108.00
title: Skin Disorders (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm
intro_text:
  ﻿















   

  108.00 Skin Disorders - Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){wind


code: 109.00
title: Endocrine Disorders (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/109.00-Endocrine-Childhood.htm
intro_text:
  ﻿















   

  109.00-Endocrine-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"true","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"SJ-7df0ab89-cccc-48b3-b5ba-b6be9b3ce660","rua.cook":"false","rua.ims":"true","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl


code: 110.00
title: Congenital Disorders (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/110.00-MultipleBody-Childhood.htm
intro_text:
  ﻿















   

  110.00-MultipleBody-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.B


code: 111.00
title: Neurological Disorders (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
intro_text:
  ﻿















   

  111.00-Neurological-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"SJ-cd14c0ac-a165-43c5-9a6b-5768dfb5f188","rua.cook":"true","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._bo


code: 112.00
title: Mental Disorders (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
intro_text:
  ﻿















   

  112.00-MentalDisorders-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){windo


code: 113.00
title: Cancer (Children)
population: child
intro_text:
  ﻿















   

  113.00-MalignantNeoplasticDiseases-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}functio

source_url:
  https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm


code: 114.00
title: Immune System Disorders (Children)
population: child
source_url: https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm
intro_text:
  ﻿















   

  114.00-Immune-Childhood
   
      






  (window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"SJ-703ff721-b35a-4c38-8111-148449ca375a","rua.cook":"true","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);
                                !function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);


# listings

code: 1.15
title: Disorders of the skeletal spine resulting in compromise of a nerve root(s)
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
summary:
  1.15  Disorders of the skeletal spine resulting in compromise of a nerve root(s) 
                              (see  1.00F ), documented by A, B, C,  and  D:…

raw_text:
  1.15  Disorders of the skeletal spine resulting in compromise of a nerve root(s) 
                              (see  1.00F ), documented by A, B, C,  and  D:
                           


                           


                               A.  Neuro-anatomic (radicular) distribution of one or more of the following  symptoms  
                              consistent with compromise of the affected nerve root(s):
                           


                           


                               1. Pain; or
                           


                           


                               2. Paresthesia; or
                           


                           


                               3. Muscle fatigue.
                           


                           

  AND 


                           


                               B.  Radicular distribution of neurological  signs  present during physical examination
                              (see  1.00C2 ) or on a diagnostic test
                              (see  1.00C3 ) and evidenced by 1, 2, and either 3 or 4:
                           


                           


                               1. Muscle weakness; and
                           


                           


                               2. Sign(s) of nerve root irritation, tension, or compression, consistent with compromise of the affected nerve root
                              (see  1.00F2 ); and
                           


                           


                               3. Sensory changes evidenced by:
                           


                           


                               a. Decreased sensation; or
                           


                           


                               b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing;  or 
                           


                           


                               4. Decreased deep tendon reflexes.
                           


                           

  AND 


                           


                               C.  Findings on imaging
                              (see  1.00C3 ) consistent with compromise of a nerve root(s) in the cervical or lumbosacral spine.
                           


                           

  AND 


                           


                               D.  Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                              or is expected to last, for a continuous period of at least 12 months, 
                              and medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need
                              (see  1.00C6a ) for a walker, bilateral canes, or bilateral crutches
                              (see  1.00C6d ) or a wheeled and seated mobility device involving the use of both hands
                              (see  1.00C6e(i) ); or
                           


                           


                               2. An inability to use  one  upper extremity to independently initiate, sustain, 
                              and complete work-related activities involving fine and gross movements
                              (see  1.00E4 ),  and  a documented medical need
                              (see  1.00C6a ) for a one-handed,
                              hand-held assistive device (see  1.00C6d )
                              that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                              (see  1.00C6e(ii) ); or
                           


                           


                               3. An inability to use  both  upper extremities to the extent that neither can be used to independently initiate, sustain, 
                              and complete work-related activities involving fine and gross movements (see  1.00E4 ).


code: 1.16
title: Lumbar spinal stenosis resulting in compromise of the cauda equina
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
summary:
  1.16
                                   
                                      Lumbar spinal stenosis resulting in compromise of the cauda equina
                                   
                               (see  1.00G ), documented by A, B,…

raw_text:
  1.16
                                   
                                      Lumbar spinal stenosis resulting in compromise of the cauda equina
                                   
                               (see  1.00G ), documented by A, B, C,  and  D:
                           


                           


                               A.  Symptom(s) of neurological compromise manifested as:
                           


                           


                               1. Nonradicular distribution of pain in one or both lower extremities; or
                           


                           


                               2. Nonradicular distribution of sensory loss in one or both lower extremities; or
                           


                           


                               3. Neurogenic claudication.
                           


                           

  AND 


                           


                               B.  Nonradicular neurological signs present during physical examination
                              (see  1.00C2 ) or on a diagnostic test
                              (see  1.00C3 ) and evidenced by 1 and either 2 or 3:
                           


                           


                               1. Muscle weakness.
                           


                           


                               2. Sensory changes evidenced by:
                           


                           


                               a. Decreased sensation; or
                           


                           


                               b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing; or
                           


                           


                               c. Areflexia, trophic ulceration, or bladder or bowel incontinence.
                           


                           


                               3. Decreased deep tendon reflexes in one or both lower extremities.
                           


                           

  AND 


                           


                               C.  Findings on imaging (see  1.00C3 ) or in an operative report
                              (see  1.00C4 ) consistent with compromise of the cauda equina with lumbar spinal stenosis.
                           


                           

  AND 


                           


                               D.  Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                              or is expected to last, for a continuous period of at least 12 months, 
                              and medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need (see  1.00C6a ) for a walker,
                              bilateral canes, or bilateral crutches
                              (see  1.00C6d ) or a wheeled and seated mobility device involving the use of both hands
                              (see  1.00C6e(i) ); or
                           


                           


                               2. An inability to use  one  upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                              (see  1.00E4 ),  and  a documented medical need
                              (see  1.00C6a ) for a one-handed, hand-held assistive device
                              (see  1.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                              (see  1.00C6e(ii) ).


code: 1.17
title: Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
summary:
  1.17
                                   
                                      Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint
                                   
                               (see  1.00H ), document…

raw_text:
  1.17
                                   
                                      Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint
                                   
                               (see  1.00H ), documented by A, B,  and  C:
                           


                           


                               A.  History of reconstructive surgery or surgical arthrodesis of a major weight-bearing joint.
                           


                           

  AND 


                           


                               B.  Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months.
                           


                           

  AND 


                           


                               C.  A documented medical need (see  1.00C6a ) for a walker,
                              bilateral canes, or bilateral crutches
                              (see  1.00C6d ) or a wheeled and seated mobility device involving the use of both hands
                              (see  1.00C6e(i) ).


code: 1.18
title: Abnormality of a major joint(s) in any extremity
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
summary:
  1.18
                                   
                                      Abnormality of a major joint(s) in any extremity
                                   
                               (see  1.00I ), documented by A, B, C,  and  D:…

raw_text:
  1.18
                                   
                                      Abnormality of a major joint(s) in any extremity
                                   
                               (see  1.00I ), documented by A, B, C,  and  D:
                           


                           


                               A.  Chronic joint pain or stiffness.
                           


                           

  AND 


                           


                               B.  Abnormal motion, instability, or immobility of the affected joint(s).
                           


                           

  AND 


                           


                               C.  Anatomical abnormality of the affected joint(s) noted on:
                           


                           


                               1. Physical examination (for example, subluxation, contracture, or bony or fibrous ankylosis); or
                           


                           


                               2. Imaging (for example, joint space narrowing, bony destruction, or ankylosis or arthrodesis of the affected joint).
                           


                           

  AND 


                           


                               D.  Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                              or is expected to last, for a continuous period of at least 12 months, 
                              and medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need
                              (see  1.00C6a ) for a walker, bilateral canes, or bilateral crutches
                              (see  1.00C6d ) or a wheeled and seated mobility device involving the use of both hands
                              (see  1.00C6e(i) ); or
                           


                           


                               2. An inability to use  one  upper extremity to independently initiate, sustain, 
                              and complete work-related activities involving fine and gross movements
                              (see  1.00E4 ),
                               and  a documented medical need (see  1.00C6a ) for a one-handed,
                              hand-held assistive device
                              (see  1.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                              (see  1.00C6e(ii) ); or
                           


                           


                               3. An inability to use  both  upper extremities to the extent that neither can be used to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                              (see  1.00E4 ).


code: 1.19
title: Pathologic fractures due to any cause
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
summary:
  1.19
                                   
                                      Pathologic fractures due to any cause
                                   
                               (see  1.00J ), documented by A  and  B:…

raw_text:
  1.19
                                   
                                      Pathologic fractures due to any cause
                                   
                               (see  1.00J ), documented by A  and  B:
                           


                           


                               A.  Pathologic fractures occurring on three separate occasions within a 12-month period.
                           


                           

  AND 


                           


                               B.  Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                              or is expected to last, for a continuous period of at least 12 months, 
                              and medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need (see  1.00C6a ) for a walker,
                              bilateral canes, or bilateral crutches (see  1.00C6d )
                              or a wheeled and seated mobility device involving the use of both hands (see  1.00C6e(i) ); or
                           


                           


                               2. An inability to use  one  upper extremity to independently initiate, sustain, 
                              and complete work-related activities involving fine and gross movements
                              (see  1.00E4 ),
                               and  a documented medical need (see  1.00C6a ) for a one-handed,
                              hand-held assistive device (see  1.00C6d )
                              that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                              (see  1.00C6e(ii) ); or
                           


                           


                               3. An inability to use  both  upper extremities to the extent that neither can be used to independently initiate, 
                              sustain, and complete work-related activities involving fine and gross movements
                              (see  1.00E4 ).


code: 1.20
title: Amputation due to any cause
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
summary:
  1.20
                                   
                                      Amputation due to any cause
                                   
                               (see  1.00K ), documented by A, B, C,  or  D:…

raw_text:
  1.20
                                   
                                      Amputation due to any cause
                                   
                               (see  1.00K ), documented by A, B, C,  or  D:
                           


                           


                               A.  Amputation of both upper extremities, occurring at any level at or above the wrists (carpal joints), up to and including the shoulder (glenohumeral) joint.
                           


                           

  OR 


                           


                               B.  Hemipelvectomy or hip disarticulation.
                           


                           

  OR 


                           


                               C.  Amputation of one upper extremity, occurring at any level at or above the wrist (carpal joints), 
                              and amputation of one lower extremity, occurring at or above the ankle (talocrural joint), 
                               and  medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need (see  1.00C6a ) for a walker,
                              bilateral canes, or bilateral crutches (see  1.00C6d )
                              or a wheeled and seated mobility device involving the use of both hands
                              (see  1.00C6e(i) ); or
                           


                           


                               2. A documented medical need (see  1.00C6a ) for a one-handed,
                              hand-held assistive device (see  1.00C6d ) requiring the use of the other upper extremity
                              or a wheeled and seated mobility device involving the use of one hand
                              (see  1.00C6e(ii) ); or
                           


                           


                               3. The inability to use the remaining upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                              ( 1.00E4 ).
                           


                           

  OR 


                           


                               D.  Amputation of one or both lower extremities, occurring at or above the ankle (talocrural joint), 
                              with complications of the residual limb(s) that have lasted, or are expected to last, 
                              for a continuous period of at least 12 months,  and  medical documentation of 1 and 2:
                           


                           


                               1. The inability to use a prosthesis(es); and
                           


                           


                               2. A documented medical need (see  1.00C6a ) for a walker,
                              bilateral canes, or bilateral crutches (see  1.00C6d )
                              or a wheeled and seated mobility device involving the use of both hands (see  1.00C6e(i) ).


code: 1.21
title: Soft tissue injury or abnormality under continuing surgical management
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
summary:
  1.21
                                   
                                      Soft tissue injury or abnormality under continuing surgical management
                                   
                               (see  1.00L ), documented by A,…

raw_text:
  1.21
                                   
                                      Soft tissue injury or abnormality under continuing surgical management
                                   
                               (see  1.00L ), documented by A, B,  and  C:
                           


                           


                               A.  Evidence confirms continuing surgical management
                              (see  1.00O1 ) directed toward saving, reconstructing, or replacing the affected part of the body.
                           


                           

  AND 


                           


                               B.  The surgical management has been, or is expected to be, ongoing for a continuous period of at least 12 months.
                           


                           

  AND 


                           


                               C.  Maximum benefit from therapy (see  1.00O2 ) has not yet been achieved.


code: 1.22
title: Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
summary:
  1.22
                                   
                                      Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones
                                   
                               (s…

raw_text:
  1.22
                                   
                                      Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones
                                   
                               (see  1.00M ), documented by A, B,  and  C:
                           


                           


                               A.  Solid union not evident on imaging (see  1.00C3 ) and not clinically solid.
                           


                           

  AND 


                           


                               B.  Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months.
                           


                           

  AND 


                           


                               C.  A documented medical need (see  1.00C6a ) for a walker,
                              bilateral canes, or bilateral crutches (see  1.00C6d )
                              or a wheeled and seated mobility device involving the use of both hands (see  1.00C6e(i) ).


code: 1.23
title: Non-healing or complex fracture of an upper extremity
source_url: https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm
summary:
  1.23
                                   
                                      Non-healing or complex fracture of an upper extremity
                                   
                               (see  1.00N ), documented by A  and  B:…

raw_text:
  1.23
                                   
                                      Non-healing or complex fracture of an upper extremity
                                   
                               (see  1.00N ), documented by A  and  B:
                           


                           


                               A.  Nonunion or complex fracture of the shaft of the humerus, radius, or ulna, under continuing surgical management
                              (see  1.00O1)  directed toward restoration of functional use of the extremity.
                           


                           

  AND 


                           


                               B.  Medical documentation of an inability to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                              (see  1.00E4 ) that has lasted, or is expected to last, for a continuous period of at least 12 months.
                           


                          
                           

  Back to Top 



                       
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 2.02
title:
  Loss of
  Central visual acuity

source_url: https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm
summary:
  2.02   Loss of Central Visual Acuity.     Remaining vision in the better eye after best correction is 20/200 or less.

raw_text:
  2.02   Loss of Central Visual Acuity.     Remaining vision in the better eye after best correction is 20/200 or less.


code: 2.03
title: Contraction of the visual fields in the better eye
source_url: https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm
summary:
  2.03   Contraction of the visual field in the better eye,  with: 


                   


      A. The widest diameter subtending an angle around the point of fixation no greater than 20 degrees; 


      OR
   


                   

  B.  An MD of 22…

raw_text:
  2.03   Contraction of the visual field in the better eye,  with: 


                   


      A. The widest diameter subtending an angle around the point of fixation no greater than 20 degrees; 


      OR
   


                   

  B.  An MD of 22 decibels or greater, determined by automated static threshold perimetry that measures the central 30 degrees of the visual field (see  2.00A6d ). 


                   

  OR 


                   

  C.  A visual field efficiency of 20 percent or less,  determined by kinetic perimetry (see  2.00A7c ).


code: 2.04
title: Loss of visual efficiency
source_url: https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm
summary:
  2.04    Loss of  visual efficiency, or visual impairment, in the better eye: 


                   

  A. A visual  efficiency percentage of 20 or less after best correction (see  2.00A7d ). 


                   

  OR 


                   

  B. A…

raw_text:
  2.04    Loss of  visual efficiency, or visual impairment, in the better eye: 


                   

  A. A visual  efficiency percentage of 20 or less after best correction (see  2.00A7d ). 


                   

  OR 


                   

  B. A visual impairment value of 1.00 or greater after best correction (see  2.00A8d ).


code: 2.07
title: Disturbance of labyrinthine-vestibular function
source_url: https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm
summary:
  2.07  Disturbance of labyrinthine-vestibular function   (Including Ménière's disease), characterized by a history of frequent attacks of balance disturbance, tinnitus, and progressive loss of hearing.  With both A and B:…

raw_text:
  2.07  Disturbance of labyrinthine-vestibular function   (Including Ménière's disease), characterized by a history of frequent attacks of balance disturbance, tinnitus, and progressive loss of hearing.  With both A and B:  


                   

   A.   Disturbed function of vestibular labyrinth demonstrated by caloric or other vestibular tests; and  


                   

   B.   Hearing loss established by audiometry.


code: 2.09
title:
  Loss of
  speech

source_url: https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm
summary:
  2.09   Loss of speech   due to any cause, with inability to produce by any means speech that can be heard, understood, or sustained.

raw_text:
  2.09   Loss of speech   due to any cause, with inability to produce by any means speech that can be heard, understood, or sustained.


code: 2.10
title: Hearing loss not treated with cochlear implantation
source_url: https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm
summary:
  2.10   Hearing loss not treated with cochlear implantation.  


                   

   A.   An average air conduction hearing threshold of 90 decibels or greater in the better ear and an average bone conduction hearing threshold of 60 decibel…

raw_text:
  2.10   Hearing loss not treated with cochlear implantation.  


                   

   A.   An average air conduction hearing threshold of 90 decibels or greater in the better ear and an average bone conduction hearing threshold of 60 decibels or greater in the better ear (see  2.00B2c ).  


                   

   OR  


                   

   B.   A word recognition score of 40 percent or less in the better ear determined using a standardized list of phonetically balanced monosyllabic words (see  2.00B2e ).


code: 2.11
title: 2.11
source_url: https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm
summary:
  2.11   Hearing loss treated with cochlear implantation.  


                   

   A.   Consider under a disability for 1 year after initial implantation.  


                   

   OR  


                   

   B.   If more than 1 year after init…

raw_text:
  2.11   Hearing loss treated with cochlear implantation.  


                   

   A.   Consider under a disability for 1 year after initial implantation.  


                   

   OR  


                   

   B.   If more than 1 year after initial implantation, a word recognition score of 60 percent or less determined using the HINT (see  2.00B3b ). 


                   

  Back to Top 



    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 3.02
title: Chronic Respiratory Disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm
summary:
  3.02
                 Chronic respiratory disorders 
             due to any cause except CF (for CF, see  3.04 ) with A, B, C, or D:
   


         

  A.  FEV 1  (see  3.00E ) less than or equal to the value in Table I-A or I-B for your age, gender…

raw_text:
  3.02
                 Chronic respiratory disorders 
             due to any cause except CF (for CF, see  3.04 ) with A, B, C, or D:
   


         

  A.  FEV 1  (see  3.00E ) less than or equal to the value in Table I-A or I-B for your age, gender, 
            and height without shoes (see  3.00E3a ). 


         

  Table I: FEV 1  Criteria for 3.02A 


         
             


                 
                     

    


                     


                        Height 


                        without 


                        shoes 


                         (centimeters) 
                     


                     


                        <    means 


                         less than 
                     


                 
                 
                     

    


                     


                        Height 


                        without 


                        shoes 


                         (inches) 
                     


                     


                        <    means 


                         less than 
                     


                 
                 

  Table    I-A 


                 

  Table    I-B 


             


             


                 
                     


                         Age 18 


                         to attainment of age 20 
                     


                 
                 
                     


                         Age 20 


                         or older 
                     


                 
             


             


                 
                     


                         Females  


                        FEV 1 


                        less    than or equal to 


                        (L,    BTPS)
                     


                 
                 
                     


                         Males 


                        FEV 1 


                        less    than or equal to 


                        (L,    BTPS)
                     


                 
                 
                     


                         Females 


                        FEV 1 


                        less    than or equal to 


                        (L,    BTPS)
                     


                 
                 
                     


                         Males 


                        FEV 1 


                        less    than or equal to 


                        (L,    BTPS)
                     


                 
             


             


                 

  <153.0 


                 

  <60.25 


                 

  1.20 


                 

  1.45 


                 

  1.05 


                 

  1.20 


             


             


                 

  153.0    to <159.0 


                 

  60.25    to <62.50 


                 

  1.30 


                 

  1.55 


                 

  1.15 


                 

  1.35 


             


             


                 

  159.0    to <164.0 


                 

  62.50    to <64.50 


                 

  1.40 


                 

  1.65 


                 

  1.25 


                 

  1.40 


             


             


                 

  164.0    to <169.0 


                 

  64.50    to <66.50 


                 

  1.45 


                 

  1.75 


                 

  1.35 


                 

  1.50 


             


             


                 

  169.0    to <174.0 


                 

  66.50    to <68.50 


                 

  1.55 


                 

  1.85 


                 

  1.45 


                 

  1.60 


             


             


                 

  174.0    to <180.0 


                 

  68.50    to <70.75 


                 

  1.65 


                 

  2.00 


                 

  1.55 


                 

  1.75 


             


             


                 

  180.0    to <185.0 


                 

  70.75    to <72.75 


                 

  1.75 


                 

  2.10 


                 

  1.65 


                 

  1.85 


             


             


                 

  185.0    or more 


                 

  72.75    or more 


                 

  1.80 


                 

  2.15 


                 

  1.70 


                 

  1.90 


             


         
         

    


         

  OR 


         

  B.  FVC (see  3.00E ) less than or equal to the value in Table II-A or II-B for your age, gender, 
            and height without shoes (see  3.00E3a ). 


         

  Table II: FVC Criteria for 3.02B 


         
             


                 
                     

    


                     


                        Height 


                        without 


                        shoes 


                         (centimeters) 
                     


                     


                        <    means 


                         less than 
                     


                 
                 
                     

    


                     


                        Height 


                        without 


                        shoes 


                         (inches) 
                     


                     


                        <    means 


                         less than 
                     


                 
                 

  Table    II-A 


                 

  Table    II-B 


             


             


                 
                     


                         Age 18 


                         to attainment of age 20 
                     


                 
                 
                     


                         Age 20 


                         or older 
                     


                 
             


             


                 
                     


                         Females  


                        FVC 


                        less    than or equal to 


                        (L,    BTPS)
                     


                 
                 
                     


                         Males 


                        FVC 


                        less    than or equal to 


                        (L,    BTPS)
                     


                 
                 
                     


                         Females 


                        FVC 


                        less    than or equal to 


                        (L,    BTPS)
                     


                 
                 
                     


                         Males 


                        FVC 


                        less    than or equal to 


                        (L,    BTPS)
                     


                 
             


             


                 

  <153.0 


                 

  <60.25 


                 

  1.35 


                 

  1.65 


                 

  1.30 


                 

  1.50 


             


             


                 

  153.0    to <159.0 


                 

  60.25    to <62.50 


                 

  1.50 


                 

  1.80 


                 

  1.40 


                 

  1.65 


             


             


                 

  159.0    to <164.0 


                 

  62.50    to <64.50 


                 

  1.60 


                 

  1.90 


                 

  1.50 


                 

  1.75 


             


             


                 

  164.0    to <169.0 


                 

  64.50    to <66.50 


                 

  1.70 


                 

  2.05 


                 

  1.60 


                 

  1.90 


             


             


                 

  169.0    to <174.0 


                 

  66.50    to <68.50 


                 

  1.80 


                 

  2.20 


                 

  1.70 


                 

  2.00 


             


             


                 

  174.0    to <180.0 


                 

  68.50    to <70.75 


                 

  1.90 


                 

  2.35 


                 

  1.85 


                 

  2.20 


             


             


                 

  180.0    to <185.0 


                 

  70.75    to <72.75 


                 

  2.05 


                 

  2.50 


                 

  1.95 


                 

  2.30 


             


             


                 

  185.0    or more 


                 

  72.75    or more 


                 

  2.10 


                 

  2.60 


                 

  2.00 


                 

  2.40 


             


         
         

    


         

  OR 


         

  C.  Chronic impairment of gas exchange demonstrated by 1, 2, or 3:


code: 3.03
title: Asthma
source_url: https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm
summary:
  3.03
                     Asthma 
                 . (see  3.00I), with both A and B:
             


             

  A.  FEV 1  (see  3.00E1 ) less than or equal to the value in Table VI-A or VI-B for your age, gender, 
            and height without…

raw_text:
  3.03
                     Asthma 
                 . (see  3.00I), with both A and B:
             


             

  A.  FEV 1  (see  3.00E1 ) less than or equal to the value in Table VI-A or VI-B for your age, gender, 
            and height without shoes (see  3.00E3a ) measured within the same  12-month period as the hospitalizations in  3.03B . 


             

  Table VI: FEV 1  Criteria for 3.03A 


             
                 


                     
                         

    


                         


                            Height 


                            without 


                            shoes 


                             (centimeters) 


                            <    means 


                             less than 
                         


                     
                     
                         

    


                         


                            Height 


                            without 


                            shoes 


                             (inches) 
                         


                         


                            <    means 


                             less than 
                         


                     
                     

  Table    VI-A 


                     

  Table    VI-B 


                 


                 


                     
                         


                             Age 18 


                             to attainment of age 20 
                         


                     
                     
                         


                             Age 20 


                             or older 
                         


                     
                 


                 


                     
                         


                             Females  


                            FEV 1 


                            less    than or equal to 


                            (L,    BTPS)
                         


                     
                     
                         


                             Males 


                            FEV 1 


                            less    than or equal to 


                            (L,    BTPS)
                         


                     
                     
                         


                             Females 


                            FEV 1 


                            less    than or equal to 


                            (L,    BTPS)
                         


                     
                     
                         


                             Males 


                            FEV 1 


                            less    than or equal to 


                            (L,    BTPS)
                         


                     
                 


                 


                     

  <153.0 


                     

  <60.25 


                     

  1.65 


                     

  1.90 


                     

  1.45 


                     

  1.60 


                 


                 


                     

  153.0    to <159.0 


                     

  60.25    to <62.50 


                     

  1.75 


                     

  2.05 


                     

  1.55 


                     

  1.75 


                 


                 


                     

  159.0    to <164.0 


                     

  62.50    to <64.50 


                     

  1.85 


                     

  2.15 


                     

  1.65 


                     

  1.90 


                 


                 


                     

  164.0    to <169.0 


                     

  64.50    to <66.50 


                     

  1.95 


                     

  2.30 


                     

  1.75 


                     

  2.00 


                 


                 


                     

  169.0    to <174.0 


                     

  66.50    to <68.50 


                     

  2.05 


                     

  2.45 


                     

  1.85 


                     

  2.15 


                 


                 


                     

  174.0    to <180.0 


                     

  68.50    to <70.75 


                     

  2.20 


                     

  2.60 


                     

  2.00 


                     

  2.30 


                 


                 


                     

  180.0    to <185.0 


                     

  70.75    to <72.75 


                     

  2.35 


                     

  2.75 


                     

  2.10 


                     

  2.45 


                 


                 


                     

  185.0    or more 


                     

  72.75    or more 


                     

  2.40 


                     

  2.85 


                     

  2.20 


                     

  2.55 


                 


             
             

    


             

  AND 


             

  B.  Exacerbations or complications requiring three hospitalizations within a 12-month period and at least 30 days apart 
            (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review). Each hospitalization must last at least 48 hours, 
            including hours in a hospital emergency department immediately before the hospitalization. 
            Consider under a disability for 1 year from the discharge date of the last hospitalization; after that, evaluate the residual impairment(s) under  3.03  or another appropriate listing.


code: 3.04
title: Cystic Fibrosis
source_url: https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm
summary:
  3.04
                     Cystic fibrosis 
                 .  (documented  as described in 3.00J2) with A, B, C, D, E, F, or G:
             


             

  A.  FEV 1  (see  3.00E ) less than or equal to the value in Table VII-A or VII-B for  yo…

raw_text:
  3.04
                     Cystic fibrosis 
                 .  (documented  as described in 3.00J2) with A, B, C, D, E, F, or G:
             


             

  A.  FEV 1  (see  3.00E ) less than or equal to the value in Table VII-A or VII-B for  your age, gender, 
            and height without shoes (see  3.00E3a ). 


             

  Table VII: FEV 1  Criteria for 3.04A 


             
                 


                     
                         

    


                         


                            Height 


                            without 


                            shoes 


                             (centimeters) 
                         


                         


                            <    means 


                             less than 
                         


                     
                     
                         

    


                         


                            Height 


                            without 


                            shoes 


                             (inches) 
                         


                         


                            <    means 


                             less than 
                         


                     
                     

  Table    VII-A 


                     

  Table    VII-B 


                 


                 


                     
                         


                             Age 18 


                             to attainment of age 20 
                         


                     
                     
                         


                             Age 20 


                             or older 
                         


                     
                 


                 


                     
                         


                             Females  


                            FEV 1 


                            less    than or equal to 


                            (L,    BTPS)
                         


                     
                     
                         


                             Males 


                            FEV 1 


                            less    than or equal to 


                            (L,    BTPS)
                         


                     
                     
                         


                             Females 


                            FEV 1 


                            less    than or equal to 


                            (L,    BTPS)
                         


                     
                     
                         


                             Males 


                            FEV 1 


                            less    than or equal to 


                            (L,    BTPS)
                         


                     
                 


                 


                     

  <153.0 


                     

  <60.25 


                     

  1.65 


                     

  1.90 


                     

  1.45 


                     

  1.60 


                 


                 


                     

  153.0    to <159.0 


                     

  60.25    to <62.50 


                     

  1.75 


                     

  2.05 


                     

  1.55 


                     

  1.75 


                 


                 


                     

  159.0    to <164.0 


                     

  62.50    to <64.50 


                     

  1.85 


                     

  2.15 


                     

  1.65 


                     

  1.90 


                 


                 


                     

  164.0    to <169.0 


                     

  64.50    to <66.50 


                     

  1.95 


                     

  2.30 


                     

  1.75 


                     

  2.00 


                 


                 


                     

  169.0    to <174.0 


                     

  66.50    to <68.50 


                     

  2.05 


                     

  2.45 


                     

  1.85 


                     

  2.15 


                 


                 


                     

  174.0    to <180.0 


                     

  68.50    to <70.75 


                     

  2.20 


                     

  2.60 


                     

  2.00 


                     

  2.30 


                 


                 


                     

  180.0    to <185.0 


                     

  70.75    to <72.75 


                     

  2.35 


                     

  2.75 


                     

  2.10 


                     

  2.45 


                 


                 


                     

  185.0    or more 


                     

  72.75    or more 


                     

  2.40 


                     

  2.85 


                     

  2.20 


                     

  2.55 


                 


             
             


                 


                 OR 
             


             

  B.  Exacerbations or complications (see  3.00J3 ) requiring three hospitalizations of  any length within a 12-month period and at least 30 days apart (the 12-month  period must occur within the period we are considering in connection with your  application or continuing disability review).  


             

  OR 


             

  C.  Spontaneous pneumothorax, secondary to CF, requiring chest tube placement. 


             

  OR 


             

  D.  Respiratory failure (see  3.00N ) requiring invasive mechanical ventilation, 
            noninvasive ventilation with BiPAP, or a combination of both treatments, for a continuous period of at least 48 hours, or for a continuous period of at least 72 hours if postoperatively. 


             

  OR 


             

  E.  Pulmonary hemorrhage requiring vascular embolization to control bleeding. 


             

  OR 


             

  F.  SpO 2  measured by pulse oximetry (see  3.00H3 ) either at rest, during a 6MWT, or after a 6MWT, 
            less than or equal to the value in Table  VIII,  twice  within a 12-month period and at least 30 days apart 
            (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review). 


             

  Tables VIII: SpO 2   Criteria for 3.04F 


             


                 
                     


                         

  Test    site altitude (feet above sea level) 


                         

  SpO 2  less than or equal to 


                     


                     


                         

  Less than 3,000 


                         

  89 percent 


                     


                     


                         

  3,000 through 6,000 


                         

  87 percent 


                     


                     


                         

  Over 6,000 


                         

  85 percent 


                     


                 
             


             

    


             

  OR 


             

  G.  Two of the following exacerbations or complications 
            (either two of the same or two different, see  3.00J3  and  3.00J4 )
      within a 12-month period (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review):
   


             


                 

  Pulmonary exacerbation requiring 10 consecutive days of intravenous antibiotic treatment. 


                 

  Pulmonary hemorrhage (hemoptysis with more than blood-streaked sputum but not requiring vascular embolization) requiring hospitalization of any length. 


                 


                    Weight loss requiring daily supplemental enteral nutrition via a gastrostomy for at least 90 consecutive days  or  parenteral nutrition via a central venous catheter for at least 90 consecutive days.
                 


                 

  CFRD requiring daily insulin therapy for at least 90 consecutive days.


code: 3.07
title: Bronchiectasis
source_url: https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm
summary:
  3.07
                     Bronchiectasis 
                  (see  3.00K ), documented by imaging (see  3.00D3 ), 
                with exacerbations or complications requiring three hospitalizations within a 12-month period and at least 30 days a…

raw_text:
  3.07
                     Bronchiectasis 
                  (see  3.00K ), documented by imaging (see  3.00D3 ), 
                with exacerbations or complications requiring three hospitalizations within a 12-month period and at least 30 days apart 
                (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review). 
                Each hospitalization must last at least 48 hours, including hours in a hospital  emergency department immediately before the hospitalization.


code: 3.09
title: Chronic pulmonary hypertension due to any cause
source_url: https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm
summary:
  3.09  Chronic pulmonary hypertension due to any cause 
                 (see  3.00L ) documented by mean pulmonary artery pressure equal to or greater than 40 mm Hg as determined by cardiac catheterization while medically stable…

raw_text:
  3.09  Chronic pulmonary hypertension due to any cause 
                 (see  3.00L ) documented by mean pulmonary artery pressure equal to or greater than 40 mm Hg as determined by cardiac catheterization while medically stable 
                (see  3.00E2a ).


code: 3.11
title: Lung transplant
source_url: https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm
summary:
  3.11  Lung transplantation  (see  3.00M ).
      Consider under a disability for 3 years from the date of the transplant; after  that, evaluate the residual impairment(s).

raw_text:
  3.11  Lung transplantation  (see  3.00M ).
      Consider under a disability for 3 years from the date of the transplant; after  that, evaluate the residual impairment(s).


code: 3.14
title: Respiratory Failure
source_url: https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm
summary:
  3.14  Respiratory failure  
            (see  3.00N ) resulting from any underlying chronic respiratory disorder except CF (for CF, see  3.04D ),
      requiring invasive mechanical ventilation, noninvasive ventilation with BiPAP, or a combinat…

raw_text:
  3.14  Respiratory failure  
            (see  3.00N ) resulting from any underlying chronic respiratory disorder except CF (for CF, see  3.04D ),
      requiring invasive mechanical ventilation, noninvasive ventilation with BiPAP, or a combination of both treatments, for a continuous period of at least 48 hours, 
            or for a continuous period of at least 72 hours if postoperatively,  twice  within a 12-month period and at least 30 days apart 
            (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review).
   



    


   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 4.02
title: Chronic heart failure
source_url: https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm
summary:
  4.02  Chronic heart failure  while on a regimen of  prescribed treatment, with symptoms and signs described in  4.00D2 . 
                  The required  level of severity for this impairment is met when the requirements in  both  A and B  ar…

raw_text:
  4.02  Chronic heart failure  while on a regimen of  prescribed treatment, with symptoms and signs described in  4.00D2 . 
                  The required  level of severity for this impairment is met when the requirements in  both  A and B  are satisfied. 


               

  A.  Medically documented  presence of one of the following: 


               

  1. Systolic failure (see  4.00D1a(i) ),
      with left ventricular end diastolic dimensions greater than 6.0 cm  or ejection fraction of 30 percent or less during a period of stability (not  during an episode of acute heart failure); or
   


               

  2. Diastolic failure (see  4.00D1a(ii) ),
      with left ventricular posterior wall plus septal thickness totaling 2.5 cm or greater on imaging, with an enlarged left atrium greater than or equal to 4.5 cm, with normal or elevated ejection fraction during a period of stability (not during an episode of acute heart failure);
   


               

  AND 


               

  B.  Resulting in one of the  following: 


               

  1. Persistent symptoms of heart failure which very seriously limit the ability to independently initiate,  sustain, or complete activities of daily living in an individual for whom an  MC, preferably one experienced in the care of patients with cardiovascular  disease, has concluded that the performance of an exercise test would present a  significant risk to the individual; or 


              
               

  2. Three or more separate episodes of acute congestive heart failure within a consecutive 12-month period 
                  (see  4.00A3e ), with evidence of fluid retention 
      (see  4.00D2b(ii) ) from clinical  and imaging assessments at the time of the episodes,
      requiring acute extended physician intervention such as hospitalization or emergency room treatment for  12 hours or more,
      separated by periods of stabilization (see  4.00D4c ); or
   


              
               

  3. Inability to perform on an exercise tolerance test at a workload equivalent to 5 METs or less due to: 


              
               

  a. Dyspnea, fatigue, palpitations, or chest discomfort; or 


              
               

  b. Three or more consecutive premature ventricular contractions (ventricular tachycardia), or increasing  frequency of ventricular ectopy with at least 6 premature ventricular  contractions per minute; or 


              
               

  c. Decrease of 10 mm Hg or more in systolic pressure below the baseline systolic blood pressure or the  preceding systolic pressure measured during exercise 
                  (see  4.00D4d ) due to left  ventricular dysfunction, despite an increase in workload; or 


              
               

  d. Signs attributable to inadequate cerebral perfusion, such as ataxic gait or mental confusion. 


               

  Back to Top


code: 4.04
title: Ischemic heart disease
source_url: https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm
summary:
  4.04 
                Ischemic heart disease , with symptoms due to myocardial ischemia, 
                as described in  4.00E3 - 4.00E7 ,
      while on a regimen  of prescribed treatment (see  4.00B3  if there is no regimen of prescribed  tre…

raw_text:
  4.04 
                Ischemic heart disease , with symptoms due to myocardial ischemia, 
                as described in  4.00E3 - 4.00E7 ,
      while on a regimen  of prescribed treatment (see  4.00B3  if there is no regimen of prescribed  treatment), with one of the following:
   


               

  A.  Sign-or symptom-limited exercise tolerance test demonstrating at least one of the following manifestations at a workload equivalent to 5 METs or less: 


              
               

  1. Horizontal or downsloping  depression, in the absence of digitalis glycoside treatment or hypokalemia, of  the ST segment of at least −0.10 millivolts (−1.0 mm) in at least 3 consecutive  complexes that are on a level baseline in any lead other than a VR, and  depression of at least −0.10 millivolts lasting for at least 1 minute of  recovery; or 


              
               

  2. At least 0.1 millivolt (1  mm) ST elevation above resting baseline in non-infarct leads during both  exercise and 1 or more minutes of recovery; or 


              
               

  3. Decrease of 10 mm Hg or more in systolic pressure below the baseline blood pressure or the preceding  systolic pressure measured during exercise 
              (see  4.00E9e ) due to left ventricular dysfunction, despite an increase in workload; or 


              
               

  4. Documented ischemia at an  exercise level equivalent to 5 METs or less on appropriate medically acceptable imaging, such as radionuclide perfusion scans or stress echocardiography.  


              
               

  OR 


               

  B.  Three separate ischemic episodes, each requiring revascularization or not amenable to revascularization  
                  (see  4.00E9f ), within a consecutive 12-month period (see  4.00A3e ).  


               

  OR 


               

  C.  Coronary artery disease,  demonstrated by angiography (obtained independent of Social Security disability  evaluation) or other appropriate medically acceptable imaging, and in the  absence of a timely exercise tolerance test or a timely normal drug-induced  stress test, an MC, preferably one experienced in the care of patients with  cardiovascular disease, has concluded that performance of exercise tolerance  testing would present a significant risk to the individual, with both 1 and 2: 


               

  1. Angiographic evidence  showing: 


              
               

  a. 50 percent or more  narrowing of a nonbypassed left main coronary artery; or 


              
               

  b. 70 percent or more  narrowing of another nonbypassed coronary artery; or 


              
               

  c. 50 percent or more  narrowing involving a long (greater than 1 cm) segment of a nonbypassed  coronary artery; or 


              
               

  d. 50 percent or more narrowing  of at least two nonbypassed coronary arteries; or 


              
               

  e. 70 percent or more  narrowing of a bypass graft vessel; and 


              
               

  2. Resulting in very serious  limitations in the ability to independently initiate, sustain, or complete  activities of daily living. 


               

  Back to Top


code: 4.05
title: Recurrent arrhythmias
source_url: https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm
summary:
  4.05 
                Recurrent arrhythmias , not related to reversible  causes, such as electrolyte abnormalities or digitalis glycoside or  antiarrhythmic drug toxicity, 
                  resulting in uncontrolled (see  4.00A3f ),…

raw_text:
  4.05 
                Recurrent arrhythmias , not related to reversible  causes, such as electrolyte abnormalities or digitalis glycoside or  antiarrhythmic drug toxicity, 
                  resulting in uncontrolled (see  4.00A3f ),  
                  recurrent (see  4.00A3c ) episodes of cardiac syncope or near syncope (see   4.00F3b ), 
                  despite prescribed treatment(see  4.00B3  if there is no prescribed  treatment), and documented by resting or ambulatory (Holter)  electrocardiography,
      or by other appropriate medically acceptable testing,
      coincident with the occurrence of syncope or near syncope (see  4.00F3c ).
   


               

  Back to Top


code: 4.06
title: Symptomatic congenital heart disease
source_url: https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm
summary:
  4.06 
                Symptomatic congenital heart disease  
                 (cyanotic or acyanotic),  documented by appropriate medically acceptable imaging (see  4.00A3d ) or cardiac  catheterization, with one of the following:…

raw_text:
  4.06 
                Symptomatic congenital heart disease  
                 (cyanotic or acyanotic),  documented by appropriate medically acceptable imaging (see  4.00A3d ) or cardiac  catheterization, with one of the following: 


               

  A.  Cyanosis at rest, and: 


              
               

  1. Hematocrit of 55 percent  or greater; or 


              
               

  2. Arterial O2  saturation of less than 90 percent in room air, or resting arterial PO2  of 60 Torr or less.  


              
               

  OR 


              
               

  B.  Intermittent  right-to-left shunting resulting in cyanosis on exertion (e.g., Eisenmenger's  physiology) and with arterial PO2 of 60 Torr or less at a workload  equivalent to 5 METs or less.  


              
               

  OR 


              
               

  C.  Secondary pulmonary  vascular obstructive disease with pulmonary arterial systolic pressure elevated  to at least 70 percent of the systemic arterial systolic pressure. 


               

  Back to Top


code: 4.09
title: Heart transplant
source_url: https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm
summary:
  4.09 
                Heart transplant . Consider under a disability for 1 year  following surgery; thereafter, evaluate residual impairment under the  appropriate listing. 


               

  Back to Top

raw_text:
  4.09 
                Heart transplant . Consider under a disability for 1 year  following surgery; thereafter, evaluate residual impairment under the  appropriate listing. 


               

  Back to Top


code: 4.10
title: Aneurysm of aorta or major branches
source_url: https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm
summary:
  4.10
                Aneurysm of aorta or major branches , due to any cause (e.g.,  atherosclerosis, cystic medial necrosis, Marfan syndrome, trauma), 
              demonstrated  by appropriate medically acceptable imaging, with dissection not…

raw_text:
  4.10
                Aneurysm of aorta or major branches , due to any cause (e.g.,  atherosclerosis, cystic medial necrosis, Marfan syndrome, trauma), 
              demonstrated  by appropriate medically acceptable imaging, with dissection not controlled by prescribed treatment (see  4.00H6 ). 


               

  Back to Top


code: 4.11
title: Chronic venous insufficiency
source_url: https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm
summary:
  4.11  Chronic venous insufficiency   of a lower extremity with  incompetency or obstruction of the deep venous system and one of the following: 


               

  A.  Extensive brawny edema  (see  4.00G3 ) 
                  involving at least…

raw_text:
  4.11  Chronic venous insufficiency   of a lower extremity with  incompetency or obstruction of the deep venous system and one of the following: 


               

  A.  Extensive brawny edema  (see  4.00G3 ) 
                  involving at least two-thirds of the leg between the ankle and knee or the distal one-third of the lower extremity between the ankle and hip.  


              
               

  OR 


              
               

  B.  Superficial varicosities, stasis dermatitis, and either recurrent ulceration or persistent ulceration that has not healed following at least 3 months of prescribed treatment. 


               

  Back to Top


code: 4.12
title: Peripheral arterial disease
source_url: https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm
summary:
  4.12  Peripheral  arterial disease , 
                  as determined by appropriate medically acceptable imaging (see  4.00A3d , 
                                                                                      4.00G2 ,…

raw_text:
  4.12  Peripheral  arterial disease , 
                  as determined by appropriate medically acceptable imaging (see  4.00A3d , 
                                                                                      4.00G2 , 
                                                                                          4.00G5 , and  
                                                                                              4.00G6 ), causing intermittent claudication 
                                                                                                 (see  4.00G1 ) and one of the  following: 


               

  A.  Resting ankle/brachial  systolic blood pressure ratio of less than 0.50.  


              
               

  OR 


              
               

  B.  Decrease in systolic  blood pressure at the ankle on exercise 
              (see  4.00G7a  and  4.00C16 - 4.00C17 ) 
                  of 50 percent or more of pre-exercise level and requiring 10 minutes or more to return to pre-exercise level.  


              
               

  OR 


              
               

  C.  Resting toe systolic  pressure of less than 30 mm Hg 
              (see  4.00G7c  and  4.00G8 ).  


              
               

  OR 


              
               

  D.  Resting toe/brachial  systolic blood pressure ratio of less than 0.40 (see  4.00G7c ). 


               

  Back to Top 


              
    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 6.01
title: Category of Impairments, Genitourinary Disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/6.00-Genitourinary-Adult.htm
summary:
  6.01 Category of Impairments, Genitourinary
                    Disorders
                 
             
         


         

  Back to Top

raw_text:
  6.01 Category of Impairments, Genitourinary
                    Disorders
                 
             
         


         

  Back to Top


code: 6.03
title: Chronic kidney disease, with chronic hemodialysis or peritoneal dialysis
source_url: https://www.ssa.gov/disability/professionals/bluebook/6.00-Genitourinary-Adult.htm
summary:
  6.03  Chronic kidney disease,   with chronic hemodialysis or peritoneal  dialysis (see  6.00C1 ). 


         

  Back to Top

raw_text:
  6.03  Chronic kidney disease,   with chronic hemodialysis or peritoneal  dialysis (see  6.00C1 ). 


         

  Back to Top


code: 6.04
title: Chronic kidney disease, with kidney transplant
source_url: https://www.ssa.gov/disability/professionals/bluebook/6.00-Genitourinary-Adult.htm
summary:
  6.04  Chronic kidney  disease,    
        with kidney transplant. Consider under a disability for 1 year  following the transplant; thereafter, evaluate the residual impairment (see  6.00C2 ). 


         

  Back to Top

raw_text:
  6.04  Chronic kidney  disease,    
        with kidney transplant. Consider under a disability for 1 year  following the transplant; thereafter, evaluate the residual impairment (see  6.00C2 ). 


         

  Back to Top


code: 6.05
title: Chronic kidney disease, with impairment of kidney function
source_url: https://www.ssa.gov/disability/professionals/bluebook/6.00-Genitourinary-Adult.htm
summary:
  6.05  Chronic kidney disease ,  with impairment  of kidney function, with A and B: 


         

  A. Reduced glomerular filtration evidenced by one of the  following laboratory findings documented on at least two occasions at least 90  days ap…

raw_text:
  6.05  Chronic kidney disease ,  with impairment  of kidney function, with A and B: 


         

  A. Reduced glomerular filtration evidenced by one of the  following laboratory findings documented on at least two occasions at least 90  days apart during a consecutive 12-month period: 


         


             


                 Serum  creatinine of 4 mg/dL or greater; or 


                 


             


             


                 Creatinine clearance of 20 ml/min. or less; or  


                 


             


             

  Estimated glomerular filtration rate (eGFR) of 20 ml/min/1.73m2 or  less. 


         


         

  AND 


         

   B. One of the following: 


         


             


                 Renal  osteodystrophy (see  6.00C3 ) with severe bone pain and imaging studies  documenting bone abnormalities, such as osteitis fibrosa, osteomalacia, or  pathologic fractures; or 


       


   


             


                 Peripheral neuropathy (see  6.00C4 ); or 


       


   


             


                 Fluid  overload syndrome (see  6.00C5 ) documented by one of the following: 


       


   


             


                 


                     Diastolic hypertension greater than or equal to diastolic blood pressure of 110 mm Hg despite at least 90 consecutive days of prescribed therapy, documented by at least two measurements of diastolic blood pressure at least 90 days apart  during a consecutive 12-month period; or 


                     


                 


                 


                     Signs of vascular congestion or anasarca (see  6.00C6 ) despite at least 90 consecutive days of prescribed therapy, documented on at least two occasions at least 90  days apart during a consecutive 12-month period; or 


       


   


             


             


                 Anorexia with weight loss (see  6.00C7 ) determined by body mass index (BMI) of 18.0 or less,
      calculated on at least two occasions at least 90 days apart during a consecutive 12-month period. 


   



         


         

  Back to Top


code: 6.06
title: Nephrotic syndrome
source_url: https://www.ssa.gov/disability/professionals/bluebook/6.00-Genitourinary-Adult.htm
summary:
  6.06  Nephrotic syndrome,  with A and B 


         

   A. Laboratory findings as described in 1 or 2, documented on at  least two occasions at least 90 days apart during a consecutive 12-month  period:…

raw_text:
  6.06  Nephrotic syndrome,  with A and B 


         

   A. Laboratory findings as described in 1 or 2, documented on at  least two occasions at least 90 days apart during a consecutive 12-month  period: 


         


             


                 Proteinuria of 10.0 g or greater per 24 hours; or 


                 


             


             


                 Serum  albumin of 3.0 g/dL or less, and  


                 


             


             


                 


                     Proteinuria of 3.5 g or greater per 24 hours; or  


                     


                 


                 

  Urine total-protein-to-creatinine ratio of 3.5 or greater. 


             


         


         

  AND 


         

  B. Anasarca (see  6.00C6 ) persisting for at least 90 days despite prescribed treatment. 


         

  Back to Top


code: 6.09
title: Complications of chronic kidney disease
source_url: https://www.ssa.gov/disability/professionals/bluebook/6.00-Genitourinary-Adult.htm
summary:
  6.09  Complications of chronic kidney disease   
        (see  6.00C8 ) requiring at least three hospitalizations within a consecutive 12-month  period and occurring at least 30 days apart. 
        Each hospitalization must last at least 48 ho…

raw_text:
  6.09  Complications of chronic kidney disease   
        (see  6.00C8 ) requiring at least three hospitalizations within a consecutive 12-month  period and occurring at least 30 days apart. 
        Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately  before the hospitalization. 


         


             Back to Top 
         


        
    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 8.07
title: Genetic photosensitivity disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/8.00-Skin-Adult.htm
summary:
  8.07
                            Genetic photosensitivity disorders 
                        , established as described in  8.00E .
                       The requirements of this listing are met if either paragraph A or paragraph B is satisfied.…

raw_text:
  8.07
                            Genetic photosensitivity disorders 
                        , established as described in  8.00E .
                       The requirements of this listing are met if either paragraph A or paragraph B is satisfied.
                    


                    


                        
                        A.  Xeroderma pigmentosum (see  8.00E1 ).
                    


                    

  OR 


                    


                        B.  Other genetic photosensitivity disorders (see  8.00E2 ) with either 1 or 2:
                    


                    


                        1. Chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ) that cause an inability to function outside of a highly protective environment
                       (see  8.00E4 ); or
                    


                    


                        2. Chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ) causing chronic pain or other physical limitation(s) that result in impairment-related functional limitations
                       (see  8.00D2 ), as evidenced by:
                    


                    


                        
                       a. Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                       (see  8.00B5 ) due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ); or
                    


                    


                        
                       b. Inability to use one upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                       (see  8.00B5 ) due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ), and a documented medical need (see  8.00B4 ) for an assistive device
                       (see  8.00B1 ) that requires the use of the other upper extremity; or
                    


                    


                        
                       c. Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain, and complete work-related activities due to chronic skin lesions
                       (see  8.00B2 ) or contractures (see  8.00B3 )
                       affecting at least two extremities (including when the limitations are due to involvement of the perineum or the inguinal region); or
                    


                    


                        
                       d. Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain, and complete work-related activities,
                       due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 )
                       affecting both lower extremities (including when the limitations are due to involvement of the perineum or the inguinal region).
                    


                    

  Back to Top


code: 8.08
title: Burns
source_url: https://www.ssa.gov/disability/professionals/bluebook/8.00-Skin-Adult.htm
summary:
  8.08  Burns 
                       (see  8.00F ). Burns that do not require continuing surgical management (see  8.00B6 ),
                       or that have been documented by an acceptable medical source to have reached maximum therapeutic…

raw_text:
  8.08  Burns 
                       (see  8.00F ). Burns that do not require continuing surgical management (see  8.00B6 ),
                       or that have been documented by an acceptable medical source to have reached maximum therapeutic benefit and therefore are no longer receiving surgical management,
                       resulting in chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ) causing chronic pain or other physical limitation(s) that result in impairment-related functional limitations
                       (see  8.00D2 ), as evidenced by:
                    


                    


                        
                        A.  Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                       (see  8.00B5 ) due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ).
                    


                    

  OR 


                    


                        B.  Inability to use one upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                       (see  8.00B5 ) due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ),
                       and a documented medical need (see  8.00B4 ) for an assistive device
                       (see  8.00B1 ) that requires the use of the other upper extremity.
                    


                    

  OR 


                    


                        C.  Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain,
                       and complete work-related activities due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ) affecting at least two extremities
                       (including when the limitations are due to involvement of the perineum or the inguinal region).
                    


                    

  OR 


                    


                        D.  Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain,
                       and complete work-related activities due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ) affecting both lower extremities
                       (including when the limitations are due to involvement of the perineum or the inguinal region).
                    


                    

  Back to Top


code: 8.09
title: Chronic conditions of the skin or mucous membranes
source_url: https://www.ssa.gov/disability/professionals/bluebook/8.00-Skin-Adult.htm
summary:
  8.09  Chronic conditions of the skin or mucous membranes 
                       (see  8.00G ) resulting in:
                    


                    


                        
                        A.  Chronic skin lesions (see  8.00B2 )…

raw_text:
  8.09  Chronic conditions of the skin or mucous membranes 
                       (see  8.00G ) resulting in:
                    


                    


                        
                        A.  Chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ) causing chronic pain
                       or other physical limitation(s) that persist despite adherence to prescribed medical treatment for 3 months
                       (see  8.00D5b ).
                    


                    

  AND 


                    


                        B. 
                       Impairment-related functional limitations (see  8.00D2 ) demonstrated by 1, 2, 3, or 4:
                    


                    


                        1. Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain,
                       and complete work-related activities involving fine and gross movements
                       (see  8.00B5 ) due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ); or
                    


                    


                        2. Inability to use one upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                       (see  8.00B5 ) due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ),
                       and a documented medical need (see  8.00B4 ) for an assistive device
                       (see  8.00B1 ) that requires the use of the other upper extremity; or
                    


                    


                        3. Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain,
                       and complete work-related activities due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ) affecting at least two extremities
                       (including when the limitations are due to involvement of the perineum or the inguinal region); or
                    


                    


                        4. Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain,
                       and complete work-related activities due to chronic skin lesions (see  8.00B2 )
                       or contractures (see  8.00B3 ) affecting both lower extremities
                       (including when the limitations are due to involvement of the perineum or the inguinal region).
                    


                    Back to Top 

                

            



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 10.01
title: Category of Impairments, Congenital Disorders That Affect Multiple Body Systems
source_url: https://www.ssa.gov/disability/professionals/bluebook/10.00-MultipleBody-Adult.htm
summary:
  10.01 Category of Impairments, Congenital Disorders That Affect Multiple Body Systems 


               

  Back to Top

raw_text:
  10.01 Category of Impairments, Congenital Disorders That Affect Multiple Body Systems 


               

  Back to Top


code: 10.06
title: Non-mosaic Down syndrome (chromosome 21 trisomy or chromosome 21 translocation)
source_url: https://www.ssa.gov/disability/professionals/bluebook/10.00-MultipleBody-Adult.htm
summary:
  10.06  Non-mosaic Down syndrome,   (chromosome  21 trisomy or chromosome 21 translocation),   documented by: 


               

  A. A laboratory report of karyotype analysis signed by a physician, 
                  or both a laboratory report…

raw_text:
  10.06  Non-mosaic Down syndrome,   (chromosome  21 trisomy or chromosome 21 translocation),   documented by: 


               

  A. A laboratory report of karyotype analysis signed by a physician, 
                  or both a laboratory report of karyotype analysis not signed by a physician  and  a statement by a physician that you have Down syndrome 
                  (see  10.00C1 ).  


               

  OR 


               

  B. A physician’s report stating that you have chromosome 21 trisomy or chromosome 21 translocation consistent with prior karyotype analysis with the distinctive facial or 
                  other physical features of Down syndrome (see  10.00C2a ). 


               

  OR  


               

  C. A physician’s report stating that you have Down syndrome with the distinctive facial or other physical features  and  
                  evidence demonstrating that you function at a level consistent with non-mosaic Down syndrome (see  10.00C2b ). 


               

  Back to Top 


   
    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 11.02
title: Epilepsy
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.02
             Epilepsy , documented by a detailed description of a typical seizure and characterized by A, B, C, or D: 
         


         

   A. Generalized tonic-clonic seizures (see  11.00H1a ), 
        occurring at least once a month for…

raw_text:
  11.02
             Epilepsy , documented by a detailed description of a typical seizure and characterized by A, B, C, or D: 
         


         

   A. Generalized tonic-clonic seizures (see  11.00H1a ), 
        occurring at least once a month for at least 3 consecutive months (see  11.00H4 ) despite adherence to prescribed treatment 
        (see  11.00C ).  


         

  OR 


         

   B. Dyscognitive seizures (see  11.00H1b ), 
        occurring at least once a week for at least 3 consecutive months (see  11.00H4 ) despite adherence to prescribed treatment 
        (see  11.00C ). 


         


            OR 


             C. Generalized tonic-clonic seizures
            (see  11.00H1a ),
            occurring at least once every 2 months for at least 4 consecutive months (see   11.00H4 )
            despite adherence to prescribed treatment (see   11.00C ); and a marked limitation in one of the following:
         


         


             

  Physical functioning  (see  11.00G3a ); or 


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing oneself (see  11.00G3b(iv) ).  


         


         


            OR 


               D. Dyscognitive seizures (see  11.00H1b ), 
            occurring at least once every 2 weeks for at least 3  consecutive months (see  11.00H4 ) despite adherence to prescribed treatment 
            (see  11.00C ); and a marked limitation in one of the following:
   


         


             

  Physical functioning (see  11.00G3a ); or 


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing oneself (see  11.00G3b(iv) ).


code: 11.04
title: Vascular insult to the brain
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.04  Vascular insult to the brain , characterized by A, B, or C: 
             
         


         


            A. Sensory or motor aphasia resulting in ineffective speech or communication (see  11.00E1 ) persisting for at least 3 consecutive…

raw_text:
  11.04  Vascular insult to the brain , characterized by A, B, or C: 
             
         


         


            A. Sensory or motor aphasia resulting in ineffective speech or communication (see  11.00E1 ) persisting for at least 3 consecutive months after the insult. 


   


         

  OR 


         

  B. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, 
        balance while standing or walking, or use the upper extremities, persisting for at least 3 consecutive months after the insult.  


         

  OR 


         

   C. Marked limitation (see  11.00G2 ) in physical functioning 
        (see  11.00G3a ) and in one of the following areas of mental functioning, both persisting for at least 3 consecutive months after the insult: 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing oneself (see  11.00G3b(iv) ).


code: 11.05
title: Benign brain tumors
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.05  Benign brain tumors , characterized by A or B:  
             
             


         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the a…

raw_text:
  11.05  Benign brain tumors , characterized by A or B:  
             
             


         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up  from a seated position, balance while standing or walking, or use the upper  extremities. 


         

  OR 


         

  B. Marked  limitation (see  11.00G2 ) in physical functioning 
        (see  11.00G3a ), and in one of the following: 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing  oneself (see  11.00G3b(iv) ).


code: 11.06
title: Parkinsonian syndrome
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.06  Parkinsonian syndrome 
             , characterized by A or B despite adherence to prescribed treatment for at least 3 consecutive  months (see  11.00C ):
   


         

  A. Disorganization of motor function in two extremities (see  11.00…

raw_text:
  11.06  Parkinsonian syndrome 
             , characterized by A or B despite adherence to prescribed treatment for at least 3 consecutive  months (see  11.00C ):
   


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities. 


         

  OR 


         

  B. Marked limitation (see  11.00G2 ) in physical functioning 
        (see  11.00G3a ), and in one of  the following: 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing oneself (see  11.00G3b(iv) ).


code: 11.07
title: Cerebral palsy
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.07
             Cerebral palsy , characterized by A, B, or C:
         


         


             A. Disorganization of motor function in two extremities (see   11.00D1 ),
            resulting in an extreme limitation (see  11.00D2 ) in the abil…

raw_text:
  11.07
             Cerebral palsy , characterized by A, B, or C:
         


         


             A. Disorganization of motor function in two extremities (see   11.00D1 ),
            resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities.
         


         

  OR 


         


             B. Marked limitation (see   11.00G2 ) in physical functioning
            (see  11.00G3a ), and in one of the following:
         


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing oneself (see  11.00G3b(iv) ).  


         


         

  OR 


         

  C. Significant interference in communication due to speech, hearing, or visual deficit (see  11.00E2 ).


code: 11.08
title: Spinal cord disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.08
             Spinal cord disorders , characterized by A, B, or C:
         


         

  A. Complete loss of function, as described in  11.00M2 , 
        persisting for 3 consecutive months after the disorder (see  11.00M4 ). 


         

  OR…

raw_text:
  11.08
             Spinal cord disorders , characterized by A, B, or C:
         


         

  A. Complete loss of function, as described in  11.00M2 , 
        persisting for 3 consecutive months after the disorder (see  11.00M4 ). 


         

  OR 


         

  B. Disorganization  of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, balance while standing or walking, 
        or use the upper extremities persisting for 3 consecutive months after the disorder (see  11.00M4 ). 


         

  OR 


         

  C. Marked limitation (see  11.00G2 ) 
        in physical functioning (see  11.00G3a ) and in one of the following areas of mental functioning, 
        both persisting for 3 consecutive months after the disorder (see  11.00M4 ): 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             


                 Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or
   


             

  Adapting or managing  oneself (see  11.00G3b(iv) ).


code: 11.09
title: Multiple sclerosis
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.09
             Multiple sclerosis , characterized by A or B:
         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ),  
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up…

raw_text:
  11.09
             Multiple sclerosis , characterized by A or B:
         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ),  
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities.  


         

  OR 


         

  B. Marked limitation (see  11.00G2 ) in physical functioning (see  11.00G3a ), 
        and in one of  the following: 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing oneself (see  11.00G3b(iv) ).


code: 11.10
title: Amyotrophic lateral sclerosis (ALS)
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.10  Amyotrophic lateral sclerosis (ALS)  established by clinical and laboratory findings (see  11.00O ).

raw_text:
  11.10  Amyotrophic lateral sclerosis (ALS)  established by clinical and laboratory findings (see  11.00O ).


code: 11.11
title: Post-polio syndrome
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.11
             Post-polio syndrome , characterized by A, B, C, or D:
         


         

    A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to…

raw_text:
  11.11
             Post-polio syndrome , characterized by A, B, C, or D:
         


         

    A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities. 


         

  OR 


         

    B. Unintelligible speech (see  11.00E3 ). 


         

  OR 


         

    C. Bulbar and neuromuscular dysfunction (see  11.00F ), resulting in: 


         


             

  Acute respiratory failure requiring mechanical ventilation; or 


             

  Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter. 


         


         

  OR 


         

  D. Marked limitation (see  11.00G2 ) in physical functioning (see  11.00G3a ), and in one of  the following: 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing oneself (see  11.00G3b(iv) ).


code: 11.12
title: Myasthenia gravis
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.12
             Myasthenia gravis , characterized by A, B, or C despite adherence  to prescribed treatment for at least 3 months (see  11.00C ):
   


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        r…

raw_text:
  11.12
             Myasthenia gravis , characterized by A, B, or C despite adherence  to prescribed treatment for at least 3 months (see  11.00C ):
   


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities. 


         

  OR 


         

  B. Bulbar and neuromuscular dysfunction (see  11.00F ), resulting in: 


         


             

  One myasthenic crisis requiring mechanical ventilation; or 


             

  Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter. 


         


         

  OR 


         

   C. Marked limitation (see  11.00G2 ) in physical functioning 
        (see  11.00G3a ), and in one of  the following: 


         


             

  Understanding,  remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with  others (see  11.00G3b(ii) ); or 


             

  Concentrating,  persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             


                 Adapting or managing oneself (see  11.00G3b(iv) ).


code: 11.13
title: Muscular dystrophy
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.13
             Muscular dystrophy , characterized by A or B:
         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up…

raw_text:
  11.13
             Muscular dystrophy , characterized by A or B:
         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up  from a seated position, balance while standing or walking, or use the upper extremities. 


         

  OR 


         

  B. Marked limitation (see  11.00G2 ) in physical functioning 
        (see  11.00G3a ), and in one of the following: 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing  oneself (see  11.00G3b(iv) ).


code: 11.14
title: Peripheral neuropathy
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.14
             Peripheral neuropathy , characterized by A or B:
         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand…

raw_text:
  11.14
             Peripheral neuropathy , characterized by A or B:
         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities. 


         

  OR 


         

  B. Marked  limitation (see  11.00G2 ) in physical functioning 
        (see  11.00G3a ), and in one of the following: 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             


                 Interacting with others (see  11.00G3b(ii) ); or
   


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing oneself (see  11.00G3b(iv) ).


code: 11.17
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
title:
  Neurodegenerative disorders of the central nervous system, such as Huntington’s disease, Friedreich’s ataxia, and spinocerebellar degeneration

summary:
  11.17
             Neurodegenerative disorders of the central nervous system, such as Huntington’s disease, Friedreich’s ataxia, and spinocerebellar degeneration , characterized by A or B:
         


         

  A. Disorganization of motor fu…

raw_text:
  11.17
             Neurodegenerative disorders of the central nervous system, such as Huntington’s disease, Friedreich’s ataxia, and spinocerebellar degeneration , characterized by A or B:
         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, balance while standing or walking, or use the upper  extremities. 


         

  OR 


         

  B. Marked limitation (see  11.00G2 ) in physical functioning (see  11.00G3a ), and in one of the following:  


         


             

  Understanding,  remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with  others (see  11.00G3b(ii) ); or 


             

  Concentrating,  persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             


                 Adapting or managing oneself (see  11.00G3b(iv) ).


code: 11.18
title: Traumatic brain injury
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.18
             Traumatic brain injury , characterized by A or B:
         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ),
      resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up…

raw_text:
  11.18
             Traumatic brain injury , characterized by A or B:
         


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ),
      resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up  from a seated position, balance while standing or walking, or use the upper extremities, 
        persisting for at least 3 consecutive months after the injury.
   


         

  OR 


         

  B. Marked  limitation (see  11.00G2 ) in physical functioning 
        (see  11.00G3a ), and in one of  the following areas of mental functioning, persisting for at least 3 consecutive months after the injury: 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing  oneself (see  11.00G3b(iv) ).


code: 11.22
title: Motor neuron disorders other than ALS
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.22  Motor neuron disorders other than ALS , characterized by A, B, or C: 


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to sta…

raw_text:
  11.22  Motor neuron disorders other than ALS , characterized by A, B, or C: 


         

  A. Disorganization of motor function in two extremities (see  11.00D1 ), 
        resulting in an extreme limitation (see  11.00D2 ) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities. 


         

  OR 


         

  B. Bulbar and neuromuscular dysfunction (see  11.00F ), resulting in: 


         


             

  Acute respiratory failure requiring invasive mechanical ventilation; or 


             

  Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter. 


         


         

  C. Marked limitation (see  11.00G2 ) in physical functioning (see  11.00G3a ), and in one of the following: 


         


             

  Understanding, remembering, or applying information (see  11.00G3b(i) ); or 


             

  Interacting with others (see  11.00G3b(ii) ); or 


             

  Concentrating, persisting, or maintaining pace (see  11.00G3b(iii) ); or 


             

  Adapting or managing  oneself (see  11.00G3b(iv) ).  


         



    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 11.00
title: 11.00
source_url: https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm
summary:
  11.00 Neurological 


         


              A.  Which neurological  disorders do we evaluate under these listings? 
         


         


            We evaluate epilepsy, amyotrophic lateral sclerosis, coma or persistent vegetative state (PVS)…

raw_text:
  11.00 Neurological 


         


              A.  Which neurological  disorders do we evaluate under these listings? 
         


         


            We evaluate epilepsy, amyotrophic lateral sclerosis, coma or persistent vegetative state (PVS), and neurological disorders that cause disorganization of motor function, bulbar and neuromuscular dysfunction, 
            communication impairment, or a combination of  limitations in physical and mental functioning such as early-onset Alzheimer’s  disease. 
            We evaluate neurological disorders that may manifest in a combination of limitations in physical and mental functioning. For example, if you have a neurological disorder that causes mental limitations, 
            such as Huntington’s disease, which may limit executive functioning (e.g., regulating attention, planning, inhibiting responses, decision-making), 
            we evaluate your limitations using the functional criteria under these listings (see  11.00G ). Under this body system, 
            we evaluate the limitations resulting from the impact of the  neurological disease process itself. 
            If your neurological disorder results in only mental impairment or if you have a co-occurring mental condition that is not caused by  your neurological disorder (for example, dementia), 
            we will evaluate your  mental impairment under the mental disorders body system,  12.00 .


       
   


         

    B.  What evidence do we need to document your neurological disorder? 


         


             

  We need both medical and non-medical evidence (signs, symptoms, and laboratory findings) to assess  the effects of your neurological disorder. Medical evidence should include your  medical history, examination findings, relevant laboratory tests, and the  results of imaging. Imaging refers to medical imaging techniques, such as  x-ray, computerized tomography (CT), magnetic resonance imaging (MRI), and  electroencephalography (EEG). The imaging must be consistent with the  prevailing state of medical knowledge and clinical practice as the proper  technique to support the evaluation of the disorder. In addition, the medical  evidence may include descriptions of any prescribed treatment and your response  to it. We consider non-medical evidence such as statements you or others make  about your impairments, your restrictions, your daily activities, or your  efforts to work.  


             


                 
                We will make every reasonable effort to obtain the results of your laboratory and imaging evidence. When the results of any of these tests are part of the existing evidence in your case record, we will evaluate the test results and all other relevant evidence. We will not  purchase imaging, or other diagnostic tests, or laboratory tests that are complex, may involve significant risk, or that  are invasive. We will not routinely purchase tests that are expensive or not  readily available. 
             


         



         

  C.  How do we consider  adherence to prescribed treatment in neurological disorders? 


         

  In  11.02  (Epilepsy),  11.06  (Parkinsonian  syndrome), 
        and  11.12  (Myasthenia gravis), we require that limitations from  these neurological disorders exist despite adherence to prescribed treatment.  
        “Despite adherence to prescribed treatment” means that you have taken medication(s) or followed other treatment procedures for your neurological disorder(s) 
        as prescribed by a physician for three consecutive months but your impairment  continues to meet the other listing requirements despite this treatment. 
        You  may receive your treatment at a health care facility that you visit regularly, even if you do not see the same physician on each visit.  


         


            D.  What do we mean by disorganization of motor function? 


             


                 


                     Disorganization of motor function  means interference, due to your neurological disorder, with movement of two extremities; i.e., the lower extremities, or upper extremities 
                      (including fingers, wrists, hands, arms, and shoulders). By two  extremities we mean both lower extremities, or both upper extremities, or one  upper extremity and one lower extremity. 
                      All listings in this body system,  except for  11.02  (Epilepsy),  11.10  (Amyotrophic lateral sclerosis), 
                      and  11.20  (Coma and persistent vegetative state), include criteria for disorganization of motor function that results in an extreme limitation in your ability to:
       


           

  Stand up from a seated position; or 


           

  Balance while standing or walking; or  


           


              Use the upper extremities (including fingers, wrists, hands, arms, and shoulders). 


               


           


       


   


                 


                     Extreme limitation  means the inability to stand up from a seated position, maintain balance in a  standing position and while walking, or use your upper extremities to  independently initiate, sustain, and complete work-related activities. The  assessment of motor function depends on the degree of interference with standing  up; balancing while standing or walking; or using the upper extremities  (including fingers, hands, arms, and shoulders).
                     


                         

  Inability to stand up from a seated position means that once seated you are unable to stand and maintain an upright position without the assistance of another person or the  use of an assistive device, such as a walker, two crutches, or two canes.  


                         

  Inability to maintain balance in a standing position means that you are unable to maintain an upright position while standing or walking without the assistance of another person or  an assistive device, such as a walker, two crutches, or two canes.  


                         

  Inability to use your upper extremities means that you have a loss of function of both upper extremities (including fingers, wrists, hands, arms, and shoulders) that very seriously limits your ability to independently initiate, sustain, and complete  work-related activities involving fine and gross motor movements. Inability to  perform fine and gross motor movements could include not being able to pinch,  manipulate, and use your fingers; or not being able to use your hands, arms,  and shoulders to perform gross motor movements, such as handling, gripping,  grasping, holding, turning, and reaching; or not being able to engage in  exertional movements such a lifting, carrying, pushing, and pulling. 


                     


                 


               


         


            E.  How do we evaluate communication impairments under these listings?  We must have a description of a recent comprehensive evaluation including all areas of communication, performed by an acceptable medical source, 
              to document a communication impairment associated  with a neurological disorder. 
              A communication impairment may occur when a medically determinable neurological impairment results in dysfunction in the  parts of the brain responsible for speech and language. 
              We evaluate communication impairments associated with neurological disorders under  11.04A ,   11.07C , 
              or  11.11B . 
              We evaluate communication impairments due to  non-neurological disorders under  2.09 .
   


             


                 


                  Under  11.04A , we need evidence documenting that your central nervous system vascular accident or insult (CVA) 
                    and sensory or motor aphasia have resulted in ineffective speech or communication. 
                     Ineffective speech or communication  means there is an extreme limitation in your ability to understand or convey your message in simple spoken language resulting in your inability to demonstrate basic 
                    communication skills, such as following one-step commands or telling someone about your basic personal needs without assistance.


code: 12.02
title: Neurocognitive disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.02 
                Neurocognitive disorders (see  12.00B1 ), satisfied by A and B, or A and C: 



   



   

  Medical documentation of a significant cognitive decline from a prior level of functioning in  one  or more of the cognitive areas:…

raw_text:
  12.02 
                Neurocognitive disorders (see  12.00B1 ), satisfied by A and B, or A and C: 



   



   

  Medical documentation of a significant cognitive decline from a prior level of functioning in  one  or more of the cognitive areas: 



   



   

  Complex attention; 


   

  Executive function; 


   

  Learning and memory; 


   

  Language; 


   

  Perceptual-motor; or 


   

  Social cognition. 



   


   



   

  AND 



   

              
   

  Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see  12.00F ): 



   



   

  Understand, remember, or apply information (see  12.00E1 ). 


   

  Interact with others (see  12.00E2 ).  


   

  Concentrate, persist, or maintain pace (see  12.00E3 ). 


   

  Adapt or manage oneself (see  12.00E4 ). 



   


   



   

  OR 



   

    
   

  Your mental disorder in this listing category is “serious and persistent;” that is, you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both: 



   



   

  Medical treatment, mental health therapy, psychosocial support(s), or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder 
      (see  12.00G2b );  and 



   

  Marginal adjustment, that is, you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life 
      (see  12.00G2c ).


code: 12.03
title: Schizophrenia spectrum and other psychotic disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.03 
    Schizophrenia spectrum and other psychotic disorders (see  12.00B2 ), satisfied by A and B, or A and C: 



   


   

  Medical documentation of  one  or more of the following: 



   



   

  Delusions or hallucinations; 


   

  Disorganized…

raw_text:
  12.03 
    Schizophrenia spectrum and other psychotic disorders (see  12.00B2 ), satisfied by A and B, or A and C: 



   


   

  Medical documentation of  one  or more of the following: 



   



   

  Delusions or hallucinations; 


   

  Disorganized thinking (speech); or 


   

  Grossly disorganized behavior or catatonia. 



   


   



   

  AND 



   



   

  Extreme limitation  of one, or marked limitation of two, of the following areas of mental functioning (see  12.00F ): 



   



   

  Understand, remember, or apply information (see  12.00E1 ). 


   

  Interact with others (see  12.00E2 ).  


   

  Concentrate, persist, or maintain pace (see  12.00E3 ). 


   

  Adapt or manage oneself (see  12.00E4 ). 



   


   



   

  OR 



   



   

  Your mental disorder in this listing category is “serious and persistent;” that is, you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both: 



   



   

  Medical treatment, mental health therapy, psychosocial support(s), or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder 
      (see  12.00G2b );  and 



   

  Marginal adjustment, that is, you have  minimal capacity to adapt to changes in your environment or to demands that are  not already part of your daily life 
      (see  12.00G2c ).


code: 12.04
title: Depressive, bipolar and related disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.04 
                Depressive, bipolar and related disorders (see 12.00B3), satisfied by A and B, or A and C: 



   



   

  Medical documentation of the requirements of paragraph 1 or 2: 



   



   

  Depressive disorder, characterized by  fi…

raw_text:
  12.04 
                Depressive, bipolar and related disorders (see 12.00B3), satisfied by A and B, or A and C: 



   



   

  Medical documentation of the requirements of paragraph 1 or 2: 



   



   

  Depressive disorder, characterized by  five  or more of the following:  



   



   

  Depressed mood; 


   

  Diminished interest in almost all activities;  


   

  Appetite disturbance with change in weight;  


   

  Sleep disturbance;  


   

  Observable psychomotor agitation or retardation;  


   

  Decreased energy;  


   

  Feelings of guilt or worthlessness;  


   

  Difficulty concentrating or thinking; or  


   

  Thoughts of death or suicide.  



   



   

  Bipolar disorder, characterized by  three  or more of the following: 



   



   

  Pressured speech; 


   

  Flight of ideas;  


   

  Inflated self-esteem;  


   

  Decreased need for sleep;  


   

  Distractibility;  


   

  Involvement in activities that have a high probability of painful consequences that are not recognized; or  


   

  Increase in goal-directed activity or psychomotor agitation. 



   


   


   



   

  AND 



   



   

  Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see  12.00F ): 



   



   

  Understand, remember, or apply information (see  12.00E1 ). 


   

  Interact with others  (see  12.00E2 ).  


   

  Concentrate, persist, or maintain pace (see  12.00E3 ). 


   

  Adapt or manage oneself (see  12.00E4 ). 



   


   



   

  OR 



   



   

  Your mental disorder in this listing category is “serious and persistent;” that is, you have a medically documented history of the existence of the disorder over a period of  at least 2 years, and there is evidence of both: 



   



   

  Medical treatment, mental health therapy, psychosocial support(s), or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder 
      (see  12.00G2b );  and 



   

  Marginal adjustment, that is, you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life 
      (see  12.00G2c ).


code: 12.05
title: Intellectual disorder
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.05 Intellectual disorder (see  12.00B4 ), satisfied by A or B: 



   



   

  Satisfied by 1, 2, and 3 (see  12.00H ): 



   



   

  Significantly subaverage general intellectual functioning evident in your cognitive inability to function at…

raw_text:
  12.05 Intellectual disorder (see  12.00B4 ), satisfied by A or B: 



   



   

  Satisfied by 1, 2, and 3 (see  12.00H ): 



   



   

  Significantly subaverage general intellectual functioning evident in your cognitive inability to function at a level required to participate in standardized testing of intellectual functioning; and  



   

  Significant deficits in adaptive functioning currently manifested by your dependence upon others for  personal needs (for example, toileting, eating, dressing, or bathing); and  



   

  The evidence about your current intellectual and adaptive functioning and about the history of your disorder  demonstrates or supports the conclusion that the disorder began prior to your  attainment of age 22. 



   


   



   

  OR 



   



   

  Satisfied by 1, 2, and 3 (see  12.00H ): 



   



   

  Significantly  subaverage general intellectual functioning evidenced by a or b: 



   



   

  A full scale (or comparable) IQ score of 70 or below on an individually administered  standardized test of general intelligence; or 



   

  A full scale (or comparable) IQ score of 71-75 accompanied by a verbal or performance IQ score (or comparable part score) of 70 or below on an individually administered standardized test of general intelligence; and 



   



   

  Significant deficits in adaptive functioning currently manifested by extreme limitation of one, or marked limitation of two, of the following areas of mental functioning: 



   



   

  Understand, remember, or apply information (see  12.00E1 ); or 



   

  Interact with others (see  12.00E2 ); or 



   

  Concentrate, persist, or maintain pace (see  12.00E3 ); or 



   

  Adapt or manage oneself (see  12.00E4 ); and 



   



   

  The evidence about your current intellectual and adaptive functioning and about the history of your disorder demonstrates or supports the conclusion that the disorder began prior to your  attainment of age 22.


code: 12.06
title: Anxiety and obsessive-compulsive disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.06 Anxiety and obsessive-compulsive disorders (see  12.00B5 ), satisfied by A and B, or A and C: 



   



   

  Medical documentation of the requirements of paragraph 1, 2, or 3: 



   



   

  Anxiety disorder, characterized  by  three  or mo…

raw_text:
  12.06 Anxiety and obsessive-compulsive disorders (see  12.00B5 ), satisfied by A and B, or A and C: 



   



   

  Medical documentation of the requirements of paragraph 1, 2, or 3: 



   



   

  Anxiety disorder, characterized  by  three  or more of the following; 



   



   

  Restlessness; 


   

  Easily fatigued; 


   

  Difficulty concentrating; 


   

  Irritability; 


   

  Muscle tension; or 


   

  Sleep disturbance. 



   



   

  Panic disorder or agoraphobia, characterized by  one  or both: 



   



   

  Panic attacks followed by a  persistent concern or worry about additional panic attacks or their consequences;  or 



   

  Disproportionate fear or anxiety about at least two different situations  (for example, using public transportation, being in a crowd, being in a line,  being outside of your home, being in open spaces). 



   



   

  Obsessive-compulsive disorder, characterized by  one  or both: 



   



   

  Involuntary, time-consuming  preoccupation with intrusive, unwanted thoughts; or 



   

  Repetitive behaviors aimed at reducing anxiety. 



   


   


   



   

  AND 



   



   

  Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see  12.00F ): 



   



   

  Understand,  remember, or apply information (see  12.00E1 ). 


   

  Interact with others  (see  12.00E2 ).  


   

  Concentrate,  persist, or maintain pace (see  12.00E3 ). 


   

  Adapt or manage  oneself (see  12.00E4 ). 



   


   



   

  OR 



   



   

  Your mental disorder in this listing category is “serious and persistent;” that is, you have a  medically documented history of the existence of the disorder over a period of  at least 2 years, and there is evidence of both: 



   



   

  Medical treatment, mental health therapy, psychosocial support(s), or a highly structured  setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder 
      (see  12.00G2b );  and 



   

  Marginal adjustment, that is, you have  minimal capacity to adapt to changes in your environment or to demands that are  not already part of your daily life 
      (see  12.00G2c ).


code: 12.07
title: Somatic symptom and related disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.07 Somatic symptom and related disorders (see  12.00B6 ), satisfied by A and B: 



   



   

  Medical documentation of  one  or more of the following: 



   



   

  Symptoms of altered voluntary motor or sensory function that are not better…

raw_text:
  12.07 Somatic symptom and related disorders (see  12.00B6 ), satisfied by A and B: 



   



   

  Medical documentation of  one  or more of the following: 



   



   

  Symptoms of altered voluntary motor or sensory function that are not better explained by another medical or mental disorder;  



   

  One or more somatic symptoms that are distressing, with excessive thoughts, feelings, or behaviors related to the symptoms; or 



   

  Preoccupation with having or acquiring a serious illness without significant symptoms present.  



   


   



   

  AND 



   



   

  Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see  12.00F ): 



   



   

  Understand, remember, or apply information (see  12.00E1 ). 


   

  Interact with others (see  12.00E2 ).  


   

  Concentrate, persist, or maintain pace (see  12.00E3 ). 


   

  Adapt or manage oneself (see  12.00E4 ).


code: 12.08
title: Personality and impulse-control disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.08 Personality and impulse-control disorders (see  12.00B7 ), satisfied by A and B: 



   



   

  Medical documentation of a pervasive pattern of  one  or more of the following: 



   



   

  Distrust and suspiciousness of others; 


   

  Deta…

raw_text:
  12.08 Personality and impulse-control disorders (see  12.00B7 ), satisfied by A and B: 



   



   

  Medical documentation of a pervasive pattern of  one  or more of the following: 



   



   

  Distrust and suspiciousness of others; 


   

  Detachment from social relationships;  


   

  Disregard for and violation of the rights of  others; 


   

  Instability of interpersonal relationships; 


   

  Excessive emotionality and attention seeking; 


   

  Feelings of inadequacy; 


   

  Excessive need to be taken care of; 


   

  Preoccupation with perfectionism and orderliness;  or 


   

  Recurrent, impulsive, aggressive behavioral outbursts.  



   


   



   

  AND 



   



   

  Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see  12.00F ): 



   



   

  Understand, remember, or apply information (see  12.00E1 ). 


   

  Interact with others (see  12.00E2 ).  


   

  Concentrate, persist, or maintain pace (see  12.00E3 ). 


   

  Adapt or manage oneself (see  12.00E4 ).


code: 12.10
title: Autism spectrum disorder
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.10 
                Autism spectrum disorder (see  12.00B8 ), satisfied by A and B: 


   


   

  Medical documentation of  both  of the following: 



   


   

  Qualitative deficits in verbal communication, nonverbal communication, and  social i…

raw_text:
  12.10 
                Autism spectrum disorder (see  12.00B8 ), satisfied by A and B: 


   


   

  Medical documentation of  both  of the following: 



   


   

  Qualitative deficits in verbal communication, nonverbal communication, and  social interaction; and 



   

  Significantly restricted, repetitive patterns of behavior, interests, or  activities. 



   


   



   

  AND 



   



   

  Extreme limitation  of one, or marked limitation of two, of the following areas of mental  functioning (see  12.00F ): 



   



   

  Understand,  remember, or apply information (see  12.00E1 ). 


   

  Interact with others  (see  12.00E2 ).  


   

  Concentrate,  persist, or maintain pace (see  12.00E3 ). 


   

  Adapt or manage oneself (see  12.00E4 ).


code: 12.11
title: Neurodevelopmental disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.11 Neurodevelopmental disorders (see  12.00B9 ), satisfied by A and B: 



   



   

  Medical documentation of the requirements of paragraph 1, 2, or 3: 



   



   

  One  or both of the following: 



   



   

  Frequent distractibility, diffic…

raw_text:
  12.11 Neurodevelopmental disorders (see  12.00B9 ), satisfied by A and B: 



   



   

  Medical documentation of the requirements of paragraph 1, 2, or 3: 



   



   

  One  or both of the following: 



   



   

  Frequent distractibility, difficulty sustaining attention, and difficulty organizing  tasks; or 



   

  Hyperactive and impulsive behavior (for example, difficulty remaining seated, talking excessively, difficulty waiting, appearing restless, or behaving as if being  “driven by a motor”).  



   



   

  Significant difficulties learning and using academic skills; or 


   

  Recurrent motor movement or vocalization.  



   


   



   

  AND 



   



   

  Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see  12.00F ): 



   



   

  Understand,  remember, or apply information (see  12.00E1 ). 


   

  Interact with others  (see  12.00E2 ). 


   

  Concentrate, persist,  or maintain pace (see  12.00E3 ). 


   

  Adapt or manage  oneself (see  12.00E4 ).


code: 12.13
title: Eating disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.13 Eating disorders (see  12.00B10 ), satisfied by A and B: 



   



   

  Medical  documentation of a persistent alteration in eating or eating-related behavior that results in a change in consumption or absorption of food and that signifi…

raw_text:
  12.13 Eating disorders (see  12.00B10 ), satisfied by A and B: 



   



   

  Medical  documentation of a persistent alteration in eating or eating-related behavior that results in a change in consumption or absorption of food and that significantly impairs  physical or psychological health. 



   



   

  AND 



   



   

  Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see  12.00F ): 



   



   

  Understand,  remember, or apply information (see  12.00E1 ). 


   

  Interact with others  (see  12.00E2 ). 


   

  Concentrate,  persist, or maintain pace (see  12.00E3 ). 


   

  Adapt or manage oneself (see  12.00E4 ).


code: 12.15
title: Trauma- and stressor-related disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm
summary:
  12.15 Trauma- and stressor-related disorders (see  12.00B11 ), satisfied by A and B, or A and C: 



   



   

  Medical documentation of  all  of the following: 



   



   

  Exposure to actual or threatened  death, serious injury, or violence;…

raw_text:
  12.15 Trauma- and stressor-related disorders (see  12.00B11 ), satisfied by A and B, or A and C: 



   



   

  Medical documentation of  all  of the following: 



   



   

  Exposure to actual or threatened  death, serious injury, or violence; 


   

  Subsequent involuntary re-experiencing of the  traumatic event (for example, intrusive memories, dreams, or flashbacks);  


   

  Avoidance of external reminders  of the event; 


   

  Disturbance in mood and  behavior; and 


   

  Increases in arousal and reactivity (for example, exaggerated startle response, sleep disturbance).  



   


   



   

  AND 



   



   

  Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning  (see  12.00F ): 



   



   

  Understand, remember, or apply information (see  12.00E1 ). 


   

  Interact with others (see  12.00E2 ).  


   

  Concentrate, persist, or maintain pace (see  12.00E3 ). 


   

  Adapt or manage  oneself (see  12.00E4 ). 



   


   



   

  OR 



   



   

  Your mental disorder in this listing category is “serious and persistent;” that is, you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both:  



   



   

  Medical treatment, mental health therapy, psychosocial support(s), or a highly structured  setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder 
      (see  12.00G2b );  and 



   

  Marginal adjustment, that is, you have minimal capacity to adapt to changes  in your environment or to demands that are not already part of your daily life 
      (see  12.00G2c ). 



   


   



    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 13.02
title: Soft tissue cancers of the head and neck
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.02
                    Soft tissue cancer of the head and neck (except salivary glands— 13.08 —and
      thyroid gland –  13.09 ).
   
             
         


         

  A. Inoperable or unresectable.  


         

   OR…

raw_text:
  13.02
                    Soft tissue cancer of the head and neck (except salivary glands— 13.08 —and
      thyroid gland –  13.09 ).
   
             
         


         

  A. Inoperable or unresectable.  


         

   OR  


         


            B. Persistent or recurrent disease following initial
            anticancer therapy, except persistence or recurrence in the true vocal cord.
         


         

   OR  


         

  C. With metastases beyond the regional lymph nodes.  


         

  OR  


         

  D. Small cell (oat cell) carcinoma.   


         

   OR  


         


            E. Soft tissue cancers originating in the head and neck treated with
            multimodal anticancer therapy (see  13.00E3c ). Consider under
      a disability until at least 18 months from the date of diagnosis.
      Thereafter, evaluate any residual impairment(s) under the criteria
      for the affected body system.


code: 13.03
title: Skin
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.03 Skin. 


         


            A. Sarcoma or
            carcinoma with metastases to or beyond the regional lymph nodes.
         


         

  OR  


         

  B. Carcinoma invading deep extradermal structures (for example, skeletal muscle,…

raw_text:
  13.03 Skin. 


         


            A. Sarcoma or
            carcinoma with metastases to or beyond the regional lymph nodes.
         


         

  OR  


         

  B. Carcinoma invading deep extradermal structures (for example, skeletal muscle, cartilage, or bone).


code: 13.04
title: Soft tissue sarcoma
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.04
                    Soft tissue sarcoma.
                 
             
         


         

  A. With regional or distant metastases.  


         

  OR  


         

  B. Persistent or recurrent following initial anticancer therapy.

raw_text:
  13.04
                    Soft tissue sarcoma.
                 
             
         


         

  A. With regional or distant metastases.  


         

  OR  


         

  B. Persistent or recurrent following initial anticancer therapy.


code: 13.05
title: Lymphoma
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.05
                    Lymphoma ( including mycosis fungoides, but  excluding T-cell
                    lymphoblastic lymphoma- 13.06  )
   
             .
            (See  13.00K1  and  13.00K2c .)
   


         


            A. Non-Hodgkin lymphom…

raw_text:
  13.05
                    Lymphoma ( including mycosis fungoides, but  excluding T-cell
                    lymphoblastic lymphoma- 13.06  )
   
             .
            (See  13.00K1  and  13.00K2c .)
   


         


            A. Non-Hodgkin lymphoma, as described in 1 or
            2:
         


         

  1. Aggressive  lymphoma (including diffuse large B-cell lymphoma) persistent or recurrent  following initial anticancer therapy. 


         

  2: Indolent lymphoma (including mycosis fungoides and follicular small cleaved cell) requiring initiation of more than one 
        (single mode or multimodal) anticancer treatment regimen within a period of 12 consecutive months. Consider under a disability from at least the date of initiation of the treatment regimen that failed within 12 months. 


         

  OR  


         

  B. Hodgkin lymphoma with failure to achieve clinically complete remission, or recurrent lymphoma within 12 months of completing initial anticancer therapy.  


         

  OR  


         


            C. With bone marrow or stem cell transplantation. Consider under
            a disability until at least 12 months from the date of transplantation.
            Thereafter, evaluate any residual impairment(s) under the criteria
            for the affected body system.
         


         

  OR 


         

  D. Mantle cell lymphoma.


code: 13.06
title: Leukemia
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.06
                    Leukemia.
                 
              (See  13.00K2 .)
   


         


            A. Acute leukemia (including T-cell lymphoblastic lymphoma).
            Consider under a disability until at least 24 months from the date…

raw_text:
  13.06
                    Leukemia.
                 
              (See  13.00K2 .)
   


         


            A. Acute leukemia (including T-cell lymphoblastic lymphoma).
            Consider under a disability until at least 24 months from the date
            of diagnosis or relapse, or at least 12 months from the date of
            bone marrow or stem cell transplantation, whichever is later. Thereafter,
            evaluate any residual impairment(s) under the criteria for the
            affected body system.
         


         

  OR  


         

  B. Chronic myelogenous leukemia, as described in 1 or 2:  


         


            1. Accelerated or blast phase (see  13.00K2b ). Consider under a disability until
      at least 24 months from the date of diagnosis or relapse, or at
      least 12 months from the date of bone marrow or stem cell transplantation,
      whichever is later. Thereafter, evaluate any residual impairment(s)
      under the criteria for the affected body system.
   


         

  2. Chronic phase, as described in a or b:  


         


            a. Consider under a disability until at least 12 months from
            the date of bone marrow or stem cell transplantation. Thereafter,
            evaluate any residual impairment(s) under the criteria for the
            affected body system.
         


         

  b. Progressive disease following initial anticancer therapy.


code: 13.07
title: Multiple myeloma
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.07  Multiple myeloma  (confirmed by appropriate serum or urine protein electrophoresis and bone marrow findings). 


         


      A. Failure to respond or progressive disease following initial
      anticancer therapy.
   


         

  OR…

raw_text:
  13.07  Multiple myeloma  (confirmed by appropriate serum or urine protein electrophoresis and bone marrow findings). 


         


      A. Failure to respond or progressive disease following initial
      anticancer therapy.
   


         

  OR  


         


      B. With bone marrow or stem cell transplantation. Consider under
      a disability until at least 12 months from the date of transplantation.
      Thereafter, evaluate any residual impairment(s) under the criteria
      for the affected body system.


code: 13.08
title: Salivary glands
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.08  Salivary glands --carcinoma
            or sarcoma with metastases beyond the regional lymph nodes.

raw_text:
  13.08  Salivary glands --carcinoma
            or sarcoma with metastases beyond the regional lymph nodes.


code: 13.09
title: Thyroid gland
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.09   
                 
                    Thyroid
                    gland.
                 
             
         


         

  A. Anaplastic (undifferentiated) carcinoma.  


         

  OR  


         


            B. Carcinoma with metastases beyo…

raw_text:
  13.09   
                 
                    Thyroid
                    gland.
                 
             
         


         

  A. Anaplastic (undifferentiated) carcinoma.  


         

  OR  


         


            B. Carcinoma with metastases beyond the regional lymph nodes
            progressive despite radioactive iodine therapy. 
         


         

  OR  


         


            C. Medullary carcinoma with metastases beyond the  regional lymph nodes.


code: 13.10
title: Breast
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.10 Breast
                    (except sarcoma— 13.04 )
    (See
                 13.00K4 .)
   
         


         


            A. Locally advanced cancer (inflammatory carcinoma, cancer
            of any size with direct extension to the chest w…

raw_text:
  13.10 Breast
                    (except sarcoma— 13.04 )
    (See
                 13.00K4 .)
   
         


         


            A. Locally advanced cancer (inflammatory carcinoma, cancer
            of any size with direct extension to the chest wall or skin, or cancer
            of any size with metastases to the ipsilateral internal mammary
            nodes).
         


         


            OR 


         


         

  B. Carcinoma with metastases to the supraclavicular or infraclavicular nodes, to 10 or more axillary nodes, or with distant metastases. 


         

  OR  


         


            C. Recurrent carcinoma, except local recurrence that remits with
            anticancer therapy.
         



         

   OR  


         

   D. Small-cell (oat cell) carcinoma.  


         

   OR  


         


            E. With secondary lymphedema that is caused by anticancer therapy and treated by surgery to salvage or restore the functioning of an upper extremity. 
        (See  13.00K4b .) Consider under a disability until at least 12 months from the date of the surgery that treated the secondary lymphedema.
      Thereafter, evaluate any residual impairment(s) under the criteria for the affected body system.


code: 13.11
title: Skeletal system--sarcoma
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.11   Skeletal system  -- sarcoma.  


         

  A. Inoperable or unresectable.  


         

  OR  


         


            B. Recurrent cancer (except local recurrence) after initial anticancer
            therapy.
         


         

  OR…

raw_text:
  13.11   Skeletal system  -- sarcoma.  


         

  A. Inoperable or unresectable.  


         

  OR  


         


            B. Recurrent cancer (except local recurrence) after initial anticancer
            therapy.
         


         

  OR  


         

  C. With distant metastases.  


         

  OR  


         


            D. All other cancer originating in bone with multimodal anticancer
            therapy (see  13.00E3c ). Consider under a disability for 12 months from the date
      of diagnosis. Thereafter, evaluate any residual impairment(s) under
      the criteria for the affected body system.


code: 13.12
title: Maxilla, orbit or temporal fossa
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.12  
                 
                    Maxilla,
                    orbit, or temporal fossa.
                 
             
         


         


            A. Sarcoma or carcinoma of any type with regional
            or distant metastases.…

raw_text:
  13.12  
                 
                    Maxilla,
                    orbit, or temporal fossa.
                 
             
         


         


            A. Sarcoma or carcinoma of any type with regional
            or distant metastases.
         


         

  OR  


         


            B. Carcinoma of the antrum with extension into the orbit or ethmoid
            or sphenoid sinus.
         


         

   OR  


         

   C. Cancer with extension to the orbit, meninges, sinuses, or base of the skull.


code: 13.13
title: Nervous system
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.13 Nervous system.  (See
             13.00K6 .)
   


         


            A. Primary central nervous system (CNS; that is brain and spinal cord) cancers,
            as described in 1,2 or 3:
         


         

  1. Glioblastoma multiforme, epe…

raw_text:
  13.13 Nervous system.  (See
             13.00K6 .)
   


         


            A. Primary central nervous system (CNS; that is brain and spinal cord) cancers,
            as described in 1,2 or 3:
         


         

  1. Glioblastoma multiforme, ependymoblastoma, and diffuse intrinsic brain stem gliomas (see  13.00K6a ). 


         

  2. Any Grade III or Grade IV CNS cancer (see  13.00K6b ), including astrocytomas, sarcomas, 
        and medulloblastoma and other primitive neuroectodermal tumors (PNETs). 


         

  3. Any primary CNS cancer, as described in a or b:  


         

  a. Metastatic.  


         

  b. Progressive or recurrent following initial anticancer therapy. 


         

  OR  


         


            B. Primary peripheral nerve or spinal root cancers, as
            described in 1 or 2:
         


         

  1. Metastatic.  


         


            2. Progressive or recurrent following initial anticancer
            therapy.


code: 13.14
title: Lungs
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.14 Lungs. 


         


            A. Non-small-cell carcinoma--inoperable, unresectable, recurrent,
            or metastatic disease to or beyond the hilar nodes.
         


         

   OR  


         


            B. Small-cell (oat cell) carc…

raw_text:
  13.14 Lungs. 


         


            A. Non-small-cell carcinoma--inoperable, unresectable, recurrent,
            or metastatic disease to or beyond the hilar nodes.
         


         

   OR  


         


            B. Small-cell (oat cell) carcinoma.  


         

  OR  


         


            C. Carcinoma of the superior sulcus (including Pancoast  tumors) with multimodal anticancer therapy (see  13.00E3c ).
      Consider under a disability until at least 18 months from the date of diagnosis. Thereafter, evaluate any residual impairment(s) under the criteria for the affected body system.


code: 13.15
title: Pleura or mediastinum
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.15  Pleura or mediastinum. 


         

  A. Malignant mesothelioma of pleura.  


         

  OR  


         

  B. Tumors of the mediastinum, as described in 1 or 2:  


         

  1. With metastases to or beyond the regional lymph nodes.…

raw_text:
  13.15  Pleura or mediastinum. 


         

  A. Malignant mesothelioma of pleura.  


         

  OR  


         

  B. Tumors of the mediastinum, as described in 1 or 2:  


         

  1. With metastases to or beyond the regional lymph nodes.  


         

  2. Persistent or recurrent following initial anticancer therapy.  


         

  OR  


         

  C. Small-cell (oat cell) carcinoma.


code: 13.16
title: Esophagus or stomach
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.16  Esophagus or stomach. 


         

  A. Carcinoma or sarcoma of the esophagus.  


         

  OR  


         


            B. Carcinoma or sarcoma of the stomach, as described in 1 or
            2:
         


         


            1. Inoperable…

raw_text:
  13.16  Esophagus or stomach. 


         

  A. Carcinoma or sarcoma of the esophagus.  


         

  OR  


         


            B. Carcinoma or sarcoma of the stomach, as described in 1 or
            2:
         


         


            1. Inoperable, unresectable, extending to surrounding structures,
            or recurrent.
         


         

  2. With metastases to or beyond the regional lymph nodes.  


         

  OR  


         

  C. Small-cell (oat cell) carcinoma.


code: 13.17
title: Small intestine
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.17  Small intestine  --carcinoma,
            sarcoma, or carcinoid.
         


         

  A. Inoperable, unresectable, or recurrent.  


         

  OR  


         

  B. With metastases beyond the regional lymph nodes.  


         

  OR…

raw_text:
  13.17  Small intestine  --carcinoma,
            sarcoma, or carcinoid.
         


         

  A. Inoperable, unresectable, or recurrent.  


         

  OR  


         

  B. With metastases beyond the regional lymph nodes.  


         

  OR  


         

  C. Small-cell (oat cell) carcinoma.


code: 13.18
title: Large intestine
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.18   
                 
                    Large
                    intestine (from ileocecal valve to and including anal canal).
                 
             
         


         


            A.
            Adenocarcinoma that is inoperable, unres…

raw_text:
  13.18   
                 
                    Large
                    intestine (from ileocecal valve to and including anal canal).
                 
             
         


         


            A.
            Adenocarcinoma that is inoperable, unresectable, or recurrent.
         


         

  OR  


         

   B. Squamous cell carcinoma of the anus, recurrent after surgery.  


         

  OR  


         

   C. With metastases beyond the regional lymph nodes.  


         

   OR  


         

   D. Small-cell (oat cell) carcinoma.


code: 13.20
title: Pancreas
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.20   Pancreas. 


         

  A. Carcinoma (except islet cell carcinoma).  


         

  OR  


         


            B. Islet cell carcinoma that is physiologically active and is either inoperable or unresectable.

raw_text:
  13.20   Pancreas. 


         

  A. Carcinoma (except islet cell carcinoma).  


         

  OR  


         


            B. Islet cell carcinoma that is physiologically active and is either inoperable or unresectable.


code: 13.21
title: Kidneys, adrenal glands, or ureters--carcinoma
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.21 Kidneys, adrenal glands, or ureters-  carcinoma . 


         

  A. Inoperable, unresectable, or recurrent.  


         

  OR  


         

  B. With metastases to or beyond the regional lymph nodes.

raw_text:
  13.21 Kidneys, adrenal glands, or ureters-  carcinoma . 


         

  A. Inoperable, unresectable, or recurrent.  


         

  OR  


         

  B. With metastases to or beyond the regional lymph nodes.


code: 13.22
title: Urinary bladder--carcinoma
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.22 Urinary bladder  -carcinoma .  


         


                A. With infiltration beyond the bladder
            wall.
         


         

  OR  


         

  B. Recurrent after total cystectomy.  


         

  OR  


         

  C. Inoperable or u…

raw_text:
  13.22 Urinary bladder  -carcinoma .  


         


                A. With infiltration beyond the bladder
            wall.
         


         

  OR  


         

  B. Recurrent after total cystectomy.  


         

  OR  


         

  C. Inoperable or unresectable.  


         

  OR  


         

   D. With metastases to or beyond the regional lymph nodes.  


         

  OR  


         

  E. Small-cell (oat cell) carcinoma.


code: 13.23
title:
  Cancers
  of the female genital tract--carcinoma or sarcoma

source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.23 Cancers
                    of the female genital tract
                 
              -carcinoma
            or sarcoma (including primary peritoneal carcinoma).  .  
         


         


                A. Uterus (corpus),
            as descr…

raw_text:
  13.23 Cancers
                    of the female genital tract
                 
              -carcinoma
            or sarcoma (including primary peritoneal carcinoma).  .  
         


         


                A. Uterus (corpus),
            as described in 1, 2, or 3:
         


         

  1. Invading adjoining organs.  


         

  2. With metastases to or beyond the regional lymph nodes.  


         

  3. Persistent or recurrent following initial anticancer therapy.  


         

   OR  


         

  B. Uterine cervix, as described in 1, 2 or 3:  


         


            1. Extending to the pelvic wall, lower portion of the vagina,
            or adjacent or distant organs.
         


         

  2. Persistent or recurrent following initial anticancer therapy.  


         

  3. With metastases to distant (for example, para-aortic or supraclavicular) lymph nodes. 


         

  OR  


         

  C. Vulva or vagina, as described in 1, 2, or 3:  


         

  1. Invading adjoining organs.  


         

  2. With metastases to or beyond the regional lymph nodes.  


         

  3. Persistent or recurrent following initial anticancer therapy.  


         

  OR  


         

  D. Fallopian tubes, as described in 1 or 2:  


         

  1. Extending to the serosa or beyond.  


         

  2. Persistent or recurrent following initial anticancer therapy.  


         

  OR  


         

  E. Ovaries, as described in 1 or 2:  


         


            1. All cancers except germ-cell cancers, with at least one of the
            following:
         


         


            a. Extension beyond the pelvis; for example,
            implants on, or direct extension to, peritoneal, omental, or bowel surfaces.
         


         

  b. Metastases to or beyond the regional lymph nodes.  


         

  c. Recurrent following initial anticancer therapy.  


         


            2. Germ-cell cancer--progressive or recurrent following initial
            anticancer therapy.
         


         

  OR  


         

  F. Small-cell (oat cell) carcinoma.


code: 13.24
title: Prostate gland-- carcinoma
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.24 Prostate
                    gland-
                 
              carcinoma.
         


         

  A. Progressive or recurrent (not including biochemical recurrence) despite initial hormonal intervention. (See  13.00K8 .)  


         

  OR…

raw_text:
  13.24 Prostate
                    gland-
                 
              carcinoma.
         


         

  A. Progressive or recurrent (not including biochemical recurrence) despite initial hormonal intervention. (See  13.00K8 .)  


         

  OR  


         

   B. With visceral metastases (metastases to internal organs).  


         

  OR  


         

  C. Small-cell (oat cell) carcinoma.


code: 13.25
title: Testicles
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.25 Testicles—  cancer
            with metastatic disease progressive or recurrent following initial
            chemotherapy.

raw_text:
  13.25 Testicles—  cancer
            with metastatic disease progressive or recurrent following initial
            chemotherapy.


code: 13.27
title: Primary site unknown
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.27  
                 
                    Primary site unknown after appropriate search
                    for primary
                 
             —metastatic carcinoma or sarcoma, except for squamous cell carcinoma confined to the neck  no…

raw_text:
  13.27  
                 
                    Primary site unknown after appropriate search
                    for primary
                 
             —metastatic carcinoma or sarcoma, except for squamous cell carcinoma confined to the neck  nodes.


code: 13.28
title:
  Cancer treated by bone marrow
  or stem cell transplantation

source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.28   
                 
                    Cancer treated by bone
                    marrow or stem cell transplantation
                 
             . (See  13.00L .)
   


         


            A. Allogeneic transplantation. Consider under a dis…

raw_text:
  13.28   
                 
                    Cancer treated by bone
                    marrow or stem cell transplantation
                 
             . (See  13.00L .)
   


         


            A. Allogeneic transplantation. Consider under a disability until
            at least 12 months from the date of transplantation. Thereafter,
            evaluate any residual impairment(s) under the criteria for the
            affected body system.
         


         

  OR  


         


            B. Autologous transplantation. Consider under a disability until
            at least 12 months from the date of the first treatment under the
            treatment plan that includes transplantation. Thereafter, evaluate
            any residual impairment(s) under the criteria for the affected
            body system.


code: 13.29
title: Malignant melanoma
source_url: https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm
summary:
  13.29   Malignant melanoma  (including skin, ocular, or mucosal melanomas), as described in either A, B, or C:  



         

   A. Recurrent (except an additional primary melanoma at a different site, which is not considered to be recurrent d…

raw_text:
  13.29   Malignant melanoma  (including skin, ocular, or mucosal melanomas), as described in either A, B, or C:  



         

   A. Recurrent (except an additional primary melanoma at a different site, which is not considered to be recurrent disease) following either 1 or 2:  


         

  1. Wide excision (skin melanoma).  


         

  2. Enucleation of the eye (ocular melanoma). 


         

  OR  


         

  B. With metastases as described in 1, 2, or 3:  


         

  1. Metastases to one or more clinically apparent nodes; that is, nodes that are detected by imaging studies (excluding lymphoscintigraphy) or by clinical evaluation (palpable). 


         

  2. If the nodes are not clinically apparent, with metastases to four or more nodes. 


         

  3. Metastases to adjacent skin (satellite lesions) or distant sites (for example, liver, lung, or brain). 


         

  OR  


         

  C. Mucosal melanoma. 


         


             Back to Top 
         


        
    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 14.02
title: Systemic lupus erythematosus
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.02  Systemic lupus erythematosus.   As described in  14.00D1 . With:  


                           

  A.  Involvement of two or more organs/body systems, with: 



                           

  1. One of the organs/body systems involved to a…

raw_text:
  14.02  Systemic lupus erythematosus.   As described in  14.00D1 . With:  


                           

  A.  Involvement of two or more organs/body systems, with: 



                           

  1. One of the organs/body systems involved to at least a moderate level of severity; and 



                           

  2. At least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss).  



                           

  OR 



                           

  B.  Repeated manifestations of SLE, with at least two of the constitutional symptoms or signs (severe  fatigue, fever, malaise, or involuntary weight loss) and one of the following  at the marked level: 



                           

  1. Limitation of activities  of daily living. 



                           

  2. Limitation in maintaining  social functioning. 



                           

  3. Limitation in completing  tasks in a timely manner due to deficiencies in concentration, persistence, or  pace. 


                           

  Back to Top


code: 14.03
title: Systemic vasculitis
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.03 Systemic vasculitis .  As described in  14.00D2 . With: 



                           

  A.  Involvement of two or  more organs/body systems, with: 



                           

  1. One of the organs/body  systems involved to at least a…

raw_text:
  14.03 Systemic vasculitis .  As described in  14.00D2 . With: 



                           

  A.  Involvement of two or  more organs/body systems, with: 



                           

  1. One of the organs/body  systems involved to at least a moderate level of severity; and 



                           

  2. At least two of the  constitutional symptoms or signs (severe fatigue, fever, malaise, or  involuntary weight loss).  



                           

  OR 



                           

  B.  Repeated manifestations of systemic vasculitis, with at least two of the constitutional symptoms or  signs (severe fatigue, fever, malaise, or involuntary weight loss) and one of  the following at the marked level: 



                           

  1. Limitation of activities  of daily living. 



                           

  2. Limitation in maintaining  social functioning. 



                           

  3. Limitation in completing  tasks in a timely manner due to deficiencies in concentration, persistence, or pace. 


                           

  Back to Top


code: 14.04
title: Systemic sclerosis (scleroderma)
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.04 Systemic sclerosis (scleroderma)   As described in  14.00D3 . With: 



                           

  A.  Involvement of two or  more organs/body systems, with: 



                           

  1. One of the organs/body systems involved t…

raw_text:
  14.04 Systemic sclerosis (scleroderma)   As described in  14.00D3 . With: 



                           

  A.  Involvement of two or  more organs/body systems, with: 



                           

  1. One of the organs/body systems involved to at least a moderate level of severity; and 



                           

  2. At least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss).  



                           

  OR 



                           

  B.  With one of the following: 



                           


                               1. Toe contractures or fixed deformity of one or both feet  and medical documentation of at least  one  of the following: 


                               


                                   
                                   


                                      A documented medical need (see  14.00C6 ) for a walker, bilateral canes, or bilateral crutches (see  1.00C6d ) or a wheeled and seated mobility device involving the use of both hands (see  1.00C6e(i) ); or
                                   


                                   


                                   
                                   


                                      An inability to use  one  upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see  14.00C7 ), and a documented medical need (see  14.00C6 ) for a one-handed, hand-held assistive device (see  1.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see  1.00C6e(ii) ); or
                                   


                               


                           



                           

  2. Finger contractures or fixed deformity in both hands and medical documentation of an inability to use  both  upper extremities to the extent that neither can be used to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see  14.00C7 ); or 



                           


                               3. Atrophy with irreversible damage in one or both lower extremities   and medical documentation of at least  one  of the following: 


                               


                                   
                                   


                                      A documented medical need (see  14.00C6 ) for a walker, bilateral canes, or bilateral crutches (see  1.00C6d ) or a wheeled and seated mobility device involving the use of both hands (see  1.00C6e(i) ); or
                                   


                                   
                                   


                                      An inability to use  one  upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see  14.00C7 ), and a documented medical need (see  14.00C6 ) for a one-handed, hand-held assistive device (see 1.00C6d) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see  1.00C6e(ii) ); or
                                   


                               


                           



                           

  4. Atrophy with irreversible damage in both upper extremities (see  14.00C8 ) and medical documentation of an inability to use  both  upper extremities to the extent that neither can be used to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see 14.00C7 );  



                           

  OR 



                           

  C.  Raynaud's phenomenon, characterized by: 



                           

  1. Gangrene involving at least two extremities; or 



                           


                               2. Ischemia with ulcerations of toes or fingers
                              and medical documentation of at least  one  of the following: 


                               


                                   


                                      A documented medical need (see  14.00C6 ) for a walker, bilateral canes, or bilateral crutches (see  1.00C6d ) or a wheeled and seated mobility device involving the use of both hands (see  1.00C6e(i) ); or
                                   


                                   


                                      An inability to use  one  upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see  14.00C7 ), and a documented medical need (see  14.00C6 ) for a one-handed, hand-held assistive device (see  1.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see  1.00C6e(ii) ); or
                                   


                                   


                                      An inability to use  both  upper extremities to the extent that neither can be used to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see  14.00C7 );
                                   


                               


                           



                           

  OR 



                           

  D.  Repeated manifestations of systemic sclerosis (scleroderma), with at least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss)  and one of the following at the marked level: 



                           

  1. Limitation of activities of daily living. 



                           

  2. Limitation in maintaining social functioning. 



                           

  3. Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace. 


                           

  Back to Top


code: 14.05
title: Polymyositis and dermatomyositis
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.05  Polymyositis and dermatomyositis .  As described in  14.00D4 . With: 



                           


                               A. Proximal limb-girdle (pelvic or shoulder) muscle weakness and medical documentation of at least  one…

raw_text:
  14.05  Polymyositis and dermatomyositis .  As described in  14.00D4 . With: 



                           


                               A. Proximal limb-girdle (pelvic or shoulder) muscle weakness and medical documentation of at least  one  of the following: 


                               


                                   


                                      A documented medical need (see  14.00C6 ) for a walker, bilateral canes, or bilateral crutches (see  1.00C6d )
                                      or a wheeled and seated mobility device involving the use of both hands (see  1.00C6e(i) ); or
                                   


                                   


                                      An inability to use  one  upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see  14.00C7 ), and a documented medical need (see  14.00C6 ) for a one-handed, hand-held assistive device (see  1.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see  1.00C6e(ii) ); or
                                   


                                   


                                      An inability to use  both  upper extremities to the extent that neither can be used to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see  14.00C7 );
                                   


                               


                           



                           

  OR 



                           

  B. Impaired swallowing (dysphagia) with aspiration due to muscle weakness.  



                           

  OR 



                           

  C. Impaired respiration due to intercostal and diaphragmatic muscle weakness.  



                           

  OR 



                           

  D. Diffuse calcinosis with limitation of joint mobility or intestinal motility.  



                           

  OR 



                           

  E. Repeated manifestations of polymyositis or dermatomyositis, with at least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss) and one of the following at the marked level: 



                           

  1. Limitation of activities of daily living. 



                           

  2. Limitation in maintaining social functioning.  



                           

  3. Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace. 



                           

  Back to Top


code: 14.06
title: Undifferentiated and mixed connective tissue disease
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.06 Undifferentiated and mixed connective tissue disease .  As described in  14.00D5 . With: 



                           

  A. Involvement of two or  more organs/body systems, with: 



                           

  1. One of the organs/body…

raw_text:
  14.06 Undifferentiated and mixed connective tissue disease .  As described in  14.00D5 . With: 



                           

  A. Involvement of two or  more organs/body systems, with: 



                           

  1. One of the organs/body systems involved to at least a moderate level of severity; and 



                           

  2. At least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss).  



                           

  OR 



                           


                               B. Repeated manifestations of undifferentiated or mixed connective tissue disease, with at least two of the constitutional symptoms or signs
                              (severe fatigue, fever, malaise, or involuntary weight loss) and one of the following at the marked level:
                           



                           

  1. Limitation of activities of daily living. 



                           

  2. Limitation in maintaining social functioning. 



                           

  3. Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace. 


                           

  Back to Top


code: 14.07
title: Immune deficiency disorders, excluding HIV infection
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.07  Immune deficiency disorders, excluding  HIV infection .  As described in  14.00E . With: 



                           

  A.  One or more of the  following infections. The infection(s) must either be resistant to treatment or require h…

raw_text:
  14.07  Immune deficiency disorders, excluding  HIV infection .  As described in  14.00E . With: 



                           

  A.  One or more of the  following infections. The infection(s) must either be resistant to treatment or require hospitalization or intravenous treatment three or more times in a 12-month period. 



                           

  1. Sepsis; or 



                           

  2. Meningitis; or 



                           

  3. Pneumonia; or 



                           

  4. Septic arthritis; or 



                           

  5. Endocarditis; or 



                           

  6. Sinusitis documented by appropriate medically acceptable imaging.  



                           

  OR 



                           


                               B.  Stem cell transplantation as described under  14.00E3 . Consider under a disability until at least 12 months from the date of transplantation.
                              Thereafter, evaluate any residual impairment(s) under the criteria for the affected body system.
                           



                           

  OR 



                           

  C.  Repeated manifestations of an immune deficiency disorder, with at least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss)  and one of the following at the marked level: 



                           

  1. Limitation of activities of daily living. 



                           

  2. Limitation in maintaining social function. 



                           

  3. Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace. 



                           

  Back to Top


code: 14.09
title: Inflammatory arthritis
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.09  Inflammatory arthritis . As described in  14.00D6 . With: 


                           

  A.  Persistent inflammation  or persistent deformity of: 



                           


                               1. One or more major periph…

raw_text:
  14.09  Inflammatory arthritis . As described in  14.00D6 . With: 


                           

  A.  Persistent inflammation  or persistent deformity of: 



                           


                               1. One or more major peripheral   joints   in a lower extremity (see  14.00C8 ) and medical documentation of at least  one  of the following: 


                               


                                   


                                      A documented medical need (see  14.00C6 ) for a walker, bilateral canes, or bilateral crutches (see  1.00C6d ) or a wheeled and seated mobility device involving the use of both hands
                                      (see  1.00C6e(i) ); or
                                   


                                   


                                      An inability to use  one  upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see  14.00C7 ), and a documented medical need (see  14.00C6 ) for a one-handed, hand-held assistive device (see  1.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see  1.00C6e(ii) ); or
                                   


                               


                           



                           


                               2. One or more major peripheral joints in each upper extremity (see  14.00C8 ) and medical documentation of an inability to use  both  upper extremities to the extent that neither can be used to independently initiate, sustain, and complete work-related activities involving fine and gross movements (see  14.00C7 ).
                           



                           

  OR 



                           


                               B.  Inflammation or deformity in one or more major   joints of an upper or a lower extremity (see  14.00C8 ) with:
                           



                           

  1. Involvement of two or  more organs/body systems with one of the organs/body systems involved to at least a moderate level of severity; and 



                           

  2. At least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss).  



                           

  OR 



                           

  C.  Ankylosing spondylitis or other spondyloarthropathies, with: 



                           

  1. Ankylosis (fixation) of the dorsolumbar or cervical spine as shown by appropriate medically acceptable imaging and measured on physical examination at 45° or more of flexion from the  vertical position (zero degrees); or 



                           

  2. Ankylosis (fixation) of the dorsolumbar or cervical spine as shown by appropriate medically acceptable imaging and measured on physical examination at 30° or more of flexion (but  less than 45°) measured from the vertical position (zero degrees), and  involvement of two or more organs/body systems with one of the organs/body systems involved to at least a moderate level of severity.  



                           

  OR 



                           

  D.  Repeated manifestations of inflammatory arthritis, with at least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss) and one of  the following at the marked level: 



                           

  1. Limitation of activities of daily living. 



                           

  2. Limitation in maintaining social functioning. 



                           

  3. Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace. 



                           

  Back to Top


code: 14.10
title: Sjögren’s syndrome
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.10 Sjögren’s syndrome . As  described in  14.00D7 . With: 


                           

  A.  Involvement of two or  more organs/body systems, with: 



                           

  1. One of the organs/body systems involved to at least a…

raw_text:
  14.10 Sjögren’s syndrome . As  described in  14.00D7 . With: 


                           

  A.  Involvement of two or  more organs/body systems, with: 



                           

  1. One of the organs/body systems involved to at least a moderate level of severity; and 



                           

  2. At least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss). 



                           

  OR 



                           

  B.  Repeated manifestations of Sjögren's syndrome, with at least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or involuntary weight loss) and one of  the following at the marked level: 



                           

  1. Limitation of activities  of daily living. 



                           

  2. Limitation in maintaining  social functioning. 



                           

  3. Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace. 



                           


                               Back to Top


code: 14.11
title: Human immunodeficiency virus (HIV) infection
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.11  Human immunodeficiency virus (HIV)  infection.  With  documentation as described in  14.00F1  and one of the following: 



                           


                               A.  Multicentric (not localized or  unicentric) Cast…

raw_text:
  14.11  Human immunodeficiency virus (HIV)  infection.  With  documentation as described in  14.00F1  and one of the following: 



                           


                               A.  Multicentric (not localized or  unicentric) Castleman disease affecting multiple groups of lymph nodes or  organs containing lymphoid tissue
                              (see  14.00F3a ).
                           


                           

  OR 


                           

  B.  Primary central nervous system lymphoma (see  14.00F3b ). 


                           

  OR 


                           

  C.  Primary effusion lymphoma (see  14.00F3c ). 


                           

  OR 


                           

  D.  Progressive multifocal  leukoencephalopathy (see  14.00F3d ). 


                           

  OR 


                           


                               E.  Pulmonary Kaposi sarcoma (see  14.00F3e ). 


                               


                              OR
                           


                           

  F.  Absolute CD4 count of 50 cells/mm3 or less (see  14.00F4 ). 


                           

  OR 


                           


                               G.  Absolute CD4 count of less than 200 cells/mm3 or CD4 percentage of less than 14 percent,  and  one of the following
                              (values do not have to be measured on the same date) (see  14.00F5 ):
                           


                           

  1. BMI measurement of less than 18.5; or 


                           

  2. Hemoglobin measurement of less than 8.0 grams per deciliter (g/dL). 


                           

  OR 


                           


                               H.  Complication(s) of HIV infection requiring at least three hospitalizations within a 12-month period and at least 30 days apart
                              (see  14.00F6 ). Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization.
                           


                           

  OR 


                           


                               I.  Repeated (as defined in  14.00I3 ) manifestations of HIV infection,
                              including those listed in  14.11A-H , but without the requisite findings for those listings
                              (for example, Kaposi sarcoma not meeting the criteria in  14.11E ),
                              or other manifestations (including, but  not limited to, cardiovascular disease (including myocarditis, pericardial  effusion, pericarditis, endocarditis, or pulmonary arteritis),
                              diarrhea, distal  sensory polyneuropathy, glucose intolerance, gynecologic conditions (including cervical cancer or pelvic inflammatory disease,
                              see  14.00F7 ), hepatitis, HIV-associated dementia,
                              immune reconstitution inflammatory syndrome (IRIS),  infections (bacterial, fungal, parasitic, or viral), lipodystrophy (lipoatrophy  or lipohypertrophy), malnutrition, muscle weakness, myositis,
                              neurocognitive or other mental limitations not meeting the criteria in  12.00 ,
                              oral hairy leukoplakia, osteoporosis, pancreatitis, peripheral neuropathy) resulting in  significant, documented symptoms or signs (for example, but not limited to, fever, headaches, insomnia,
                              involuntary weight loss, malaise, nausea, night sweats, pain, severe fatigue, or vomiting) and one of the following at the marked level:
                           


                           

  1. Limitation of activities of daily living. 


                           

  2. Limitation in maintaining social functioning. 


                           

  3. Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace. 


                           

  Back to Top 



                       
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 14.00
title: 14.00
source_url: https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm
summary:
  14.00 Immune System Disorders  


                           

  A.   What disorders do we  evaluate under the immune system disorders listings? 



                           

  1.  We evaluate immune system disorders that cause dysfunction in on…

raw_text:
  14.00 Immune System Disorders  


                           

  A.   What disorders do we  evaluate under the immune system disorders listings? 



                           

  1.  We evaluate immune system disorders that cause dysfunction in one or more components of your immune system . 



                           

  a. The dysfunction may be due to problems in antibody production, impaired cell-mediated immunity, a combined type of antibody/cellular deficiency, impaired phagocytosis, or  complement deficiency. 



                           

  b. Immune system disorders may result in recurrent and unusual infections, or inflammation and dysfunction  of the body's own tissues. Immune system disorders can cause a deficit in a  single organ or body system that results in extreme (that is, very serious)  loss of function. They can also cause lesser degrees of limitations in two or  more organs or body systems, and when associated with symptoms or signs, such  as severe fatigue, fever, malaise, diffuse musculoskeletal pain, or involuntary  weight loss, can also result in extreme limitation. 



                           

  c. We organize the discussions of immune system disorders in three categories: Autoimmune  disorders; Immune deficiency disorders, excluding human immunodeficiency virus  (HIV) infection; and HIV infection. 



                           


                               2.  Autoimmune disorders ( 14.00D ). 
                              Autoimmune disorders are caused by dysfunctional immune responses directed against the body's own tissues, resulting in chronic, multisystem impairments that differ in clinical manifestations, course, and outcome.
                              They are sometimes referred to as rheumatic diseases, connective tissue disorders, or collagen vascular disorders. Some of the features of autoimmune disorders in adults differ from the features of the same disorders in children.
                           



                           


                               3.  Immune deficiency  disorders, excluding HIV infection ( 14.00E ). 
                              Immune deficiency disorders are characterized by recurrent or unusual infections that respond poorly to  treatment, and are often associated with complications affecting other parts of the body.
                              Immune deficiency disorders are classified as either  primary  (congenital) or  acquired . Individuals with immune deficiency disorders also have an increased risk of malignancies and of having autoimmune disorders.
                           



                           


                               4.  Human immunodeficiency virus (HIV) infection ( 14.00F ). 
                              HIV infection may be characterized by increased susceptibility to common infections as well as opportunistic infections, cancers, or other conditions listed in  14.11 .
                           



                           

  B.   What information do we need to show that you have an immune system disorder?  Generally, we need your medical history, a report(s) of a physical examination, a report(s) of laboratory  findings, and in some instances, appropriate medically acceptable imaging or  tissue biopsy reports to show that you have an immune system disorder.  Therefore, we will make every reasonable effort to obtain your medical history,  medical findings, and results of laboratory tests. We explain the information  we need in more detail in the sections below. 


                           

  C.   Definitions  



                           

  1.  Appropriate medically  acceptable imaging  includes, but is not limited to, angiography, x-ray  imaging, computerized axial tomography (CAT scan) or magnetic resonance imaging  (MRI), with or without contrast material, myelography, and radionuclear bone  scans. “Appropriate” means that the technique used is the proper one to support  the evaluation and diagnosis of the impairment. 



                           

  2.  Constitutional  symptoms or signs , as used in these listings, means severe fatigue, fever,  malaise, or involuntary weight loss.  Severe fatigue  means a frequent  sense of exhaustion that results in significantly reduced physical activity or  mental function.  Malaise  means frequent feelings of illness, bodily  discomfort, or lack of well-being that result in significantly reduced physical  activity or mental function. 



                           

  3.  Disseminated  means that a condition is spread over a considerable area. The type and extent  of the spread will depend on your specific disease. 



                           

  4.  Dysfunction  means that one or more of the body regulatory mechanisms are impaired, causing  either an excess or deficiency of immunocompetent cells or their products. 



                           

  5.  Extra-articular  means “other than the joints”; for example, an organ(s) such as the heart, lungs, kidneys, or skin. 



                           

  6.  Documented medical need  has the same meaning as in  1.00C6a . 



                           

  7.  Fine and gross movements  has the same meaning as in  1.00E4 . 



                           

  8.  Major joint of an upper or a lower extremity  has the same meaning as in  1.00I2  and  1.00I3 . 



                           


                               9.  Persistent  means that a sign(s) or symptom(s) has continued over time.
                              The precise meaning will depend on the specific immune system disorder, the usual course of the disorder, and the other circumstances of your clinical course.
                           



                           

  10.  Recurrent  means that a condition that previously responded adequately to an appropriate course  of treatment returns after a period of remission or regression. The precise  meaning, such as the extent of response or remission and the time periods  involved, will depend on the specific disease or condition you have, the body  system affected, the usual course of the disorder and its treatment, and the  other facts of your particular case.  



                           

  11.  Resistant to treatment  means that a condition did not respond adequately to an appropriate course of treatment. Whether a response is adequate or a course of treatment is appropriate will depend on the specific disease or condition you have, the body system affected, the usual course of the disorder and its treatment, and the other facts of your particular case. 



                           


                               12.  Severe  means medical severity as used by the medical community.
                              The term does not have the same meaning as it does when we use it in connection with a finding at the second step of the sequential evaluation processes in
                              §§  404.1520  and
                               416.920  of this chapter
                               .
                           



                           

  D.   How do we document and evaluate the listed autoimmune disorders?  



                           

  1.  Systemic lupus erythematosus ( 14.02 ).   



                           


                               a.  General.  Systemic lupus erythematosus (SLE) is a chronic inflammatory disease that can  affect any organ or body system.
                              It is frequently, but not always, accompanied  by constitutional symptoms or signs (severe fatigue, fever, malaise, involuntary weight loss). Major organ or body system involvement can include:
                              Respiratory (pleuritis, pneumonitis), cardiovascular (endocarditis,  myocarditis, pericarditis, vasculitis), renal (glomerulonephritis), hematologic (anemia, leukopenia, thrombocytopenia), skin (photosensitivity),
                              neurologic (seizures), mental (anxiety, fluctuating cognition (“lupus fog”), mood  disorders, organic brain syndrome, psychosis), or immune system disorders (inflammatory arthritis).
                              Immunologically, there is an array of circulating serum auto-antibodies and pro- and anti-coagulant proteins that may occur in a highly variable pattern.


code: 100.04
title: Low birth weight in infants from birth to attainment of age 1
source_url: https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm
summary:
  100.04 Low birth weight in infants from birth to attainment of age 1.   


         

  A. Birth weight (see  100.00B ) of less than 1200 grams.  


         

  OR  


         


             B. The following gestational age and birth weight:…

raw_text:
  100.04 Low birth weight in infants from birth to attainment of age 1.   


         

  A. Birth weight (see  100.00B ) of less than 1200 grams.  


         

  OR  


         


             B. The following gestational age and birth weight: 


         


         
             


                 
                    Gestational Age (in weeks)
                    
                 
                 
                    Birth Weight 
                    
                 
             


             


                 
                    37-40 
                    
                 
                 
                    2000 grams or less 
                    
                 
             


             


                 
                 36 
                    
                 
                 
                    1875 grams or less 
                    
                 
             


             


                 
                    35
                    
                 
                 
                    1700 grams or less
                    
                 
             


             


                 
                    34 
                    
                 
                 
                   1500 grams or less 
                    
                 
             


             


                 
                   33 
                    
                 
                 
                    1325 grams or less 
                    
                 
             


             


                 
                   32 
                    
                 
                 
                    1250 grams or less


code: 100.05
title: Failure to thrive in children from birth to attainment of age 3
source_url: https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm
summary:
  100.05 Failure to thrive in children from birth to attainment of age 3 (see  100.00C ), documented by A and B, or A and C.   


         

  A.  Growth failure as required in 1 or 2:  


         

  1.  For children from birth to attainment of age…

raw_text:
  100.05 Failure to thrive in children from birth to attainment of age 3 (see  100.00C ), documented by A and B, or A and C.   


         

  A.  Growth failure as required in 1 or 2:  


         

  1.  For children from birth to attainment of age 2,  three weight-for-length measurements that are:  


         

  a.  Within a consecutive 12-month period; and  


         

  b.  At least 60 days apart; and  


         

  c.  Less than the third percentile on the appropriate weight-for-length table under  105.08B1 ; or   


         

  2.  For children age 2 to attainment of age 3,  three BMI-for-age measurements that are:  


         

  a.  Within a consecutive 12-month period; and  


         

  b.  At least 60 days apart; and  


         

  c.  Less than the third percentile on the appropriate BMI-for-age table under  105.08B2 .  


         

  AND  


         

  B.  Developmental delay (see  100.00C1  and  C3 ), 
        established by an acceptable medical source and documented by findings from one current report of a standardized developmental assessment (see  100.00C3b ) that:  


         

  1.  Shows development not more than two-thirds of the level typically expected for the child’s age; or  


         

  2.  Results in a valid score that is at least two standard deviations below the mean.  


         

  OR  


         

  C.  Developmental delay (see  100.00C3 ), 
        established by an acceptable medical source and documented by findings from two narrative developmental reports (see  100.00C3c ) that:  


         

  1.  Are dated at least 120 days apart (see  100.00C1 ); and  


         

  2. Indicate current development not more than two-thirds of the level typically expected for the child’s age.  


         


             
                 
                     


                    Back to Top
                 
             
         



    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 101.15
title: Disorders of the skeletal spine resulting in compromise of a nerve root(s)
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
summary:
  101.15
                                   
                                      Disorders of the skeletal spine resulting in compromise of a nerve root(s)
                                   
                               (see  101.00F ), document…

raw_text:
  101.15
                                   
                                      Disorders of the skeletal spine resulting in compromise of a nerve root(s)
                                   
                               (see  101.00F ), documented by A, B, C,  and  D:
                           


                           


                               A.   Neuro-anatomic (radicular) distribution of one or more of the 
                              following  symptoms  consistent with compromise of the affected nerve root(s):
                           


                           


                               1. Pain; or
                           


                           


                               2. Paresthesia; or
                           


                           


                               3. Muscle fatigue.
                           


                           

  AND 


                           


                               B.   Radicular distribution of neurological  
                              signs  present during physical examination
                              (see  101.00C2 ) or on a diagnostic test
                              (see  101.00C3 ) and evidenced by 1, 2, and either 3 or 4:
                           


                           


                               1. Muscle weakness; and
                           


                           


                               2. Sign(s) of nerve root irritation, tension, or compression, consistent with compromise of the affected nerve root 
                              (see  101.00F2 )
                           


                           


                               3. Sensory changes evidenced by:
                           


                           


                               a. Decreased sensation; or
                           


                           


                               b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing;  or 
                           


                           


                               4. Decreased deep tendon reflexes.
                           


                           

  AND 


                           


                               C.   Findings on imaging
                              (see  101.00C3 ) consistent with compromise of a nerve root(s) in the cervical or lumbosacral spine.
                           


                           

  AND 


                           


                               D.   Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                              or is expected to last, for a continuous period of at least 12 months, 
                              and medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need
                              (see  101.00C6a ) for a walker, bilateral canes, or bilateral crutches
                              (see  101.00C6d ) or a wheeled and seated mobility device involving the use of both hands
                              (see  101.00C6e(i) ); or
                           


                           


                               2. An inability to use  one  upper extremity to independently initiate, sustain,
                              and complete age-appropriate activities involving fine and gross movements
                              (see  101.00E4 ),  and  a documented medical need
                              (see  101.00C6a ) for a one-handed,
                              hand-held assistive device (see  101.00C6d )
                              that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                              (see  101.00C6e(ii) ); or
                           


                           


                               3. An inability to use  both  upper extremities to the extent that neither can be used to independently initiate, 
                              sustain, and complete age-appropriate activities involving fine and gross movements (see  101.00E4 ).


code: 101.16
title: Lumbar spinal stenosis resulting in compromise of the cauda equina
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
summary:
  101.16
                                   
                                      Lumbar spinal stenosis resulting in compromise of the cauda equina
                                   
                               (see  101.00G ), documented by A,…

raw_text:
  101.16
                                   
                                      Lumbar spinal stenosis resulting in compromise of the cauda equina
                                   
                               (see  101.00G ), documented by A, B, C,  and  D:
                           


                           


                               A.   Symptom(s) of neurological compromise manifested as:
                           


                           


                               1. Nonradicular distribution of pain in one or both lower extremities; or
                           


                           


                               2. Nonradicular distribution of sensory loss in one or both lower extremities; or
                           


                           


                               3. Neurogenic claudication.
                           


                           

  AND 


                           


                               B.   Nonradicular neurological signs present during physical examination
                              (see  101.00C2 ) or on a diagnostic test
                              (see  101.00C3 ) and evidenced by 1 and either 2 or 3:
                           


                           


                               1. Muscle weakness.
                           


                           


                               2. Sensory changes evidenced by:
                           


                           


                               a. Decreased sensation; or
                           


                           


                               b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing; or
                           


                           


                               c. Areflexia, trophic ulceration, or bladder or bowel incontinence.
                           


                           


                               3. Decreased deep tendon reflexes in one or both lower extremities.
                           


                           

  AND 


                           


                               C.   Findings on imaging (see  101.00C3 ) or in an operative report
                              (see  101.00C4 ) consistent with compromise of the cauda equina with lumbar spinal stenosis.
                           


                           

  AND 


                           


                               D.   Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                              or is expected to last, for a continuous period of at least 12 months, 
                              and medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need (see  101.00C6a ) for a walker, 
                              bilateral canes, or bilateral crutches 
                              (see  101.00C6d ) or a wheeled and seated mobility device involving the use of both hands 
                              (see  101.00C6e(i) ); or
                           


                           


                               2. An inability to use  one  upper extremity to independently initiate, sustain,
                              and complete age-appropriate activities involving fine and gross movements
                              (see  101.00E4 ),  and  a documented medical need
                              (see  101.00C6a ) for a one-handed, hand-held assistive device
                              (see  101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                              (see  101.00C6e(ii) ).


code: 101.17
title: Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
summary:
  101.17
                                   
                                      Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint
                                   
                               (see  101.00H ), docu…

raw_text:
  101.17
                                   
                                      Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint
                                   
                               (see  101.00H ), documented by A, B,  and  C:
                           


                           


                               A.  History of reconstructive surgery or surgical arthrodesis of a major weight-bearing joint.
   


                           

  AND 


                           


                               B.  Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months.
                           


                           

  AND 


                           


                               C.  A documented medical need (see  101.00C6a ) for a walker, 
                              bilateral canes, or bilateral crutches 
                              (see  101.00C6d ) or a wheeled and seated mobility device involving the use of both hands 
                              (see  101.00C6e(i) ).


code: 101.18
title: Abnormality of a major joint(s) in any extremity
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
summary:
  101.18
                                   
                                      Abnormality of a major joint(s) in any extremity
                                   
                               (see  101.00I ), documented by A, B, C,  and  D:…

raw_text:
  101.18
                                   
                                      Abnormality of a major joint(s) in any extremity
                                   
                               (see  101.00I ), documented by A, B, C,  and  D:
                           


                           


                               A.   Chronic joint pain or stiffness.
                           


                           

  AND 


                           


                               B.   Abnormal motion, instability, or immobility of the affected joint(s).
                           


                           

  AND 


                           


                               C.   Anatomical abnormality of the affected joint(s) noted on:
                           


                           


                               1. Physical examination (for example, subluxation, contracture, or bony or fibrous ankylosis); or
                           


                           


                               2. Imaging (for example, joint space narrowing, bony destruction, or ankylosis or arthrodesis of the affected joint).
                           


                           

  AND 


                           


                               D.   Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                              or is expected to last, for a continuous period of at least 12 months, 
                              and medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need 
                              (see  101.00C6a ) for a walker, bilateral canes, or bilateral crutches 
                              (see  101.00C6d ) or a wheeled and seated mobility device involving the use of both hands 
                              (see  101.00C6e(i) ); or
                           


                           


                               2. An inability to use  one  upper extremity to independently initiate, sustain,
                              and complete age-appropriate activities involving fine and gross movements
                              (see  101.00E4 ),
                               and  a documented medical need (see  101.00C6a ) for a one-handed,
                              hand-held assistive device
                              (see  101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                              (see  101.00C6e(ii) ); or
                           


                           


                               3. An inability to use  both  upper extremities to the extent that neither can be used to independently initiate, sustain, 
                              and complete age-appropriate activities involving fine and gross movements (see  101.00E4 ).


code: 101.19
title: Pathologic fractures due to any cause
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
summary:
  101.19
                                   
                                      Pathologic fractures due to any cause
                                   
                               (see  101.00J ), documented by A  and  B:…

raw_text:
  101.19
                                   
                                      Pathologic fractures due to any cause
                                   
                               (see  101.00J ), documented by A  and  B:
                           


                           


                               A.   Pathologic fractures occurring on three separate occasions within a 12-month period.
                           


                           

  AND 


                           


                               B.   Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                              or is expected to last, for a continuous period of at least 12 months, 
                              and medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need (see  101.00C6a ) for a walker,
                              bilateral canes, or bilateral crutches (see  101.00C6d )
                              or a wheeled and seated mobility device involving the use of both hands (see  101.00C6e(i) ); or
                           


                           


                               2. An inability to use  one  upper extremity to independently initiate, sustain,
                              and complete age-appropriate activities involving fine and gross movements (see  101.00E4 ),
                               and  a documented medical need (see  101.00C6a ) for a one-handed,
                              hand-held assistive device (see  101.00C6d )
                              that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                              (see  101.00C6e(ii) ); or
                           


                           


                               3. An inability to use  both  upper extremities to the extent that neither can be used to independently initiate, sustain, 
                              and complete age-appropriate activities involving fine and gross movements (see  101.00E4 ).


code: 101.20
title: Amputation due to any cause
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
summary:
  101.20
                                   
                                      Amputation due to any cause
                                   
                               (see  101.00K ), documented by A, B, C,  or  D:…

raw_text:
  101.20
                                   
                                      Amputation due to any cause
                                   
                               (see  101.00K ), documented by A, B, C,  or  D:
                           


                           


                               A.   Amputation of both upper extremities, occurring at any level at or above the wrists (carpal joints), up to and including the shoulder (glenohumeral) joint.
                           


                           

  OR 


                           


                               B.   Hemipelvectomy or hip disarticulation.
                           


                           

  OR 


                           


                               C.   Amputation of one upper extremity, occurring at any level at or above the wrist (carpal joints), 
                              and amputation of one lower extremity, occurring at or above the ankle (talocrural joint), 
                              and medical documentation of at least  one  of the following:
                           


                           


                               1. A documented medical need (see  101.00C6a ) for a walker, 
                              bilateral canes, or bilateral crutches (see  101.00C6d ) 
                              or a wheeled and seated mobility device involving the use of both hands 
                              (see  101.00C6e(i) ); or
                           


                           


                               2. A documented medical need (see  101.00C6a ) for a one-handed, 
                              hand-held assistive device (see  101.00C6d ) requiring the use of the other upper extremity 
                              or a wheeled and seated mobility device involving the use of one hand 
                              (see  101.00C6e(ii) ); or
                           


                           


                               3. The inability to use the remaining upper extremity to independently initiate, sustain, 
                              and complete age-appropriate activities involving fine and gross movements 
                              ( 101.00E4 ).
                           


                           

  OR 


                           


                               D.   Amputation of one or both lower extremities, occurring at or above the ankle (talocrural joint), 
                              with complications of the residual limb(s) that have lasted, or are expected to last, 
                              for a continuous period of at least 12 months,  and  medical documentation of 1 and 2:
                           


                           


                               1. The inability to use a prosthesis(es); and
                           


                           


                               2. A documented medical need (see  101.00C6a ) for a walker, 
                              bilateral canes, or bilateral crutches (see  101.00C6d ) 
                              or a wheeled and seated mobility device involving the use of both hands (see  101.00C6e(i) ).


code: 101.21
title: Soft tissue injury or abnormality under continuing surgical management
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
summary:
  101.21
                                   
                                      Soft tissue injury or abnormality under continuing surgical management
                                   
                               (see  101.00L ), documented b…

raw_text:
  101.21
                                   
                                      Soft tissue injury or abnormality under continuing surgical management
                                   
                               (see  101.00L ), documented by A, B,  and  C:
                           


                           


                               A.   Evidence confirms continuing surgical management
                              (see  101.00P1 ) directed toward saving, reconstructing, or replacing the affected part of the body.
                           


                           

  AND 


                           


                               B.   The surgical management has been, or is expected to be, ongoing for a continuous period of at least 12 months.
                           


                           

  AND 


                           


                               C.   Maximum benefit from therapy (see  101.00P2 ) has not yet been achieved.


code: 101.22
title: Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
summary:
  101.22
                                   
                                      Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones…

raw_text:
  101.22
                                   
                                      Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones
                                   
                               (see  101.00M ), documented by A, B,  and  C:
                           


                           


                               A.   Solid union not evident on imaging (see  101.00C3 ) and not clinically solid.
                           


                           

  AND 


                           


                               B.   Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months.
                           


                           

  AND 


                           


                               C.  A documented medical need (see  101.00C6a ) for a walker,
                              bilateral canes, or bilateral crutches (see  101.00C6d )
                              or a wheeled and seated mobility device involving the use of both hands (see  101.00C6e(i) ).


code: 101.23
title: Non-healing or complex fracture of an upper extremity
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
summary:
  101.23
                                   
                                      Non-healing or complex fracture of an upper extremity
                                   
                               (see  101.00N ), documented by A  and  B:…

raw_text:
  101.23
                                   
                                      Non-healing or complex fracture of an upper extremity
                                   
                               (see  101.00N ), documented by A  and  B:
                           


                           


                               A.  Nonunion or complex fracture, of the shaft of the humerus, radius, or ulna, under continuing surgical management 
                              see  101.00P1 ) directed toward restoration of functional use of the extremity.
                           


                           

  AND 


                           


                               B.  Medical documentation of an inability to independently initiate, sustain, 
                              and complete age-appropriate activities involving fine and gross movements 
                              (see  101.00E4 ) that has lasted, or is expected to last, for a continuous period of at least 12 months.


code: 101.24
source_url: https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm
title:
  Musculoskeletal disorders of infants and toddlers, from birth to attainment of age 3, with developmental motor delay

summary:
  101.24
                                   
                                      Musculoskeletal disorders of infants and toddlers, from birth to attainment of age 3, with developmental motor delay…

raw_text:
  101.24
                                   
                                      Musculoskeletal disorders of infants and toddlers, from birth to attainment of age 3, with developmental motor delay
                                   
                               (see  101.00O ), documented by A  or  B:
                           


                           


                               A.   A standardized developmental motor assessment that:
                           


                           


                               1. Shows motor development not more than one-half of the level typically expected for the child’s age; or
                           


                           


                               2. Results in a valid score that is at least three standard deviations below the mean.
                           


                           

  OR 


                           


                               B.   Two narrative developmental reports that:
                           


                           


                               1. Are dated at least 120 days apart; and
                           


                           


                               2. Indicate current motor development not more than one-half of the level typically expected for the child’s age.
                           






                       
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 102.02
title: Loss of Visual Acuity
source_url: https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm
summary:
  102.02  Loss of central visual acuity. 


               

  A.  Remaining vision in the better eye after best correction is 20/200 or less. 


               

  OR 


               

  B.  An inability to participate in visual acuity  testing using…

raw_text:
  102.02  Loss of central visual acuity. 


               

  A.  Remaining vision in the better eye after best correction is 20/200 or less. 


               

  OR 


               

  B.  An inability to participate in visual acuity  testing using Snellen methodology or other comparable testing, clinical findings that fixation and visual-following behavior are absent in the better  eye, and one of the following: 


               

  1. Abnormal anatomical findings indicating a visual acuity of 20/200 or less in the better eye (such as the presence of Stage III or worse retinopathy of prematurity despite  surgery, hypoplasia of the optic nerve, albinism with macular aplasia, or  bilateral optic atrophy); or 


               

  2. Abnormal neuroimaging documenting damage to the cerebral cortex which would be expected to prevent the development of a visual acuity better than 20/200 in the better eye (such  as neuroimaging showing bilateral encephalomyelitis or bilateral  encephalomalacia); or 


               

  3. Abnormal electroretinogram documenting the presence of Leber’s congenital amaurosis or achromatopsia in the better eye; or 


               

  4. An absent response to VER testing in the better eye.


code: 102.03
title: Contraction of the visual field in the better eye
source_url: https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm
summary:
  102.03 Contraction of the visual field in the better eye,   with: 


               

  A.  The widest diameter subtending an angle around the point of fixation no greater than 20 degrees. 


               

  OR 


               

  B.  An MD of 22…

raw_text:
  102.03 Contraction of the visual field in the better eye,   with: 


               

  A.  The widest diameter subtending an angle around the point of fixation no greater than 20 degrees. 


               

  OR 


               

  B.  An MD of 22 decibels or greater, determined by automated static threshold perimetry that measures the central 30 degrees of the visual field 
              (see  102.00A6d ). 


               

  OR 


               

  C.  A visual field efficiency of 20 percent or less,  determined by kinetic perimetry 
      (see  102.00A7c ).


code: 102.04
title: Loss of visual efficiency
source_url: https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm
summary:
  102.04 Loss ofvisual efficiency, or visual impairment, in the better eye : 


   

  A. A visual efficiency percentage of 20 or less after best correction (see  102.00A7d ). 


   

  OR 


   

  B. A visual impairment value of 1.00 or greater after b…

raw_text:
  102.04 Loss ofvisual efficiency, or visual impairment, in the better eye : 


   

  A. A visual efficiency percentage of 20 or less after best correction (see  102.00A7d ). 


   

  OR 


   

  B. A visual impairment value of 1.00 or greater after best correction (see  102.00A8d ).


code: 102.10
title: 102.10
source_url: https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm
summary:
  102.10    Hearing loss not treated with cochlear implantation.  


               

   A.   For children from birth to the attainment of age 5, 
      an average air conduction hearing threshold of 50 decibels or greater in the better ear (see…

raw_text:
  102.10    Hearing loss not treated with cochlear implantation.  


               

   A.   For children from birth to the attainment of age 5, 
      an average air conduction hearing threshold of 50 decibels or greater in the better ear (see  102.00B2 ).  


               

   OR  


               

   B . For children from age 5 to the attainment of age 18:  


               

  1. An average air conduction hearing threshold of 70 decibels or greater in the better ear and an average bone conduction hearing threshold of 
      40 decibels or greater in the better ear (see  102.00B2f ); or  


               

  2. A word recognition score of 40 percent or less in the better ear determined using a standardized list of phonetically balanced monosyllabic words 
      (see  102.00B2f ); or  


               

  3. An average air conduction hearing threshold of 50 decibels or greater in the better ear and a marked limitation in speech or language 
      (see  102.00B2f  and  102.00B5 ).


code: 102.11
title: Hearing loss treated with cochlear implantation
source_url: https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm
summary:
  102.11     Hearing loss treated with cochlear implantation.  


               

   A.   Consider under a disability until the attainment of age 5 or for 1 year after initial implantation, whichever is later.  


               

   OR…

raw_text:
  102.11     Hearing loss treated with cochlear implantation.  


               

   A.   Consider under a disability until the attainment of age 5 or for 1 year after initial implantation, whichever is later.  


               

   OR  


               

   B.   Upon the attainment of age 5 or 1 year after initial implantation, whichever is later, 
      a word recognition score of 60 percent or less determined using the HINT or the HINT-C (see  102.00B3b ).  


               

  Back to Top   

  			

    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 103.02
title: Chronic Respiratory Disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm
summary:
  103.02  Chronic respiratory disorders   due to any cause except CF
            (for CF, see  103.04 ), with A, B, C, D, or E:
         


         


             A. FEV 1   (see  103.00E )
            less than or equal to the value in Table I-A or…

raw_text:
  103.02  Chronic respiratory disorders   due to any cause except CF
            (for CF, see  103.04 ), with A, B, C, D, or E:
         


         


             A. FEV 1   (see  103.00E )
            less than or equal to the value in Table I-A or I-B for your age, gender,
            and height without shoes (see  103.00E3a ).
         


         

  Table I: FEV 1  Criteria for  103.02A 


         
         


             

  Table I-A 


         


         


             
                 


                     Age 6 to attainment of age 13 


                     (For both females and males) 
                 


             
         


         


             
                 


                    Height 


                    without 


                    shoes  (centimeters) 
                 


                 


                    < means 


                     less    than  
                 


             
             
                 


                    Height    without 


                    shoes  


                     (inches) 
                 


                 


                    < means 


                     less    than  
                 


             
             
                 


                    FEV 1 


                    less    than or equal to (L, BTPS)
                 


             
         


         


             

  <123.0 


             

  <48.50 


             

  0.80 


         


         


             

  123.0 to <129.0 


             

  48.50 to <50.75 


             

  0.90 


         


         


             

  129.0 to <134.0 


             

  50.75 to <52.75 


             

  1.00 


         


         


             

  134.0 to <139.0 


             

  52.75 to <54.75 


             

  1.10 


         


         


             

  139.0 to <144.0 


             

  54.75 to <56.75 


             

  1.20 


         


         


             

  144.0 to <149.0 


             

  56.75 to <58.75 


             

  1.30 


         


         


             
                 


                    149.0 


                    or more
                 


             
             
                 


                    58.75 


                    or more
                 


             
             

  1.40 


         


         
         

    


         
             


                 

  Table I-B 


             


             


                 

  Age 13 to attainment of age 18 


             


             


                 
                     


                        Height 


                        without 


                        shoes  (centimeters) 
                     


                     


                        < means 


                         less    than  
                     


                 
                 
                     


                        Height    without 


                        shoes  


                         (inches) 
                     


                     


                        < means 


                         less    than  
                     


                 
                 
                     


                         Females 


                        FEV 1 


                        less    than 


                        or equal    to 


                        (L,    BTPS)
                     


                 
                 
                     


                         Males 


                        FEV 1 


                        less    than 


                        or equal    to 


                        (L,    BTPS)
                     


                 
             


             


                 

  <153.0 


                 

  <60.25 


                 

  1.35 


                 

  1.40 


             


             


                 

  153.0 to <159.0 


                 

  60.25 to <62.50 


                 

  1.45 


                 

  1.50 


             


             


                 

  159.0 to <164.0 


                 

  62.50 to <64.50 


                 

  1.55 


                 

  1.60 


             


             


                 

  164.0 to <169.0 


                 

  64.50 to <66.50 


                 

  1.65 


                 

  1.70 


             


             


                 

  169.0 to <174.0 


                 

  66.50 to <68.50 


                 

  1.75 


                 

  1.85 


             


             


                 

  174.0 to <180.0 


                 

  68.50 to <70.75 


                 

  1.85 


                 

  2.00 


             


             


                 
                     


                        180.0 


                        or more
                     


                 
                 
                     


                        70.75 


                        or more
                     


                 
                 

  1.95 


                 

  2.10 


             


         
         


             OR 
         


         


             B.  FVC (see  103.00E ) less than or equal to the value in Table II-A or II-B for your age,
            gender, and height without shoes (see  103.00E3a ).
         


         

  Table II: FVC Criteria for  103.02B 



         
             


                 

  Table II-A 


             


             


                 
                     


                         Age    6 to attainment of age 13 


                         (For    both females and males) 
                     


                 
             


             


                 
                     


                        Height 


                        without 


                        shoes  (centimeters) 
                     


                     


                        <    means 


                         less than  
                     


                 
                 
                     


                        Height without 


                        shoes  


                         (inches) 
                     


                     


                        <    means 


                         less than  
                     


                 
                 
                     


                        FVC 


                        less than or equal to 


                        (L, BTPS)
                     


                 
             


             


                 

  <123.0 


                 

  <48.50 


                 

  0.85 


             


             


                 

  123.0    to <129.0 


                 

  48.50    to <50.75 


                 

  1.00 


             


             


                 

  129.0    to <134.0 


                 

  50.75    to <52.75 


                 

  1.10 


             


             


                 

  134.0    to <139.0 


                 

  52.75    to <54.75 


                 

  1.30 


             


             


                 

  139.0    to <144.0 


                 

  54.75    to <56.75 


                 

  1.40 


             


             


                 

  144.0    to <149.0 


                 

  56.75    to <58.75 


                 

  1.55 


             


             


                 
                     


                        149.0 


                        or    more
                     


                 
                 
                     


                        58.75 


                        or    more
                     


                 
                 

  1.70 


             


         
         

    


         
             


                 

  Table II-B 


             


             


                 

  Age    13 to attainment of age 18 


             


             


                 
                     


                        Height 


                        without 


                        shoes  (centimeters) 
                     


                     


                        <    means 


                         less than  
                     


                 
                 
                     


                        Height without 


                        shoes  


                         (inches) 
                     


                     


                        <    means 


                         less than


code: 103.03
title: Asthma
source_url: https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm
summary:
  103.03
                     Asthma 
                 
             . (see  103.00G ) with exacerbations or complications requiring three hospitalizations within a 12-month period
            and at least 30 days apart (the 12-month period must occu…

raw_text:
  103.03
                     Asthma 
                 
             . (see  103.00G ) with exacerbations or complications requiring three hospitalizations within a 12-month period
            and at least 30 days apart (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review).
            Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization.
            Consider under a disability for 1 year from the discharge date of the last hospitalization;
            after that, evaluate the residual impairment(s) under  103.03  or another appropriate listing.


code: 103.04
title: Cystic Fibrosis
source_url: https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm
summary:
  103.04
                     Cystic fibrosis 
                 
             .  (documented as described in  103.00H ), with A, B, C, D, E, F, or G:
         


         


             A. FEV 1  (see  103.00E )
            less than or equal to the value…

raw_text:
  103.04
                     Cystic fibrosis 
                 
             .  (documented as described in  103.00H ), with A, B, C, D, E, F, or G:
         


         


             A. FEV 1  (see  103.00E )
            less than or equal to the value in Table III-A or Table III-B for your age, gender, and height without shoes (see  103.00E3a ).
         

  Table III: FEV 1  Criteria  for  103.04A 


         
             


                 

  Table III-A 


             


             


                 
                     


                         Age    6 to attainment of age 13 


                         (For    both females and males) 
                     


                 
             


             


                 
                     


                        Height 


                        without 


                        shoes  (centimeters) 
                     


                     


                        <    means 


                         less than  
                     


                 
                 
                     


                        Height without 


                        shoes  


                         (inches) 
                     


                     


                        <    means 


                         less than  
                     


                 
                 
                     


                        FEV 1 


                        less than or equal to 


                        (L, BTPS)
                     


                 
             


             


                 

  <123.0 


                 

  <48.50 


                 

  1.00 


             


             


                 

  123.0    to <129.0 


                 

  48.50    to <50.75 


                 

  1.15 


             


             


                 

  129.0    to <134.0 


                 

  50.75    to <52.75 


                 

  1.25 


             


             


                 

  134.0    to <139.0 


                 

  52.75    to <54.75 


                 

  1.40 


             


             


                 

  139.0    to <144.0 


                 

  54.75    to <56.75 


                 

  1.50 


             


             


                 

  144.0    to <149.0 


                 

  56.75    to <58.75 


                 

  1.70 


             


             


                 
                     


                        149.0 


                        or    more
                     


                 
                 
                     


                        58.75 


                        or    more
                     


                 
                 

  1.80 


             


         
         

    


         
             


                 

  Table III-B 


             


             


                 

  Age    13 to attainment of age 18 


             


             


                 
                     


                        Height 


                        without 


                        shoes  (centimeters) 
                     


                     


                        <    means 


                         less than  
                     


                 
                 
                     


                        Height without 


                        shoes  


                         (inches) 
                     


                     


                        <    means 


                         less than  
                     


                 
                 
                     


                         Females 


                        FEV 1 


                        less than 


                        or equal to 


                        (L, BTPS)
                     


                 
                 
                     


                         Males 


                        FEV 1 


                        less than 


                        or equal to 


                        (L, BTPS)
                     


                 
             


             


                 

  <153.0 


                 

  <60.25 


                 

  1.75 


                 

  1.85 


             


             


                 

  153.0    to <159.0 


                 

  60.25    to <62.50 


                 

  1.85 


                 

  2.05 


             


             


                 

  159.0    to <164.0 


                 

  62.50    to <64.50 


                 

  1.95 


                 

  2.15 


             


             


                 

  164.0    to <169.0 


                 

  64.50    to <66.50 


                 

  2.10 


                 

  2.30 


             


             


                 

  169.0    to <174.0 


                 

  66.50    to <68.50 


                 

  2.25 


                 

  2.45 


             


             


                 

  174.0    to <180.0 


                 

  68.50    to <70.75 


                 

  2.35 


                 

  2.60 


             


             


                 
                     


                        180.0 


                        or    more
                     


                 
                 
                     


                        70.75 


                        or    more
                     


                 
                 

  2.50 


                 

  2.70 


             


         
         

    


         

  OR 


         


             B. For children who have not attained age 6, findings on imaging (see  103.00D3 )
            of thickening of the proximal bronchial airways, nodular-cystic lesions, segmental or lobular atelectasis, or consolidation,  and  documentation of one of the following:
         


         


             

  Shortness of breath with activity; or 


             

  Accumulation of secretions as manifested by repetitive coughing; or 


             

  Bilateral rales or rhonchi, or reduction of breath sounds. 


         


         

  OR 


         


             C. Exacerbations or complications (see  103.00H3 )
            requiring three hospitalizations of any length within a 12-month period and at least 30 days apart
            (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review).
         


         

  OR 


         

  D. Spontaneous pneumothorax, secondary to CF, requiring chest tube placement. 


         

  OR 


         


             E. Respiratory failure (see  103.00J ) requiring invasive mechanical ventilation,
            noninvasive ventilation with BiPAP, or a combination of both treatments, for a continuous period of at least 48 hours, or for a continuous period of at least 72 hours if postoperatively.
         


         

  OR 


         

  F. Pulmonary hemorrhage requiring vascular embolization to control bleeding. 


         

  OR 


         


             G. Two of the following exacerbations or complications
            (either two of the same or two different, see  103.00H3 
            and  103.00H4 ) within a 12-month period
            (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review):
         


         


             

  Pulmonary exacerbation requiring 10 consecutive days of intravenous antibiotic treatment. 


             

  Pulmonary hemorrhage (hemoptysis with more than blood-streaked sputum but not requiring vascular embolization) requiring hospitalization of any length. 


             

  Weight loss requiring daily supplemental enteral nutrition via a gastrostomy for at least 90 consecutive days  or  parenteral nutrition via a central venous  catheter for at least 90 consecutive days. 


             

  CFRD requiring daily insulin therapy for at least 90 consecutive days.


code: 103.06
title: Growth failure due to any chronic respiratory disorder
source_url: https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm
summary:
  103.06 Growth failure due to any chronic respiratory disorder 
            (see   103.00K ), documented by:
         


         

  A. Hypoxemia with the need for at least 1.0 L per min of oxygen supplementation  for at least 4 hours per day and f…

raw_text:
  103.06 Growth failure due to any chronic respiratory disorder 
            (see   103.00K ), documented by:
         


         

  A. Hypoxemia with the need for at least 1.0 L per min of oxygen supplementation  for at least 4 hours per day and for at least 90 consecutive days.  


         

  AND  


         

  B. Growth failure as required in 1 or 2: 


         


             

  For children from birth to attainment of age 2 , three weight-for-length measurements that are: 


             


                 

  Within a consecutive 12-month period; and 


                 


                     At least 60 days apart; and
                 


                 

  Less than the third percentile on the appropriate weight-for-length table under  105.08B1 ; or 


             


             

  For children age 2 to attainment of age 18 ,  three BMI-for-age measurements that are: 


             


                 

  Within a consecutive 12-month period; and  


                 


                     At least 60 days apart; and
                 


                 

  Less than the third percentile on the appropriate BMI-for-age table under  105.08B2 .


code: 103.11
title: Lung Transplantation
source_url: https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm
summary:
  103.11 Lung transplantation  (see  103.00I ). Consider under a disability for 3 years   from the date of the  transplant; after that, evaluate the residual impairment(s).

raw_text:
  103.11 Lung transplantation  (see  103.00I ). Consider under a disability for 3 years   from the date of the  transplant; after that, evaluate the residual impairment(s).


code: 103.14
title: Respiratory failure
source_url: https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm
summary:
  103.14 Respiratory failure  (see  103.00J )
            resulting from any underlying chronic respiratory disorder except CF (for CF, see  103.04E ), requiring invasive mechanical ventilation, noninvasive  ventilation with BiPAP, or a combina…

raw_text:
  103.14 Respiratory failure  (see  103.00J )
            resulting from any underlying chronic respiratory disorder except CF (for CF, see  103.04E ), requiring invasive mechanical ventilation, noninvasive  ventilation with BiPAP, or a combination of both treatments, for a continuous  period of at least 48 hours, or for a continuous period of at least 72 hours if  postoperatively,  twice  within a 12-month period and at least 30 days  apart (the 12-month period must occur within the period we are considering in  connection with your application or continuing disability review).
         


        
    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 104.02
title: Chronic heart failure
source_url: https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm
summary:
  104.02   Chronic heart failure  
      while on a regimen of prescribed treatment with symptoms and signs described in  104.00C2  and with one of the following: 


               

  A.  Persistent tachycardia at rest (see Table I);…

raw_text:
  104.02   Chronic heart failure  
      while on a regimen of prescribed treatment with symptoms and signs described in  104.00C2  and with one of the following: 


               

  A.  Persistent tachycardia at rest (see Table I);  


               

  OR  


               

  B.  Persistent tachypnea at rest (see Table II) or  markedly decreased exercise tolerance 
      (see  104.00C2b );  


               

  OR  


               

  C.  Growth failure as required in 1 or 2:   


               

  1.  For children from birth to  attainment of age 2,  three weight-for-length measurements that are:  


               

  a. Within a consecutive 12-month  period; and  


               

  b. At least 60 days apart; and  


               

  c. Less than the third percentile on the appropriate weight-for-length Table I or II under  105.08B1 ; or   


               

  2.  For children age 2 to attainment of age 18,  three BMI-for-age measurements that are:  


               

  a. Within a consecutive 12-month  period; and  


               

  b. At least 60 days apart; and  


               

  c. Less than the third percentile on the appropriate BMI-for-age Table III or IV under  105.08B2 .  


               

  Back to Top 

  			
               

  Table I  ‑  Tachycardia at Rest 


               


                 
                   


                     

  Age 


                     

  Apical    heart rate 


                    (beats per    minute) 


                   


                   


                     

  Under 1 year 


                     

  150 


                   


                   


                     

  1 through 3 years 


                     

  130 


                   


                   


                     

  4 through 9 years 


                     

  120 


                   


                   


                     

  10 through 15 years 


                     

  110 


                   


                   


                     

  Over 15 years 


                     

  100 


                   


                 
               


               

  Table II  ‑ Tachypnea  at Rest 


               


                 
                   


                     

  Age 


                     

  Respiratory    rate over  (per minute) 


                   


                   


                     

  Under 1 year 


                     

  40 


                   


                   


                     

  1 through 5 years 


                     

  35 


                   


                   


                     

  6 through 9 years 


                     

  30 


                   


                   


                     

  Over 9 years 


                     

  25 


                   


                 
               


               

  Back to Top


code: 104.05
title: Recurrent arrhythmias
source_url: https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm
summary:
  104.05   Recurrent arrhythmias, 
      not related to reversible causes such as electrolyte abnormalities or digitalis glycoside or antiarrhythmic drug toxicity, 
      resulting in uncontrolled (see  104.00A3g ), 
                  recurrent (s…

raw_text:
  104.05   Recurrent arrhythmias, 
      not related to reversible causes such as electrolyte abnormalities or digitalis glycoside or antiarrhythmic drug toxicity, 
      resulting in uncontrolled (see  104.00A3g ), 
                  recurrent (see 

  104.00A3c )
      episodes of cardiac syncope or near syncope (see  104.00E3b ),
      despite prescribed treatment (see  104.00B3  if there is no prescribed treatment),
      and documented by resting or ambulatory (Holter) electrocardiography, or by other appropriate medically acceptable testing,
      coincident with the occurrence of syncope or near syncope (see  104.00E3c ).
   


               

  Back to Top


code: 104.06
title: Congenital heart disease
source_url: https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm
summary:
  104.06   Congenital heart disease,  
      documented by appropriate medically acceptable imaging (see  104.00A3d ) or cardiac catheterization, with one of the following: 


               

  A.  Cyanotic heart disease, with  persistent, chroni…

raw_text:
  104.06   Congenital heart disease,  
      documented by appropriate medically acceptable imaging (see  104.00A3d ) or cardiac catheterization, with one of the following: 


               

  A.  Cyanotic heart disease, with  persistent, chronic hypoxemia as manifested by: 


               

  1. Hematocrit of 55 percent or  greater on two evaluations 3 months or more apart within a consecutive 12-month  period 
      (see  104.00A3e ); or 


               

  2. Arterial O2 saturation of less than 90 percent in room air, or resting arterial PO2 of 60 Torr or less; or 


               

  3. Hypercyanotic spells, syncope, characteristic squatting, or other incapacitating symptoms directly related to  documented cyanotic heart disease; or 


               

  4. Exercise intolerance with increased hypoxemia on exertion.  


               

  OR 


               

  B.  Secondary pulmonary vascular obstructive disease with pulmonary arterial systolic pressure elevated to at least 70 percent of the systemic arterial systolic pressure. 


               

  OR 


               

  C.  Symptomatic acyanotic heart disease, with ventricular dysfunction interfering very seriously with the ability to independently initiate, sustain, or complete activities. 


               

  OR 


               

  D.  For infants under 12 months of age at the time of filing, with life-threatening congenital heart impairment that will require or already has required surgical treatment in the first year  of life, and the impairment is expected to be disabling (because of residual  impairment following surgery, or the recovery time required, or both) until the  attainment of at least 1 year of age, consider the infant to be under  disability until the attainment of at least age 1; thereafter, evaluate  impairment severity with reference to the appropriate listing. 


               

  Back to Top


code: 104.09
title: Heart transplant
source_url: https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm
summary:
  104.09   Heart transplant .  Consider under a disability for 1  year following surgery; thereafter, evaluate residual impairment under the  appropriate listing.

raw_text:
  104.09   Heart transplant .  Consider under a disability for 1  year following surgery; thereafter, evaluate residual impairment under the  appropriate listing.


code: 104.13
title: Rheumatic heart disease
source_url: https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm
summary:
  104.13   Rheumatic heart disease,  
      with persistence of rheumatic fever activity manifested by significant murmurs(s), cardiac enlargement or ventricular dysfunction 
      (see  104.00C2a ), and other associated abnormal laboratory find…

raw_text:
  104.13   Rheumatic heart disease,  
      with persistence of rheumatic fever activity manifested by significant murmurs(s), cardiac enlargement or ventricular dysfunction 
      (see  104.00C2a ), and other associated abnormal laboratory findings;
      for example, an elevated sedimentation rate or ECG findings, for 6 months or  more in a consecutive 12-month period
      (see  104.00A3e ). Consider under a disability for 18 months from the established onset of impairment, then evaluate any residual impairment(s).
       

  Back to Top 



    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 106.03
title: Chronic kidney disease, with chronic hemodialysis or peritoneal dialysis
source_url: https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm
summary:
  106.03  Chronic kidney disease ,  with chronic hemodialysis or peritoneal dialysis 
      (see  106.00C1 ). 


   

  Back to Top

raw_text:
  106.03  Chronic kidney disease ,  with chronic hemodialysis or peritoneal dialysis 
      (see  106.00C1 ). 


   

  Back to Top


code: 106.04
title: Chronic kidney disease, with kidney transplant.
source_url: https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm
summary:
  106.04  Chronic kidney disease ,  with kidney transplant. 
      Consider under a disability for 1 year following the transplant; 
      thereafter, evaluate the residual impairment (see  106.00C2 ). 


   

  Back to Top

raw_text:
  106.04  Chronic kidney disease ,  with kidney transplant. 
      Consider under a disability for 1 year following the transplant; 
      thereafter, evaluate the residual impairment (see  106.00C2 ). 


   

  Back to Top


code: 106.05
title: Chronic kidney disease, with impairment of kidney function
source_url: https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm
summary:
  106.05  Chronic kidney disease,  with impairment of kidney function, with one of  the following documented on at least two occasions at least 90 days apart  during a consecutive 12-month period: 


   

   A. Serum  creatinine of 3 mg/dL or gre…

raw_text:
  106.05  Chronic kidney disease,  with impairment of kidney function, with one of  the following documented on at least two occasions at least 90 days apart  during a consecutive 12-month period: 


   

   A. Serum  creatinine of 3 mg/dL or greater; 


   

  OR 


   

   B.  Creatinine clearance of 30 ml/min/1.73m2 or less; 


   

  OR 


   

   C.  Estimated glomerular filtration rate (eGFR) of 30 ml/min/1.73m2 or  less. 


     


                             Back to Top


code: 106.06
title:
  Nephrotic
  Syndrome

source_url: https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm
summary:
  106.06  Nephrotic syndrome,  with A and B: 


               

  A. Laboratory findings as described in 1 or 2, documented on at least two occasions at least 90 days apart during a consecutive 12-month period:…

raw_text:
  106.06  Nephrotic syndrome,  with A and B: 


               

  A. Laboratory findings as described in 1 or 2, documented on at least two occasions at least 90 days apart during a consecutive 12-month period: 


               


               

  Serum  albumin of 3.0 g/dL or less, or 


                 


               


               

  Proteinuria of 40 mg/m2/hr or greater; 


               


               

  AND 


               

  B. Anasarca (see  106.00C3 ) persisting for at least 90 days despite prescribed treatment.  


               

  Back to Top


code: 106.07
title:
  Congenital
  Genitourinary Disorder

source_url: https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm
summary:
  106.07 Congenital genitourinary disorder  
      (see  106.00C4 ) requiring urologic surgical procedures at least three times in a consecutive 12-month period, 
      with at least 30 days between procedures. Consider under a disability for 1 y…

raw_text:
  106.07 Congenital genitourinary disorder  
      (see  106.00C4 ) requiring urologic surgical procedures at least three times in a consecutive 12-month period, 
      with at least 30 days between procedures. Consider under a disability for 1 year following the date of the last surgery; thereafter, evaluate the residual impairment. 


       
           
               


              Back to Top


code: 106.08
title: Growth failure due to any chronic renal disease
source_url: https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm
summary:
  106.08 Growth failure due to any chronic renal disease   
      (see  106.00C5 ), with:  


               

  A. Serum creatinine of 2 mg/dL or greater, documented at least two times within a consecutive 12-month period with at least 60 days bet…

raw_text:
  106.08 Growth failure due to any chronic renal disease   
      (see  106.00C5 ), with:  


               

  A. Serum creatinine of 2 mg/dL or greater, documented at least two times within a consecutive 12-month period with at least 60 days between measurements.  


               

  AND  


               

  B. Growth failure as required in 1 or 2:   


               

  1.  For children from birth to attainment of age 2,  three weight-for length measurements that are:  


               

  a. Within a consecutive 12-month period; and  


               

  b. At least 60 days apart; and  


               

  c. Less than the third percentile on the appropriate weight-for-length table under  105.08B1 ; or  


               

  2. For children age 2 to attainment of age 18, three BMI-for-age measurements that are:  


               

  a. Within a consecutive 12-month period; and  


               

  b. At least 60 days apart; and  


               

  c. Less than the third percentile on the appropriate weight-for-length table under  105.08B2 .  


       
           
               


              Back to Top


code: 106.09
title:
  Congenital
  Complications of chronic kidney disease

source_url: https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm
summary:
  106.09 Complications of chronic kidney disease 
      (see  106.00C5 ) requiring at least three hospitalizations within a consecutive 12-month period and occurring at least 30 days apart. Each hospitalization must last at least 48 hours, incl…

raw_text:
  106.09 Complications of chronic kidney disease 
      (see  106.00C5 ) requiring at least three hospitalizations within a consecutive 12-month period and occurring at least 30 days apart. Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization. 


       
           
               


              Back to Top
           
       
   



    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 108.07
title: Genetic photosensitivity disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm
summary:
  108.07  Genetic photosensitivity disorders,  
                               established as described in  108.00E . The requirements of this listing are met if either paragraph A or paragraph B is satisfied.…

raw_text:
  108.07  Genetic photosensitivity disorders,  
                               established as described in  108.00E . The requirements of this listing are met if either paragraph A or paragraph B is satisfied.
                           


                           


                               
                               A.  Xeroderma pigmentosum (see  108.00E1 ).
                           


                           

  OR 


                           


                               B.  Other genetic photosensitivity disorders (see  108.00E2 ) with either 1 or 2:
                           


                           


                               
                              1. Chronic skin lesions (see  108.00B2 ) or contractures 
                              (see  108.00B3 ) that cause an inability to function outside of a highly protective environment 
                              (see  108.00E4 ); or
                           


                           


                               
                              2. Chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ) causing chronic pain or other physical limitation(s) that result in impairment-related functional limitations 
                              (see  108.00D2 ), as evidenced by:
                           


                           


                               
                              a. Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements 
                              (see  108.00B5 ) due to chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ); or
                           


                           


                               
                              b. Inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements 
                              (see  108.00B5 ) due to chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ), and a documented medical need 
                              (see  108.00B4 ) for an assistive device 
                              (see  108.00B1 ) that requires the use of the other upper extremity; or
                           


                           


                               
                              c. Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain, 
                              and complete age-appropriate activities due to chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ) affecting at least two extremities 
                              (including when the limitations are due to involvement of the perineum or the inguinal region); or
                           


                           


                               
                              d. Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain, and complete age-appropriate activities due to chronic skin lesions 
                              (see  108.00B2 ) or contractures (see  108.00B3 ) 
                              affecting both lower extremities (including when the limitations are due to involvement of the perineum or the inguinal region).


code: 108.08
title: Burns
source_url: https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm
summary:
  108.08  Burns  
                              (see  108.00F ). 
                              Burns that do not require continuing surgical management (see  108.00B6 ), 
                              or that have been documented by an acceptable…

raw_text:
  108.08  Burns  
                              (see  108.00F ). 
                              Burns that do not require continuing surgical management (see  108.00B6 ), 
                              or that have been documented by an acceptable medical source to have reached maximum therapeutic benefit and are no longer receiving surgical management, 
                              resulting in chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ) causing chronic pain 
                              or other physical limitation(s) that result in impairment-related functional limitations (see  108.00D2 ), as evidenced by:
                           


                           


                               
                               A.  
                              Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements 
                              (see  108.00B5 ) due to chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ).
                           


                           

  OR 


                           


                               B.  
                              Inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements 
                              (see  108.00B5 ) due to chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ), and a documented medical need 
                              (see  108.00B4 ) for an assistive device (see  108.00B1 ) 
                              that requires the use of the other upper extremity.
                           


                           

  OR 


                           


                               C.  
                              Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain, 
                              and complete age-appropriate activities due to chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ) affecting at least two extremities 
                              (including when the limitations are due to involvement of the perineum or the inguinal region).
                           


                           

  OR 


                           


                               D.  
                              Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain, 
                              and complete age-appropriate activities due to chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ) affecting both lower extremities 
                              (including when the limitations are due to involvement of the perineum or the inguinal region).


code: 108.09
title: Chronic conditions of the skin or mucous membranes
source_url: https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm
summary:
  108.09   Chronic conditions of the skin or mucous membranes 
                              (see  108.00G ) resulting in:
                           


                           


                               
                               A.…

raw_text:
  108.09   Chronic conditions of the skin or mucous membranes 
                              (see  108.00G ) resulting in:
                           


                           


                               
                               A.  
                              Chronic skin lesions (see  108.00B2 ) or contractures (see  108.00B3 ) 
                              causing chronic pain or other physical limitation(s) that persist despite adherence to prescribed medical treatment for 3 months 
                              (see  108.00D5b ).
                           


                           

  AND 


                           


                               B.  Impairment-related functional limitations (see  108.00D2 ) demonstrated by 1, 2, 3, or 4:
                           


                           


                               
                              1. Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements 
                              (see  108.00B5 ) due to chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ); or
                           


                           


                               
                              2. Inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements 
                              (see  108.00B5 ) due to chronic skin lesions (see  108.00B2 ) 
                              or contractures (see  108.00B3 ), and a documented medical need 
                              (see  108.00B4 ) for an assistive device (see  108.00B1 ) that requires the use of the other upper extremity; or
                           


                           


                               
                              3. Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain, and complete age-appropriate activities due to chronic skin lesions 
                              (see  108.00B2 ) or contractures (see  108.00B3 ) affecting at least two extremities 
                              (including when the limitations are due to involvement of the perineum or the inguinal region); or
                           


                           


                               
                              4. Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain, and complete age-appropriate activities due to chronic skin lesions 
                              (see  108.00B2 ) or contractures (see  108.00B3 ) affecting both lower extremities 
                              (including when the limitations are due to involvement of the perineum or the inguinal region).
                           



                           


                               
                                   
                                       


                                      Back to Top
                                   
                               
                           



                       
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 109.08
title: Any type of diabetes mellitus in a child who requires daily insulin and has not attained age 6
source_url: https://www.ssa.gov/disability/professionals/bluebook/109.00-Endocrine-Childhood.htm
summary:
  109.08  Any type of diabetes mellitus in a child who requires daily insulin and has not attained age 6. 
               
              Consider under a disability until the attainment  of age 6.  Thereafter,
              evaluate the diabetes m…

raw_text:
  109.08  Any type of diabetes mellitus in a child who requires daily insulin and has not attained age 6. 
               
              Consider under a disability until the attainment  of age 6.  Thereafter,
              evaluate the diabetes mellitus according to the rules in  109.00B5  and  C .
           


           

    



           


               
                   
                       


                      Back to Top
                   
               
           


          
    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 110.01
title: Category of Impairments, Congenital Disorders That Affect Multiple Body Systems
source_url: https://www.ssa.gov/disability/professionals/bluebook/110.00-MultipleBody-Childhood.htm
summary:
  110.01  Category of Impairments, Congenital Disorders That Affect Multiple Body Systems 


      

  Back to Top

raw_text:
  110.01  Category of Impairments, Congenital Disorders That Affect Multiple Body Systems 


      

  Back to Top


code: 110.06
title: Non-mosaic Down syndrome (chromosome 21 trisomy or chromosome 21 translocation)
source_url: https://www.ssa.gov/disability/professionals/bluebook/110.00-MultipleBody-Childhood.htm
summary:
  110.06   Non-mosaic Down syndrome  (chromosome 21 trisomy or chromosome 21 translocation), documented by: 


      

  A. A laboratory report of karyotype analysis signed by a physician, 
      or both a laboratory report of karyotype analysis n…

raw_text:
  110.06   Non-mosaic Down syndrome  (chromosome 21 trisomy or chromosome 21 translocation), documented by: 


      

  A. A laboratory report of karyotype analysis signed by a physician, 
      or both a laboratory report of karyotype analysis not signed by a physician  and  a statement by a physician that the child has Down syndrome 
      (see  110.00C1 ). 


      

  OR 


      

  B. A physician’s report stating that the child has chromosome 21 trisomy or chromosome 21 translocation consistent with karyotype analysis 
      with the distinctive facial or other physical features of Down syndrome 
      (see  110.00C2a ).  


      

  OR 


      

  C. A physician’s report stating that the child has Down syndrome with the distinctive facial or other physical features  and  
      evidence demonstrating that the  child is functioning at the level of a child with non-mosaic Down syndrome 
      (see  110.00C2b ). 


      

  Back to Top


code: 110.08
title: A catastrophic congenital disorder
source_url: https://www.ssa.gov/disability/professionals/bluebook/110.00-MultipleBody-Childhood.htm
summary:
  110.08    A catastrophic congenital disorder  
      (see  110.00D  and  110.00E ) with: 


               

  A. Death usually expected within the first months of life. 


               

  OR 


               

  B. Very serious interference with de…

raw_text:
  110.08    A catastrophic congenital disorder  
      (see  110.00D  and  110.00E ) with: 


               

  A. Death usually expected within the first months of life. 


               

  OR 


               

  B. Very serious interference with development or functioning. 


               

  Back to Top   


              
    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 111.02
title: Epilepsy
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.02  Epilepsy ,  documented by a detailed description of a typical seizure and characterized by  A or B: 


             

  A. Generalized tonic-clonic seizures (see  111.00F1a ),
      occurring at least once a month for at least 3 consecuti…

raw_text:
  111.02  Epilepsy ,  documented by a detailed description of a typical seizure and characterized by  A or B: 


             

  A. Generalized tonic-clonic seizures (see  111.00F1a ),
      occurring at least once a month for at least 3 consecutive months
      (see  111.00F4 ) despite adherence to prescribed treatment
      (see  111.00C ).
   


             

  OR 


             

  B.  Dyscognitive seizures (see  111.00F1b )
      or absence seizures (see  111.00F1c ),
      occurring at least once a week for at least 3 consecutive months (see  111.00F4 )
      despite adherence to prescribed treatment (see  111.00C ).


code: 111.04
title: Vascular insult to the brain
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.04  Vascular insult to the brain , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 ) in the ability to stand up from a seated position,…

raw_text:
  111.04  Vascular insult to the brain , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 ) in the ability to stand up from a seated position,
      balance while standing or walking, or use the upper extremities, persisting for at least 3 consecutive months after the insult.


code: 111.05
title: Benign brain tumors
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.05   Benign brain tumors , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 ) in the ability to stand up from a seated position,
      balan…

raw_text:
  111.05   Benign brain tumors , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 ) in the ability to stand up from a seated position,
      balance while standing or walking, or use the upper extremities.


code: 111.07
title: Cerebral Palsy
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.07
                 Cerebral palsy , characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 )
      in the ability to stand up from a seated position, ba…

raw_text:
  111.07
                 Cerebral palsy , characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 )
      in the ability to stand up from a seated position, balance while  standing or walking, or use the upper extremities.


code: 111.08
title: Spinal cord disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.08
                 Spinal cord disorders , characterized by A or B:
             


             

    A. Complete loss of function, 
      as described in  111.00J2 ,
      persisting for 3 consecutive months after the disorder (see  111.00J4 ).…

raw_text:
  111.08
                 Spinal cord disorders , characterized by A or B:
             


             

    A. Complete loss of function, 
      as described in  111.00J2 ,
      persisting for 3 consecutive months after the disorder (see  111.00J4 ).
   


             

  OR 


             

    B. Disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 ) in the ability to stand up from a seated position,
      balance while standing or walking,
      or use the upper extremities persisting for 3 consecutive months after the disorder (see  111.00J4 ).


code: 111.09
title: Communication impairment
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.09
                 Communication  impairment , associated with documented neurological disorder and  one of the following:
             


             

  A. Documented speech deficit that significantly affects 
      (see  111.00K1 ) the clari…

raw_text:
  111.09
                 Communication  impairment , associated with documented neurological disorder and  one of the following:
             


             

  A. Documented speech deficit that significantly affects 
      (see  111.00K1 ) the clarity and content of the speech. 


             

  OR  


             

  B. Documented comprehension deficit resulting in ineffective verbal communication 
      (see  111.00K2 ) for age. 


             

  OR  


             

  C. Impairment of hearing as described under the criteria in 
                102.10  
              or  102.11 .


code: 111.12
title: Myasthenia gravis
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.12  Myasthenia  gravis , characterized by A or B despite adherence to prescribed treatment for at least 3 months 
              (see  111.00C ):  


             

  A. Disorganization of motor function in two extremities (see  111.00D1 ),…

raw_text:
  111.12  Myasthenia  gravis , characterized by A or B despite adherence to prescribed treatment for at least 3 months 
              (see  111.00C ):  


             

  A. Disorganization of motor function in two extremities (see  111.00D1 ),
                  resulting in an extreme limitation (see  111.00D2 ) in the ability to stand up from a seated position,
                  balance while standing or walking, or use the upper extremities.
               


             

  OR 


             

  B. Bulbar and neuromuscular dysfunction (see  111.00E ), resulting in: 


             


                 

  One myasthenic crisis requiring mechanical ventilation; or 


                 

  Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter.


code: 111.13
title: Muscular dystrophy
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.13  Muscular dystrophy , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2) in the ability to stand up from a seated position, balance whil…

raw_text:
  111.13  Muscular dystrophy , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2) in the ability to stand up from a seated position, balance while  standing or walking, or use the upper extremities.


code: 111.14
title: Peripheral neuropathy
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.14  Peripheral neuropathy , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 )
      in the ability to stand up from a seated position, bala…

raw_text:
  111.14  Peripheral neuropathy , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 )
      in the ability to stand up from a seated position, balance while standing or  walking, or use the upper extremities.


code: 111.17
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
title:
  Neurodegenerative disorders of the central nervous system, such as Juvenile-onset Huntington's disease and Friedreich's ataxia

summary:
  111.17  Neurodegenerative disorders of the central nervous system, 
                such as Juvenile-onset Huntington's disease and Friedreich's ataxia ,  
      characterized by disorganization of motor function in two extremities (see  111.00…

raw_text:
  111.17  Neurodegenerative disorders of the central nervous system, 
                such as Juvenile-onset Huntington's disease and Friedreich's ataxia ,  
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 )
      in the ability to stand up from a seated position, balance while standing or walking, or use the  upper extremities.


code: 111.18
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
title:
  Traumatic brain injury, characterized by disorganization of motor function in two extremities (see 111.00D1)

summary:
  111.18  Traumatic brain injury , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 ) in the ability to stand up from a seated position,
      bal…

raw_text:
  111.18  Traumatic brain injury , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 ) in the ability to stand up from a seated position,
      balance while standing or walking, or use the upper extremities, persisting for at least 3 consecutive months after the injury.


code: 111.21
title: Multiple sclerosis
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.21  Multiple sclerosis , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 )
      in the ability to stand up from a seated position, balance…

raw_text:
  111.21  Multiple sclerosis , 
      characterized by disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 )
      in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities.


code: 111.22
title: Motor neuron disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.22  Motor neuron disorders ,  characterized by A or B: 


             

  A. Disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 )
      in the ability to stand up from…

raw_text:
  111.22  Motor neuron disorders ,  characterized by A or B: 


             

  A. Disorganization of motor function in two extremities (see  111.00D1 ),
      resulting in an extreme limitation (see  111.00D2 )
      in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities.
   


             

  OR 


             

  B. Bulbar and neuromuscular dysfunction (see  111.00E ), resulting in: 


             


                 

  Acute respiratory failure requiring invasive mechanical ventilation; or 


                 

  Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter. 


             


            
    
   
    



   

   



       


     
     
     <footer class="fs1 print-dn" id="footer" role="contentinfo"><div class="wrapper"><a class="db" href="/menu#footer">Footer menu</a></div></footer>


code: 111.00
title: 111.00
source_url: https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm
summary:
  111.00 Neurological 


     
         

    


         

  A.  Which neurological disorders do  we evaluate under these listings ?  


          

  We evaluate epilepsy, coma or persistent vegetative state (PVS), and neurological disorders that cause d…

raw_text:
  111.00 Neurological 


     
         

    


         

  A.  Which neurological disorders do  we evaluate under these listings ?  


          

  We evaluate epilepsy, coma or persistent vegetative state (PVS), and neurological disorders that cause disorganization of motor function, bulbar and neuromuscular dysfunction, 
          or communication impairment. Under this body system, we evaluate the limitations resulting from the impact of the neurological disease process itself. 
          If you have a neurological disorder(s) that affects your physical and mental functioning, we will evaluate your impairments under the rules we use to determine functional equivalence. 
          If your neurological disorder results in only mental impairment or  if you have a co-occurring mental condition that is not caused by your neurological disorder 
          (for example, Autism spectrum disorder), we will evaluate  your mental impairment under the mental disorders body system, 
           112.00 . 


             

  B.  What evidence do we need to document your neurological disorder ? 


             


                 

  We need both medical and non-medical evidence (signs, symptoms,  and laboratory findings) to assess the effects of your neurological disorder.  Medical evidence should include your medical history, examination findings,  relevant laboratory tests, and the results of imaging. Imaging refers to  medical imaging techniques, such as x-ray, computerized tomography (CT),  magnetic resonance imaging (MRI), and electroencephalography (EEG). The imaging  must be consistent with the prevailing state of medical knowledge and clinical  practice as the proper technique to support the evaluation of the disorder. In  addition, the medical evidence may include descriptions of any prescribed  treatment and your response to it. We consider non-medical evidence such as  statements you or others make about your impairments, your restrictions, your  daily activities, or, if you are an adolescent, your efforts to work.  


                 


                     We will make every  reasonable effort to obtain the results of your laboratory and imaging  evidence. When the results of any of these tests are part of the existing  evidence in your case record, we will evaluate the test results and all other  relevant evidence. We will not purchase imaging, or other diagnostic tests or  laboratory tests that are complex, may involve  significant risk, or that are invasive. We will not routinely purchase  tests that are expensive or not readily available.
                 


             


             

  C.  How do we consider adherence to prescribed treatment in neurological disorders ? 
              In  111.02  (Epilepsy) and  111.12  (Myasthenia gravis),
      we require that limitations from these neurological disorders exist despite adherence to prescribed treatment.
      “Despite adherence to prescribed treatment” means that you have taken medication(s) or followed other treatment procedures for your neurological disorder(s)
      as prescribed by a physician for three consecutive months but your impairment continues to meet the other listing requirements despite this treatment.
      You may receive your treatment at a health care facility that you visit regularly, even if you do not see the same physician on each visit.
   


             

  D.  What do we mean by disorganization of motor function ?   


             


                 


                     Disorganization of motor function means interference, due to your neurological disorder, with movement of two extremities; 
                    i.e., the lower extremities, or upper extremities (including fingers, wrists, hands, arms, and shoulders). By two extremities we mean both lower extremities, 
                    or both upper extremities, or one upper extremity and one lower extremity. 
                    All listings in this body system, except for  111.02  (Epilepsy) 
                    and  111.20  (Coma and persistent vegetative state), 
                    include criteria for disorganization of motor function that results in an extreme limitation in your ability to:
   


                 


                     

  Stand up from a seated position; or 


                     


                         

  Balance while standing or walking; or  


                     


                     


                         

  Use the upper extremities (e.g., fingers, wrists, hands, arms, and shoulders).  


                     


                 


                 


                     Extreme limitation means the inability to stand up from a seated position, maintain balance in a standing  position and while walking, or use your upper extremities to independently  initiate, sustain, and complete age-appropriate activities. The assessment of  motor function depends on the degree of interference with standing up;  balancing while standing or walking; or using the upper extremities (including  fingers, hands, arms, and shoulders).
                 


                 


                     


                         Inability to stand up from a seated position means that once seated you are unable to stand and maintain an upright  position without the assistance of another person or the use of an assistive  device, such as a walker, two crutches, or two canes.
                     


                     


                         Inability to maintain balance in a standing position means that you are unable to maintain an upright position  while standing or walking without the assistance of another person or an  assistive device, such as a walker, two crutches, or two canes.
                     


                     


                         Inability to use your upper extremities means that you have a loss of function of both upper extremities  (e.g., fingers, wrists, hands, arms, and shoulders) that very seriously limits  your ability to independently initiate, sustain, and complete age- appropriate  activities involving fine and gross motor movements. Inability to perform fine  and gross motor movements could include not being able to pinch, manipulate,  and use your fingers; or not being able to use your hands, arms, and shoulders  to perform gross motor movements, such as handling, gripping, grasping,  holding, turning, and reaching; or not being able to engage in exertional  movements such a lifting, carrying, pushing, and pulling.
                     


                 


                 


                     For children who are not yet able to balance, stand up, or walk independently, we consider their function based  on assessments of limitations in the ability to perform comparable  age-appropriate activities with the lower and upper extremities, given normal  developmental milestones. For such children, an extreme level of limitation  means developmental milestones at less than one-half of the child's  chronological age.
                 


             


             

    E.  What do we mean by bulbar and neuromuscular dysfunction ? 
      The bulbar region of the brain is responsible for controlling the bulbar muscles in  the throat, tongue, jaw, and face. 
      Bulbar and neuromuscular dysfunction refers to weakness in these muscles, resulting in breathing, swallowing, and speaking impairments. 
      Listings  111.12  (Myasthenia gravis) and  111.22  (Motor neuron  disorders) 
      include criteria for evaluating bulbar and neuromuscular dysfunction.  If your neurological disorder has resulted in a breathing disorder, we may evaluate that condition under the respiratory system, 
       103.00 . 


             

    F.  What is epilepsy, and how do we evaluate it under  111.02 ? 


             


                 


                     Epilepsy is a pattern of recurrent and unprovoked seizures that are manifestations of abnormal electrical activity in the brain. 
                    There are various types of generalized and “focal” or partial seizures. In children, the most common potentially disabling seizure types are generalized tonic-clonic seizures, 
                    dyscognitive seizures (formerly complex partial  seizures), and absence seizures. 
                    However, psychogenic nonepileptic seizures and  pseudoseizures are not epileptic seizures for the purpose of


code: 112.02
title: Neurocognitive disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.02 Neurocognitive disorders (see  112.00B1 ),
      for children age 3 to attainment of age 18, satisfied by A and B, or A and C:
   


       


           


              Medical  documentation of a clinically significant deviation in normal c…

raw_text:
  112.02 Neurocognitive disorders (see  112.00B1 ),
      for children age 3 to attainment of age 18, satisfied by A and B, or A and C:
   


       


           


              Medical  documentation of a clinically significant deviation in normal cognitive  development or by significant cognitive decline from a prior level of  functioning in  one  or more of the cognitive areas:
               


                   

  Complex attention;  


                   

  Executive function; 


                   

  Learning and memory; 


                   

  Language; 


                   

  Perceptual-motor; or 


                   

  Social cognition. 


               


           


       


       

  AND 


       


           


              Extreme limitation  of one, or marked limitation of two, of the following areas of mental  functioning (see  112.00F ):
               


                   

  Understand,  remember, or apply information (see  112.00E1 ). 


                   

  Interact with others (see  112.00E2 ).  


                   

  Concentrate, persist, or maintain pace (see  112.00E3 ). 


                   

  Adapt or manage oneself (see  112.00E4 ). 


               


           


       


       

  OR 


       


           


              Your mental disorder in this listing category is “serious and persistent;” that is, you have a  medically documented history of the existence of the disorder over a period of  at least 2 years, and there is evidence of both:
               


                   


                       Medical treatment, mental health therapy, psychosocial support(s),
                      or a highly structured  setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder
                      (see  112.00G2b );  and 
                   


                   


                       Marginal adjustment, that is,
                      you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life
                      (see  112.00G2c ).


code: 112.03
title: Schizophrenia spectrum and other psychotic disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.03 Schizophrenia spectrum and other psychotic disorders (see  112.00B2 ),
      for children age 3 to attainment of age 18, satisfied by A and B, or A and C:
   


       


           


              Medical  documentation of  one  or more of t…

raw_text:
  112.03 Schizophrenia spectrum and other psychotic disorders (see  112.00B2 ),
      for children age 3 to attainment of age 18, satisfied by A and B, or A and C:
   


       


           


              Medical  documentation of  one  or more of the following:
               


                   

  Delusions or hallucinations; 


                   

  Disorganized thinking (speech); or 


                   

  Grossly disorganized  behavior or catatonia. 


               


           


       


       

  AND 


       


           


               
              Extreme limitation  of one, or marked limitation of two, of the following areas of mental functioning (see  112.00F ):
               


                   

  Understand, remember, or apply information (see  112.00E1 ). 


                   

  Interact with others (see  112.00E2 ).  


                   

  Concentrate, persist, or maintain pace (see  112.00E3 ). 


                   

  Adapt or manage oneself (see  112.00E4 ). 


               


           


       


       

  OR 


       


           


              Your mental disorder  in this listing category is “serious and persistent;” that is,
              you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both:
               


                   


                       Medical treatment, mental health therapy, psychosocial support(s),
                      or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder
                      (see  112.00G2b );  and 
                   


                   


                       Marginal adjustment, that is,
                      you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life
                      (see  112.00G2c ).


code: 112.04
title: Depressive, bipolar and related disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.04 Depressive, bipolar and related disorders (see  112.00B3 ),
      for children age 3 to attainment of age 18, satisfied by A and B, or A and C:
   


       


           


              Medical documentation of the requirements of paragraph…

raw_text:
  112.04 Depressive, bipolar and related disorders (see  112.00B3 ),
      for children age 3 to attainment of age 18, satisfied by A and B, or A and C:
   


       


           


              Medical documentation of the requirements of paragraph 1, 2, or 3:
               


                   


                      Depressive disorder,  characterized by  five  or more of the following:
                       


                           

  Depressed or irritable mood; 


                           

  Diminished interest  in almost all activities; 


                           

  Appetite disturbance  with change in weight (or a failure to achieve an expected weight gain); 


                           

  Sleep disturbance; 


                           

  Observable psychomotor agitation or retardation;  


                           

  Decreased energy; 


                           

  Feelings of guilt or  worthlessness; 


                           

  Difficulty concentrating or thinking; or 


                           

  Thoughts of death or  suicide. 


                       


                   


                   


                      Bipolar disorder,  characterized by  three  or more of the following:
                       


                           

  Pressured speech; 


                           

  Flight of ideas; 


                           

  Inflated  self-esteem; 


                           

  Decreased need for  sleep; 


                           

  Distractibility; 


                           

  Involvement in  activities that have a high probability of painful consequences that are not  recognized; or 


                           

  Increase in goal-directed activity or psychomotor agitation. 


                       


                   


                   


                      Disruptive mood dysregulation disorder, beginning prior to age 10, and  all  of the following:
                       


                           

  Persistent, significant irritability or anger; 


                           

  Frequent, developmentally inconsistent temper outbursts; and 


                           

  Frequent aggressive or destructive behavior. 


                       


                   


               


           


       


       

  AND 


       


           


               
              Extreme limitation  of one, or marked limitation of two,
              of the following areas of mental functioning (see  112.00F ):
               


                   

  Understand, remember, or apply information (see  112.00E1 ). 


                   

  Interact with others (see  112.00E2 ).  


                   

  Concentrate, persist, or maintain pace (see  112.00E3 ). 


                   

  Adapt or manage oneself (see  112.00E4 ). 


               


           


       


       

  OR 


       


           


              Your mental disorder in this listing category is “serious and persistent;” that is,
              you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both:
               


                   


                       Medical treatment, mental health therapy, psychosocial support(s),
                      or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder
                      (see  112.00G2b );  and 
                   


                   


                       Marginal adjustment, that is,
                      you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life
                      (see  112.00G2c ).


code: 112.05
title: Intellectual disorder
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.05 Intellectual disorder (see  112.00B4 ),
      for children age 3 to attainment of age 18, satisfied by A or B:
   


       


           


               
              Satisfied by 1 and 2 (see  112.00H ):
               


                   

  S…

raw_text:
  112.05 Intellectual disorder (see  112.00B4 ),
      for children age 3 to attainment of age 18, satisfied by A or B:
   


       


           


               
              Satisfied by 1 and 2 (see  112.00H ):
               


                   

  Significantly subaverage general intellectual functioning evident in your cognitive inability  to function at a level required to participate in standardized testing of  intellectual functioning; and 


                   

  Significant deficits in adaptive functioning currently manifested by your dependence upon others for  personal needs (for example, toileting, eating, dressing, or bathing) in excess  of age-appropriate dependence. 


               


           


       


       

  OR 


       


           


               
              Satisfied by 1 and 2 (see  112.00H ):
               


                   


                       
                      Significantly subaverage general intellectual functioning evidenced by a or b:
                       


                           

  A full scale (or comparable) IQ score of 70 or below on an individually administered standardized test of general intelligence; or 


                           

  A full scale (or comparable) IQ score of 71-75 accompanied by a verbal or performance IQ score (or comparable part score) of 70 or below on an individually administered  standardized test of general intelligence; and 


                       


                   


                   


                       
                      Significant deficits in adaptive functioning currently manifested by extreme limitation of one, or marked limitation of two, of the following areas of mental functioning:
                       


                           

  Understand, remember, or apply information (see  112.00E1 ); or 


                           

  Interact with others (see  112.00E2 ); or 


                           

  Concentrate, persist, or maintain pace (see  112.00E3 ); or 


                           

  Adapt or manage oneself (see  112.00E4 ).


code: 112.06
title: Anxiety and obsessive-compulsive disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.06 Anxiety and obsessive-compulsive disorders (see  112.00B5 ),
      for children age 3 to attainment of age 18, satisfied by A and B, or A and C:
   


       


           


              Medical documentation of the requirements of paragraph…

raw_text:
  112.06 Anxiety and obsessive-compulsive disorders (see  112.00B5 ),
      for children age 3 to attainment of age 18, satisfied by A and B, or A and C:
   


       


           


              Medical documentation of the requirements of paragraph 1, 2, 3, or 4:
               


                   


                      Anxiety disorder, characterized by  one  or more of the following:
                       


                           

  Restlessness; 


                           

  Easily fatigued; 


                           

  Difficulty  concentrating; 


                           

  Irritability; 


                           

  Muscle tension; or 


                           

  Sleep disturbance. 


                       


                   


                   


                      Panic disorder or  agoraphobia, characterized by  one  or both:
                       


                           

  Panic attacks followed by a persistent concern or worry about additional panic attacks or their consequences; or 


                           

  Disproportionate fear or anxiety about at least two different situations (for example, using public transportation, being in a crowd, being in a line, being outside of your  home, being in open spaces). 


                       


                   


                   


                      Obsessive-compulsive disorder, characterized by  one  or both:
                       


                           

  Involuntary,  time-consuming preoccupation with intrusive, unwanted thoughts; or; 


                           

  Repetitive behaviors  that appear aimed at reducing anxiety. 


                       


                   


                   

  Excessive fear or anxiety concerning separation from those to whom you are attached. 


               


           


       


       

  AND 


       


           


               
              Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see  112.00F ):
               


                   

  Understand, remember, or apply information (see  112.00E1 ). 


                   

  Interact with others (see  112.00E2 ). 


                   

  Concentrate, persist, or maintain pace (see  112.00E3 ). 


                   

  Adapt or manage oneself (see  112.00E4 ). 


               


           


       


       

  OR 


       


           


              Your mental disorder in this listing category is “serious and persistent;” that is,
              you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both:
               


                   


                       Medical treatment, mental health therapy, psychosocial support(s),
                      or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder
                      (see  112.00G2b );  and 
                   


                   


                       Marginal adjustment, that is,
                      you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life
                      (see  112.00G2c ).


code: 112.07
title: Somatic symptom and related disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.07 Somatic symptom and related disorders (see  112.00B6 ),
      for children age 3 to attainment of age 18, satisfied by A and B:
   


       


           


              Medical  documentation of  one  or both of the following:…

raw_text:
  112.07 Somatic symptom and related disorders (see  112.00B6 ),
      for children age 3 to attainment of age 18, satisfied by A and B:
   


       


           


              Medical  documentation of  one  or both of the following:
               


                   

  Symptoms of altered voluntary motor or sensory function that are not better explained by  another medical or mental disorder; or 


                   

  One or more somatic symptoms that are distressing, with excessive thoughts, feelings,  or behaviors related to the symptoms. 


               


           


       


       

  AND 


       


           


               
              Extreme limitation  of one, or marked limitation of two, of the following areas of mental functioning (see  112.00F ):
               


                   

  Understand, remember, or apply information (see  112.00E1 ). 


                   

  Interact with others (see  112.00E2 ). 


                   

  Concentrate, persist, or maintain pace (see  112.00E3 ). 


                   

  Adapt or manage oneself (see  112.00E4 ).


code: 112.08
title: Personality and impulse-control disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.08 Personality and impulse-control disorders (see  112.00B7 ),
          for children age 3 to attainment of age 18, satisfied by A and B:
         


       


           


              Medical documentation of a pervasive pattern of  one  or…

raw_text:
  112.08 Personality and impulse-control disorders (see  112.00B7 ),
          for children age 3 to attainment of age 18, satisfied by A and B:
         


       


           


              Medical documentation of a pervasive pattern of  one  or more of the following:
               


                   

  Distrust and suspiciousness of others; 


                   

  Detachment from social relationships; 


                   

  Disregard for and  violation of the rights of others; 


                   

  Instability of interpersonal relationships; 


                   

  Excessive emotionality and attention seeking; 


                   

  Feelings of inadequacy; 


                   

  Excessive need to be taken care of; 


                   

  Preoccupation with perfectionism and orderliness; or 


                   

  Recurrent, impulsive, aggressive behavioral outbursts. 


               


           


       


       

  AND 


       


           


               
              Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see  112.00F ):
               


                   

  Understand, remember, or apply information (see  112.00E1 ). 


                   

  Interact with others (see  112.00E2 ). 


                   

  Concentrate, persist, or maintain pace (see  112.00E3 ). 


                   

  Adapt or manage oneself (see  112.00E4 ).


code: 112.10
title: Autism spectrum disorder
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.10 Autism spectrum disorder (see  112.00B8 ), 
          for children age 3 to attainment of age 18), satisfied by A and B:   


       


           


              Medical documentation of  both  of the following:…

raw_text:
  112.10 Autism spectrum disorder (see  112.00B8 ), 
          for children age 3 to attainment of age 18), satisfied by A and B:   


       


           


              Medical documentation of  both  of the following:
               


                   

  Qualitative deficits  in verbal communication, nonverbal communication, and social interaction; and 


                   

  Significantly  restricted, repetitive patterns of behavior, interests, or activities. 


               


           


       


       

  AND 


       


           


              Extreme limitation  of one, or marked limitation of two, of the following areas of mental functioning (see  112.00F ):
               


                   

  Understand, remember, or apply information (see  112.00E1 ). 


                   

  Interact with others (see  112.00E2 ). 


                   

  Concentrate, persist, or maintain pace (see  112.00E3 ). 


                   

  Adapt or manage oneself (see  112.00E4 ).


code: 112.11
title: Neurodevelopmental disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.11 Neurodevelopmental disorders (see  112.00B9 ), 
          for children age 3 to attainment of age 18, satisfied by A and B: 


       


           


              Medical documentation of the requirements of paragraph 1, 2, or 3:…

raw_text:
  112.11 Neurodevelopmental disorders (see  112.00B9 ), 
          for children age 3 to attainment of age 18, satisfied by A and B: 


       


           


              Medical documentation of the requirements of paragraph 1, 2, or 3:
               


                   


                       One  or both of the following:
                       


                           

  Frequent distractibility, difficulty sustaining attention, and difficulty organizing  tasks; or 


                           

  Hyperactive and  impulsive behavior (for example, difficulty remaining seated, talking  excessively, difficulty waiting, appearing restless, or behaving as if being  “driven by a motor”). 


                       


                   


                   

  Significant difficulties  learning and using academic skills; or 


                   

  Recurrent motor  movement or vocalization. 


               


           


       


       

  AND 


       


           


               
              Extreme limitation  of one, or marked limitation of two, of the following areas of mental functioning (see  112.00F ):
               


                   

  Understand, remember, or apply information (see  112.00E1 ). 


                   

  Interact with others (see  112.00E2 ). 


                   

  Concentrate, persist, or maintain pace (see  112.00E3 ). 


                   

  Adapt or manage  oneself (see  112.00E4 ).


code: 112.13
title: Eating disorders
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.13 Eating disorders (see  112.00B10 ),
      for children age 3 to  attainment of age 18, satisfied by A and B:
   


       


           

  Medical documentation of a persistent alteration in eating or eating-related  behavior that results in…

raw_text:
  112.13 Eating disorders (see  112.00B10 ),
      for children age 3 to  attainment of age 18, satisfied by A and B:
   


       


           

  Medical documentation of a persistent alteration in eating or eating-related  behavior that results in a change in consumption or absorption of food and that significantly impairs physical or psychological health. 


       


       

  AND 


       


           


               
              Extreme limitation  of one, or marked limitation of two, of the following areas of mental  functioning (see  112.00F ):
               


                   

  Understand, remember, or apply information (see  112.00E1 ). 


                   

  Interact with others (see  112.00E2 ). 


                   

  Concentrate, persist, or maintain pace (see  112.00E3 ). 


                   

  Adapt or manage oneself (see  112.00E4 ).


code: 112.14
title: Developmental disorders in infants and toddlers
source_url: https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm
summary:
  112.14 Developmental disorders in infants and toddlers
      (see  112.00B11 ,  112.00I ),
      satisfied by A and B:
   


       


           


              Medical documentation of  one  or both of the following:…

raw_text:
  112.14 Developmental disorders in infants and toddlers
      (see  112.00B11 ,  112.00I ),
      satisfied by A and B:
   


       


           


              Medical documentation of  one  or both of the following:
               


                   

  A delay or deficit in the development of age-appropriate skills; or 


                   

  A loss of previously acquired skills. 


               


           


       


       

  AND 


       


           


               
              Extreme limitation  of one, or marked limitation of two, of the following developmental abilities  (see  112.00F ):
               


                   

  Plan and control  motor movement (see  112.00I4b(i) ). 


                   

  Learn and remember  (see  112.00I4b(ii) ). 


                   

  Interact with others  (see  112.00I4b(iii) ). 


                   

  Regulate  physiological functions, attention, emotion, and behavior (see  112.00I4b(iv) ).


